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Abstract 
 
The accumulation of DNA damage has long been thought to contribute to both 
cellular and organismal ageing. The catabolic degradation process autophagy has 
also been implicated in the ageing process, as an age-dependent functional decline 
has been reported in many organisms. Moreover, interventions known to delay 
ageing such as dietary restriction and rapamycin treatment have been shown to 
require active autophagy. Recent studies have suggested a role for autophagy in the 
DNA damage response as well as DNA damage repair; however the mechanisms 
are still poorly understood. In this thesis we set out to understand how autophagy 
can influence DNA repair. We will also investigate how cross-talk between these 
processes is relevant to the ageing process. Firstly, we show that cells lacking 
autophagy have an impaired DNA damage repair kinetic, as measured by the 
resolution of DNA damage foci (DDF). Importantly, these differences were shown to 
be dependent on the intracellular levels of autophagy adaptor protein p62. It was 
recently shown that p62 shuttles rapidly between cytoplasmic and nuclear 
compartments. However, the role of p62 in the nucleus is still relatively unknown. 
Mechanistically, we show that both the PB1 and UBA domain of p62 are required for 
its effect on DNA damage repair. Furthermore we show p62 is recruited to DDF in 
response to DNA damage induction. Next, we show p62 interacts with the 
cytoskeletal protein FLNA and DNA damage protein RAD15 within the nucleus 
facilitating their proteasomal degradation. Both FLNA and RAD51 have previously 
been suggested to influence DNA repair via the homologous recombination pathway. 
Cells lacking p62 have higher nuclear levels of RAD51 and FLNA. Importantly these 
high levels correspond with an increased formation and resolution of RAD51 foci 
following induction of DNA damage, suggestive of an increase in DNA repair via the 
homologous recombination pathway. Finally, we observed an increase in co-
localisation of p62 with the marker of DDF H2A.X in mouse liver during ageing. 
Additionally, we found that life-long dietary restriction, an intervention known to 
extend lifespan in mice, prevented the age-dependent increase in frequencies of 
p62-H2A.X foci. We propose that p62 plays a novel and important role in DNA 
damage repair and hypothesise that declining autophagy or dysregulation of p62 can 
contribute to organismal ageing.
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1. Chapter 1. Introduction 
1. 1.1 DNA Damage Response (DDR) 
 
DNA damage repair is essential for the safeguarding of genomic integrity. The 
importance of understanding these processes was acknowledged this year by the 
award of the Nobel Prize in chemistry to Tomas Lindahl, Paul Modrich and Aziz 
Sancar for their study of DNA damage repair at the molecular level. 
DNA can be damaged by a number of extrinsic damaging agents such as; 
ultra-violet radiation (UV), Ionizing radiation (IR) and chemical compounds as well as 
intrinsic sources of damage such as mistakes in replication and oxidative damage 
that occurs due to free radicals generated as part of normal metabolism. It is 
estimated that on average a cell experiences 19200 DNA lesions per day (Saul and 
Ames, 1986). In order to maintain genomic integrity cells must possess effective 
mechanisms for detecting and repairing this DNA damage.  
Single stranded DNA (ssDNA), as well as double strand breaks (DSBs) are 
potent activators of the DDR. Specialised sensing complexes recognize this 
damage. The Mre11 complex (MRN) made from Mre11/Rad50/Nbs1 in mammals 
senses and processes DSBs and ataxia-telangiectasia and Rad3 related (ATR), ATR 
interacting protein (ATRIP), Replication protein A (RPA), Rad9/Rad1/Hus1, 
Rad17/RSR are all involved in sensing single stranded DNA. These sensors, in turn, 
recruit large Phosphoinositide Kinase-Related Kinases (PIKKs) ATR and ataxia-
telangiectasia (ATM) to the site of damage (Shiloh, 2006). Recruitment of these 
kinases causes the local phosphorylation of histone H2A.X (Figure 1-1).  
At DSBs the ATM mediated phosphorylation of Histone 2AX (H2A.X) to 
Phosphorylated H2A.X (H2A.X) then sets up a positive feedback loop, which 
recruits more ATM to the DNA damage lesion. This recruitment of yet more ATM 
causes H2A.X to spread along the chromatin 1-2Mb from the site of the lesion 
(Bewersdorf et al., 2006). The recruitment of ATM to H2A.X is facilitated by DDR 
mediators; mediator of DNA-Damage checkpoint 1 (MDC1) and p53 binding protein1 
(53BP1) (Wang et al., 2002). The establishment of this feedback loop and the 
spreading of H2A.X acts to amplify the signal and aids in the recruitment of ATM 
and other DDR proteins (Figure 1-1).  
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At SSBs single stranded DNA is bound by replication protein A (RPA) which 
signals the recruitment of ATR (Cortez et al., 2001). ATR activity is further boosted 
by the heterotrimeric 9–1–1 complex (RAD9, RAD1 and HUS1) and topoisomerase-
II-binding protein 1 (TOPBP1) (Weiss et al., 2002, Kumagai et al., 2006). 
Downstream of TOPBP, Claspin leads to activation of Chk1 (Liu et al., 2006).  
Activation of ATM/ATR above a certain threshold is required to activate 
checkpoint kinase 2 (CHK2) (Buscemi et al., 2004). CHK2, once activated, can freely 
diffuse through the nucleoplasm and phosphorylate further DDR protein substrates 
(Lukas et al., 2003). Similarly to CHK2, checkpoint kinase 1 (CHK1) is also 
phosphorylated by ATM and ATR and diffuses through the nucleus also spreading 
DDR signalling (Bekker-Jensen et al., 2006).Therefore DSBs favour activation of 
ATM/Chk2 and SSBs favour activation of ATR/Chk1. However, the processing of 
DSBs during S or G2 phases of the cell cycle can result in the generation of ssDNA 
and ATR activation (Jazayeri et al., 2006). 
Ultimately activation of the DDR leads to the enforcement of cell-cycle 
checkpoints through multiple signalling pathways such as p53 and cell division cycle 
25 (CDC25) phosphatase. DNA damage induces an inactivation of CDC25 that 
causes rapid cell-cycle arrest as activity of these phosphatases are required for cell 
division (Mailand et al., 2000). p53 is induced more slowly following activation of a 
DDR and leads to an increase in transcription of the cyclin dependent kinase 
inhibitor p21. Increased expression of p21 leads to a stable cell cycle arrest (Deng et 
al., 1995).  
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Figure 1-1: Schematic representation of the DDR. DSBs are sensed by the 
MRE11 RAD50-NBS1 (MRN) complex, this leads to the recruitment of the apical 
protein kinase ATM. ATM is phosphorylated and then goes on to phosphorylate 
H2A.X to H2A.X at the site of damage. H2A.X is recognised by MDC1 which leads 
to further recruitment of the MRN complex and amplification of ATM phosphorylation. 
This amplification step leads to the spreading of H2A.X many base pairs from the 
site of damage. This causes an increase in the number of DDR factors such as 
53BP1 at the site of damage which orchestrate repair. Exposure of single-stranded 
DNA leads to recruitment of RPA. Following this, ATR and its binding partner ATRIP 
are recruited and ATR activity can be increased by additional ATR targets, such as 
the RAD9–HUS1–RAD1 and RAD17–RFC complexes. ATR activity can also be 
boosted by DNA topoisomerase 2-binding protein (TOPDP1) and Claspin. Activation 
of ATM and ATR leads to phosphorylation of CHK1 and CHK2, which, through 
downstream effectors such as p53 and CDC25, leads to cell cycle arrest, 
senescence or apoptosis. Adapted from (d'Adda di Fagagna, 2008). 
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The spreading of H2A.X many megabases from the initial site of DNA damage acts 
as a platform to attract and hold a large number of DDR proteins (Downey and 
Durocher, 2006). This protein recruitment leads to the formation of nuclear foci 
known as DNA damage foci (DDF). These DDF contain multiple copies of the same 
proteins and show similarities in both structure and function to DNA replication 
factories. These replication factories are thought to serve to ensure the optimal use 
of nuclear space and available replication enzymes to allow accurate replication 
(Hozák and Cook, 1994).  It was previously believed that individual DDF could merge 
(Aten et al., 2004), however, more recent studies employing live-cell imaging indicate 
that DNA damage foci are positionally stable (Soutoglou et al., 2007). It is now 
thought that the combination of multiple DSBs in shared foci could lead to mistakes 
in ligation and unwanted fusion events and that keeping these lesions positionally 
separate is in fact advantageous (d'Adda di Fagagna, 2008). Hence, one DNA 
damage focus is formed per damage lesion and, like replication sites, it is thought to 
optimise protein interactions and enzymatic activity, which aid in the coordination 
and amplification of DNA damage signalling. Interestingly, it has even been shown 
that the artificial colocalisation of DDR proteins alone is sufficient to activate DNA 
damage checkpoints in the absence of actual DNA damage (Bonilla et al., 2008).  
 Following the repair of DNA lesions, DDF are disassembled. This is due 
primarily to the activity of dedicated phosphatases that dephosphorylate H2A.X as 
well as chromatin remodelling (Downey and Durocher, 2006). This means that DNA 
lesions that are quickly repaired give rise to small transient foci, whereas DNA 
damage that is less efficiently repaired causes larger long-lived foci (Passos et al., 
2010).  
Activation of a DDR and cell-cycle arrest can result in a number of different 
cell fates. This is dependent on the severity, type and location of the DNA damage 
as well as the cell-type. The primary aim of the DDR is to repair DNA damage and 
allow cells to progress back into the cell-cycle. If the damage persists then the 
chronic activation of a DDR can lead to apoptosis (programmed cell death) or 
cellular senescence. The mechanism that determines the cellular “decision” between 
these two cell fates is not yet fully understood. 
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1.2.1 Double Strand Break Repair 
 
There are two main pathways in eukaryotic cells that mediate double strand 
break repair: non-homologous end-joining (NHEJ) and homologous recombination 
(HR). NHEJ is active through the whole cell-cycle whereas HR is only active during 
the S and G2 phases when sister chromatids can be used as a template for repair.     
  
1.2.2 Homologous Recombination (HR)  
 
Homologous recombination is an important process that is required for 
genome maintenance as generally it performs an error-free mode of repair. In the 
absence of HR, cells must rely on the more error-prone DNA repair pathway NHEJ 
which can lead to increased mutations and rearrangements potentially leading to 
genome instability. Key components of HR such as BRCA2 and RAD51C are known 
tumor suppressors, with inactivating mutations leading to increased genomic 
instability (Golmard et al., 2013, Wooster et al., 1995). HR is also an important 
mechanism required for the restart of stalled replication forks during S phase 
(Budzowska and Kanaar, 2009, Woodbine et al., 2014). 
The initial step of HR, DNA resection, involves processing of DSBs to a 3′ 
overhanging tail. In yeast, this processing appears to require the MRX complex (Cao 
et al., 1990). Defects in this complex lead to sensitivity to IR, but the repair of “blunt” 
DSBs such as those caused by HO-endonuclease is not affected (Li and Heyer, 
2008). MRX and Sae2 initiate HR by performing short range resection (a few 
hundred nucleotides) (Mimitou and Symington, 2008), then both the 5′-3′ 
exonuclease Exo1 and DNA2 perform long range resection (two or more kilobases) 
(Zhu et al., 2008). The mammalian homolog of Sae2, CtIP has been implicated in 
DSB resection, although the exact mechanisms are still not understood. However, 
inactivation of CtIP has been shown to be mortal to cells and reduce RAD51 foci 
formation as well as HR (Nakamura et al., 2010). Following resection, ssDNA is then 
coated by the single-strand binding protein complex RPA (San Filippo et al., 2008). 
This is followed by the replacement of RPA with RAD51, a process catalysed by 
recombination mediator proteins such as BRCA1/2, resulting in RAD51 presynaptic 
nucleofilament formation (Yang et al., 2005). RAD51 is an ATP-hydrolysing protein 
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that has a high affinity for ssDNA in the ATP-bound state and is released from DNA 
following ATP hydrolysis (Petalcorin et al., 2006). BRCA2 not only recruits RAD51 
but also stabilises the resulting RAD51 nucleofilament through inhibition of RAD51 
ATP hydrolysis (Jensen et al., 2010). The RAD51 filament is responsible for 
homology search as well as catalysis of strand invasion. This leads to the formation 
of a displacement loop (D loop) once RAD51 is removed by helicases such as HELQ 
and RAD54 (Solinger et al., 2002, Ward et al., 2010). The D loop undergoes 
extension mediated by DNA polymerases such as: DNA polymerase delta (Li et al., 
2009), POLN (Moldovan et al., 2010) and eta (McIlwraith et al., 2005). Finally, these 
HR structures are processed leading to the resolution of the DSB.  
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Figure 1-2: Schematic representation of HR. HR is initiated by the formation of 
long 3ʹ single-stranded DNA (ssDNA) stretches. The DNA end-resection is complex 
and highly regulated and requires the activity of several nucleases such as: CtBP-
interacting protein (CtIP), Bloom’s syndrome helicase (BLM), exonuclease 1 (EXO1), 
DNA replication ATP-dependent helicase (DNA2) and the MRN (MRE11–RAD50–
NBS1) complex. RPA then binds to ssDNA, a key step in HR is the removal of RPA 
and its replacement with RAD51 to form a RAD51–ssDNA nucleofilament. This is 
mediated by breast cancer 1 (BRCA1), BRCA2 and RAD51 paralogues; however the 
exact mechanisms are not yet fully understood. This RAD51–ssDNA nucleofilament 
searches for homologous sequence and then undergoes strand invasion and 
displacement D-loop formation. DNA synthesis is initiated within the D-loop to 
replace DNA proximal to the break site. 
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1.2.3 Non-Homologous End Joining (NHEJ)  
 
Non-Homologous end-joining (NHEJ) is a pathway responsible for the repair 
of double stand breaks. It is named “non-homologous” because unlike homologous 
recombination, described above, NHEJ does not require a homologous template and 
DNA ends are directly joined by DNA Ligases, although short regions of homology, 
known as microhomologies, are often used to align DNA ends.    
NHEJ begins with the binding of the Ku70/80 heterodimer to an exposed DNA 
end (Weterings and van Gent, 2004). The Ku70/80 heterodimer forms a ring that 
encircles DNA, fitting to the spiral structure of DNA, positioning DNA ends in the 
correct phase to facilitate end-joining (Walker et al., 2001). The Ku70/80 heterodimer 
then recruits the DNA-dependent protein kinase (DNA-PKCS), activating its protein 
kinase activity (Smith and Jackson, 1999). Upon activation, the major function for 
this kinase is the regulation of NHEJ by autophosphorylation of DNA-PKCS (Chan et 
al., 2002). This autophosphorylation occurs following juxtaposition of DNA ends and 
facilitates proper access to DNA ends for other NHEJ proteins (Meek et al., 2007). 
Compatible ends are now able to be joined directly by the ligase IV/XRCC4 complex. 
This reaction is mediated by the interaction between XLF and XRCC4 (Ahnesorg et 
al., 2006).  
In many cases, DNA ends are not compatible and require processing before 
they can be ligated. DNA damaging agents such as IR lead to a number of complex 
lesions containing damaged bases and/or deoxyribose sugars. NHEJ is therefore 
able to incorporate DNA polymerases, nucleases, polynucleotide kinase and other 
enzymes to process ends to allow ligation by the ligase IV/XRCC4 complex.  
One such nuclease is Artemis, originally discovered as a gene commonly 
mutated in radiosensitive T-B- severe combined immunodeficiency (SCID) patients 
(Moshous et al., 2001). Artemis was implicated in V(D)J recombination, a process 
required for Immunoglobulin (Ig) and T cell receptor (TCR) diversity,  via its role in 
opening hairpin structures that result from RAG1/2 cleavage at recombination signal 
sequences (Ma et al., 2002). Cells lacking Artemis show considerable 
radiosensitivity (Riballo et al., 2004, Wang et al., 2005); similarly, cells from Artemis 
knockout mice show significant chromosomal abnormalities (Rooney et al., 2002). 
Artemis is unable to process all non-ligatable ends, as such other enzymes have 
been implicated in DNA-end processing in NHEJ such as PNPKP, an enzyme with 
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5′‐DNA kinase and 3′‐DNA phosphatase activities (Karimi-Busheri et al., 1999). 
PNPKP has been shown to interact with XRCC4 and facilitate end processing and 
disruption of this interaction has been shown to lead to increased radiosensitivity 
(Koch et al., 2004). Tyrosyl-DNA phosphodiesterase (TDP1) is another key enzyme 
involved in end-processing, specifically in response to damage caused by 
topoisomerase I. This is due to its ability to remove covalently bound tyrosyl-
phosphates and polypeptides that can result from a failure of topoisomerases to 
ligate reaction intermediates (Pommier et al., 2014). TDP1 is able to process a wide 
range of substrates such as: 3′ phosphoglycolate, chain terminating nucleosides and 
alkylated nucleosides leaving a 3′ phosphate. Cells lacking TDP1 are therefore 
sensitive to damaging agents that produce DSBs with 3′ phosphoglycolate such as 
alkylating agents, and calicheamicin (Pommier et al., 2014, Murai et al., 2012, 
Inamdar et al., 2002, Interthal et al., 2005). Mutations in TDP1 have been shown to 
result in the neurodegenerative disorder spinocerebellar ataxia with axonal 
neuropathy (SCAN1) (Takashima et al., 2002). 
NHEJ is not only involved in the repair of DSBs that are generated by 
exogenous and endogenous stress, it is also involved in the ligation of breaks 
generated during V(D)J recombination. This process takes place during B and T-cell 
differentiation and gives rise to antigen specific receptors (Jung et al., 2006). 
Immunoglobulin (Ig) and T Cell Receptor (TCR) genes contain variable (V), Diversity 
(D) and Joining (J) segments that are joined by NHEJ to form a mature V(D)J exon 
in B and T cells, respectively (Schatz, 2004). DSBs are created between 
Recombination Signal Sequences (RSSs) and coding DNA by RAG1 and 
RAG2 proteins (McBlane et al., 1995). This creates blunt DNA ends with a hairpin 
structure that require NHEJ for their successful repair (van Gent et al., 1996). 
Mutations of genes involved in NHEJ lead to SCID due to an inability to execute 
V(D)J (Woodbine et al., 2014). 
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Figure 1-3: Schematic representation of NHEJ. NHEJ is initiated by the rapid 
recruitment and binding of the Ku70-Ku80 heterodimer to DNA ends at the DSB (de 
Vries et al., 1989). This is followed by the recruitment of DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs), an ATM-related kinase, where it is activated by 
binding and stabilizing DNA ends keeping them in close proximity, as well as recruit 
end-processing factors such as: polynucleotide kinase/phosphatase (PNKP), Artemis, 
AP endonuclease 1 (APE1) and tyrosyl–DNA phosphodiesterase 1 (TDP1). These 
processing factors prepare DNA ends for re-ligation by the X-ray repair cross-
complementing protein 4 (XRCC4)–XRCC4-like factor (XLF)–DNA ligase 4 (LIG4) 
complex.  
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1.3 Ageing and Cellular Senescence 
1.3.1 Cellular Senescence 
 
  
Cellular senescence is defined as an irreversible cell-cycle arrest and is associated 
with a number of phenotypic changes (Campisi and d'Adda di Fagagna, 2007). It 
was first described in 1961 by Leonard Hayflick and Paul Moorhead (Hayflick and 
Moorhead, 1961) who demonstrated that human fibroblasts were only able to 
undergo a finite number of cell divisions before arresting irreversibly when grown in 
cell culture. This was predicted theoretically by Alexi Olovnikov and James Watson 
that a progressive shortening of telomeres was responsible for “Hayflick’s Limit 
(Watson, 1972, Olovnikov, 1971). It took a number of years to confirm experimentally 
that telomeres did in fact shorten with successive replication (Harley et al., 1990). 
However, it was still unclear if telomere shortening played a functional role in the 
induction of senescence, as their shortening could merely be associated with the 
induction of senescence. This question was answered when it was shown that over-
expression of telomerase, an enzyme able to maintain telomere length was able to 
bypass senescence and resulted in cellular immortalisation (Bodnar et al., 1998). 
 Telomere shortening is thought to be caused by what is known as the end-
replication problem, a phenomenon caused by the DNA replication machinery, 
specifically DNA polymerase’ inability to synthesise in a 3’-5’ direction. This means 
the 5’ strand or lagging strand of DNA is replicated in small sections in a 5’-3’ 
direction. These sections are known as Okazaki fragments and are joined together to 
form a complementary strand by DNA ligase (Ogawa and Okazaki, 1980). 
Replication of the lagging strand requires the binding of an RNA primer to facilitate 
the binding of DNA polymerase. The final RNA primer does not have a DNA 
template and so is unable to be replicated, leading to a loss of around 50-200Bp per 
replication (de-Lange.T, 2006). The actual rate of attrition seen at telomeres in 
fibroblasts that reach senescence is a lot greater than what can be accounted for by 
the end-replication problem alone, suggesting that other factors may contribute to 
telomere shortening (Levy et al., 1992). 
Human skin fibroblasts reach replicative senescence with an average telomere 
length of around 6-8kb (Allsopp et al., 1992), however senescent cells often contain 
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one or more extremely short telomeres (Hemann et al., 2001). It is thought that it is 
these extremely short telomeres that are responsible for the onset of senescence. 
The exact mechanism by which shortened telomeres induce senescence is not yet 
fully understood, however it has been suggested that telomere shortening leads to a 
disruption of the T-Loop (uncapping),exposing the DNA ends (Aubert and Lansdorp, 
2008). This then leads to an activation of a DDR and induction of senescence 
(d'Adda di Fagagna et al., 2003) (Herbig et al., 2004). The threshold of DNA damage 
required to activate this checkpoint is a matter of intense debate with some groups 
showing that cells are able to reach senescence with as many as 5 dysfunctional 
telomeres (Kaul et al., 2012) (Meier et al., 2007) with others showing senescent cells that 
contain just one DNA damage focusi (Herbig et al., 2006). 
 Originally it was suggested that telomeres could serve as a counting 
mechanism within cells that would allow a finite number of replications, however a 
set time or threshold for telomere length to induce senescence has not been found 
(Von Zglinicki, 2001). This, coupled with the large amount of heterogeneity in 
telomere length between cells in the same culture (Lansdorp et al., 1996) and the 
presence of senescent cells in cultures that have undergone a low number of 
divisions, suggests that telomere length is not just dictated by the number of 
divisions a cell has undergone (Martin-Ruiz et al., 2004). 
 It has been shown that telomeric DNA is especially sensitive to SSBs caused 
by reactive oxygen species (ROS), and that ROS leads to accelerated telomere 
shortening in replicating cells (von Zglinicki et al., 1995).It was later shown that 
mitochondrial superoxide levels increase with age and contribute to telomere 
shortening (Passos et al., 2007). Interestingly, overexpression of TERT (the catalytic 
subunit of telomerase) reduces mitochondrial superoxide levels independently of 
telomere length. It was shown that TERT migrates to mitochondria and it is thought 
to protect mtDNA, however the mechanisms are not entirely understood (Ahmed et 
al., 2008). It is now thought that the end-replication problem, as well as this 
stochastic damage, contributes to telomere shortening. It has been suggested that 
telomeres may act as a sentinel to oxidative stress, becoming shorter and preventing 
cells that have been exposed to high levels of potentially mutagenic factors from 
replicating (Martin-Ruiz et al., 2004).  
Recently it has been shown in work carried out by our group and Fabrizio 
d’Adda di Fagagna’s group that telomeres are more sensitive to DNA damage and 
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that this damage is irreparable (Hewitt et al., 2012, Fumagalli et al., 2012).  We also 
have shown that telomeres acquire damage independently of length or telomerase 
activity showing that is its not only telomere length that is important to the 
development of senescence. The exact mechanism by which DSB at telomeres are 
irreparable is unknown however studies have indicated that telomere binding 
proteins such as TRF2 and RAP1 have inhibitory effects on non-homologous end 
joining (NHEJ).Thus, telomeres can elicit a permanent DDR resulting in cell cycle 
arrest and induction of senescence (Hewitt et al., 2012, Cesare et al., 2009, 
Fumagalli et al., 2012). 
 As mentioned previously, activation of DDR can often lead to cellular 
senescence. It has been shown in many cell types that induction of high levels of 
DNA damage, particularly DSBs, leads to senescence (Di Leonardo et al., 1994). 
Induction of senescence via the DDR depends heavily on the tumour suppressor 
p53, which itself activates the cyclin-dependent kinase inhibitor p21 leading to a 
block in cell-cycle progression (Di Leonardo et al., 1994, Herbig et al., 2004, d'Adda 
di Fagagna et al., 2003).  Additionally the cyclin-dependent kinase inhibitor p16 has 
been shown to act downstream of the DDR to activate senescence in many cell 
types (Beausejour et al., 2003, Jacobs and de Lange, 2004, Stein et al., 1999). It has 
however also been suggested that p16 may also be upregulated independently of 
DNA damage (Herbig et al., 2004). 
Oncogene induced senescence (OIS) has also been shown to associate with 
the activation of a DDR as a result of hyper-replication (Di Micco et al., 2011, Suram 
et al., 2012, Di Micco et al., 2006). Oncogenes are genes that when aberrantly 
expressed have the potential to transform host cells into a tumour cell. The activation 
of various oncogenes has been shown to induce senescence in a number of different 
cell types, for example over-expression of RAS, RAF and BRAF have all been 
shown to induce senescence (Serrano et al., 1997, Zhu et al., 1998, Chrysiis et al., 
2005). Interestingly it has been shown that a DDR even in the absence of actual 
DNA damage is able to lead to induction of cellular senescence, a term the 
Blagosklonny group name a “Pseudo-DNA damage response” (Pospelova et al., 
2009). 
While the link between increased levels of DSBs and ageing have been well 
explored, changes in the activity and efficiency of double strand break repair are less 
well understood. The importance of DNA damage repair in the ageing process is 
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highlighted by a number of progeria syndromes where defects in genes involved in 
repair result in an accelerated ageing phenotype such as: Ataxia telangiectasia 
(Shiloh, 2001), Werner’s syndrome (Epstein et al., 1966), and mice deficient for 
Ku80 (Didier et al., 2012), DNA–PKcs (Espejel et al., 2004) and ERCC1 (Weeda et 
al., 1997). Assessing changes in DNA repair pathways is complicated by the 
changing rate of DSB generation as well as changes that occur in proliferative 
capacity with age. As mentioned previously, HR is predominantly active during S and 
G2/M phase where sister chromatids are available (Mao et al., 2008). Senescence is 
characterised by an abrupt and preeminent loss of proliferative capacity, which was 
initially thought to be in G1. Recently it was shown that a large percentage of 
senescent cells up to 60% are arrested in G2 (Mao et al., 2012a). This makes 
assessing changes in DNA damage repair as a cause or consequence of 
senescence induction particularly difficult. Early studies looking in normal human 
lymphocytes indicate an age dependent decline in DNA repair in response to X-ray 
irradiation as measured by Comet assay (Mayer et al., 1989, Singh et al., 1990). 
Assessment of damage using this technique does not allow you to asses specific 
repair mechanisms. Interestingly, it has been observed that senescent cells have a 
reduced efficiency and accuracy in NHEJ (Seluanov et al., 2004). Importantly, this 
decline in NHEJ was also observed in pre-senescent cells suggesting that it is not 
just a consequence of senescence induction. It has also been observed that NHEJ 
declines with age in mice (Vaidya et al., 2014). Work from the same group has also 
found a noted decline in HR with progressing population doublings in fibroblasts. 
This was accompanied by a decline in key components of the HR pathway such as 
RAD51, RAD51C RAD52 and CtIP. Importantly, this result was not attributed to 
changes in the cell cycle occurring with progressive PD (Mao et al., 2012b). This 
study also found that HR could be stimulated by expression of SIRT6 in middle-aged 
and pre-senescent cells. Taken together these data suggest that age dependent 
changes in DNA repair could well be a driver of the senescent phenotype and 
provide a potential therapeutic target to prevent age dependent decline in genome 
stability that is associated with many aspects of the ageing phenotype.  
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1.3.2 Senescence and Ageing 
 
Despite having been the focus of many studies, reaching back over 5 
decades, the existence of cellular senescence in vivo and its possible contribution to 
organismal ageing have been the subject of much debate (Ben-Porath and 
Weinberg, 2005). However, there have been several studies in the past decade that 
demonstrate an important role for senescence in vivo. Many studies have suggested 
that senescence plays an important role as a tumour suppressor (Braig et al., 2005, 
Chen et al., 2005, Collado et al., 2005, Michaloglou et al., 2005). However, there is 
now mounting evidence suggesting that senescence may also promote 
tumorigenesis (Krtolica et al., 2001, Dilley et al., 2003, Parrinello et al., 2005, Yang 
et al., 2006). This is thought to be as a result of the secretion of a number of pro-
inflammatory factors known as the senescence associated secretory phenotype 
(SASP) (Coppe et al., 2008). It is also believed that senescent cells contribute to an 
age-dependent decline in tissue function (Campisi and d'Adda di Fagagna, 2007).  
It was shown in 2006 by Herbig et al that the number of cells containing 
telomere-induced foci (TIF), a well-established senescence marker, increased in the 
skin of baboons with age (Herbig et al., 2006). Similar observations have been made 
in mice in a variety of tissues (Krishnamurthy et al., 2004, Wang et al., 2009, Hewitt 
et al., 2012). Cells bearing senescent markers have also been observed in the 
context of age-related diseases such as diabetes (Sone and Kagawa, 2005) and 
atherosclerosis (Minamino and Komuro, 2007). Although interesting, these data only 
demonstrate a correlation between the accumulation of senescence and age and 
age-related disease. They do not shown how causally senescence is involved in 
ageing. 
Recently the group led by Jan van Deursen attempted to address whether 
senescence was playing a causal role in the ageing process. To do this they created 
a mouse strain where the removal p16Ink4a-positive cells could be induced with 
drug treatment. This was done in the BubR1 progeroid background, a mouse model 
where improper chromosomal segregation leads to a progeroid phenotype. Using 
this model the group was able to show a delay in age-related pathology in the eye, 
adipose and skeletal tissues when p16Ink4a-positive cells were cleared (Baker et al., 
2011). This is an exciting observation and suggests a causal role of senescent cells 
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in the progression of ageing as well as age related disease. Next it is important to 
confirm these results in the context of normal ageing.  
 
1.4 The Ubiquitin Proteasome System 
 
Regulation of protein hemostasis has been heavily implicated in both DNA 
repair and ageing. The ubiquitin proteasome system (UPS) is the principle 
mechanism of protein degradation in the nucleus and cytosol. This chapter will 
introduce the key processes involved in protein degradation via the UPS as well as 
describe its known function in DNA repair pathways and the ageing process. 
In 2004 Avram Hershko, Aaron Ciechanover and Irwin Rose received the 
Nobel prize in chemistry for their work in discovering the ubiquitin-proteasome 
system (UPS) reviewed in (Herrmann et al., 2007). The exact mechanisms by which 
proteolysis was occurring remained unknown until key experiments revealed the 
majority of protein degradation was occurring independently of the lysosomal 
compartment and required  adenosine triphosphate (ATP) reviewed in (Ciechanover, 
2009). Interestingly, it was shown that proteolysis needs at least two constituents: 
one with protease activity and the other a 8.5-kDa heat-stable protein. These 
components were later recognized as the proteasome and ubiquitin, respectively 
(Arrigo et al., 1988, Waxman et al., 1987).  
The UPS is active in both the cytoplasm and nucleus and is responsible for 
the degradation of short-lived, soluble proteins. The UPS is thought to be 
responsible for the degradation of around 90% of nuclear and cytoplasmic proteins. 
Tagging of target proteins with ubiquitin serves to make the protein degradation via 
the UPS highly selective. Through the tight regulation of protein levels, the UPS has 
been shown to regulate a plethora of cellular processes such as: protein 
homeostasis, cell-cycle, signal transduction, DNA repair and many more (Glickman 
and Ciechanover, 2002). 
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Figure 1-4: Schematic representation of the ubiquitination cascade and the 
proteasome. (A) The proteasome: composed of the catalytic 20S core particle (CP) 
and the 19S regulatory particle (RP). (B) The ubiquitination cascade: involving 
enzymes E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), E3 
(ubiquitin-ligase). A series of ubiquitination events tag substrates with polyubiquitin 
chains, selectively targeting them for degradation via the UPS. Figure adapted from 
(Hewitt et al., 2015).  
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1.4.1 Ubiquitin-dependent protein targeting 
 
Proteins are targeted for degradation via the proteasome by the tagging of 
ubiquitin to lysine residues. This process is mediated by a series of enzymatic 
reactions involving E1, E2 and E3 enzymes that activate, transfer and conjugate 
ubiquitin respectively (Jentsch, 1992). It has been shown that the labelling of a 
protein substrate with one ubiquitin molecule at one or many lysine residues (mono-
ubiquitylation) is insufficient to mediate targeting to the UPS for degradation. Instead, 
multiple rounds of ubiquitylation of the same lysine residue occur, leading to a poly-
ubiquitylated substrate and successful targeting of the substrate to the UPS for 
degradation  (Thrower et al., 2000). 
This process of polyubiquitination gives the UPS an externally high degree of 
specificity. The numerous E1 enzymes present in mammalian cells can interact with 
all known E2 enzymes. E2 enzymes, however, can only act with a subset of E3 
enzymes. Moreover, E3 enzymes have to interact directly with protein substrates in 
order to perform ubiquitin conjugation, a step which confers further specificity as 
each E3 enzyme is only able to interact with a limited number of substrates (David et 
al., 2011).Ubiquitin contains numerous lysine residues on positions 6, 11, 27, 31, 33, 
48 and 63 that are susceptible to self-ubiquitylation reactions. The ability of ubiquitin 
to self-oligomerise via different linkages further contributes to the complexity and 
diversity conferred by tagging of protein substrates with polyubiquitin chains. 
Polyubiquitin chains comprised of four or more ubiquitin molecules have been 
identified as a robust signal to target substrates to the proteasome (Thrower et al., 
2000). Poly-ubiquitylation mediated by K11, K29 and K63 linkages have all been 
shown to mediate proteasomeal targeting of protein substrates (Thrower et al., 
2000). Interestingly, K11 ubiquitin linkage appears to be particularly important in 
regulating the turnover of proteins that regulate the cell cycle (Jin et al., 2008). 
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1.4.2 The molecular architecture of the proteasome 
 
The transport of polyubiquitinated substrates to the proteasome are as yet, 
poorly understood. The 26S proteasome is a large ATP-dependent protease 
complex made from two main components, the catalytic 20S core particle (CP) and 
the 19S regulatory particle (RP). Entry of ubiqutinated substrates to the CP is 
controlled by the RP. Upon entry to the CP proteins are subjected to cleavage 
reactions that result in the degradation of substrates to oligopeptides that are 
released into the cyto or nucleoplasm (Peters et al., 1993).     
The CP comprises a total of 28 subunits that are arranged in a barrel- like 
structure that is made from four ring structures, containing seven subunits per ring. 
The two outermost rings are made up from α-subunits while the two innermost rings 
are made from β subunits (Figure 1-4B). These outer α-rings are thought to serve as 
a gate controlling the entry of protein substrates into the inner chamber formed by 
the β-rings. It is within this catalytic chamber that trypsin, caspase and chymotrypsin-
like catalytic reactions degrade proteins (Heinemeyer et al., 1997). Different subunit 
compositions of the β-ring inner chamber confer further specificity of the proteolytic 
activity of the UPS (Nandi et al., 2006). 
Entry of ubiquitylated proteins into the CP is controlled by the RP which 
regulates the opening and closing of the α-ring structures, acting as a gate to the CP. 
The RP is formed from 19 subunits arranged to form lid and base structures. The 
base is formed from 4 non-ATPase and 6 ATPase subunits (referred to as Rpn 1-2, 
10 and 12 and Rpt 1-6, respectively) . This ATPase activity is required to provide 
energy required for the de-ubiquitylation and protein unfolding required to facilitate 
entry of protein substrates into the 20S CP (Nandi et al., 2006). 
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1.4.3 DNA damage and the UPS 
 
 The controlled recruitment, retention and disassembly of proteins at the site of 
damaged DNA are essential for the correct execution of DNA repair pathways. The 
link between DNA damage repair and the UPS was first suggested when Jentsch et 
al showed that the DNA repair gene Rad6 in Saccharomyces cerevisiae encoded a 
ubiquitin-conjugating enzyme (Jentsch et al., 1987). Since then the study of the UPS 
in the context of many DNA repair pathways has expanded massively. In keeping 
with the focus of this thesis, the role of the UPS in DSB repair will be reviewed 
below. 
Crosslinking and CHIP analysis have shown the presences of subunits of the 
26s proteasome at DSBs, suggesting that proteolysis is occurring alongside DSB 
repair (Krogan et al., 2004). Components of both NHEJ and HR have been shown to 
interact with the proteasome, such as DNA polymerase IV (Pol4) and Rad52 (Tseng 
and Tomkinson, 2002, Krogan et al., 2004). In yeast, HR protein Rad52 has been 
shown to associate with Sem, a component of the 19s proteasome. Following 
knockout of Rad52 the recruitment of Sem1 to DSBs is reduced. Furthermore, 
knockout of Sem1 in yeast capable of only HR or NHEJ, but not both, conferred 
impaired cell growth suggesting that Sem1 and the proteasome are required for the 
successful repair of DSBs by HR (Krogan et al., 2004). Interestingly, the human 
homolog of yeast Sem1 Deleted in Split hand/Split foot 1 (DSS1), is also part of the 
human 19s proteasome and implicated in HR through its interaction with Brca2 
(Marston et al., 1999). Similar to the knockout of BRCA2 (Yuan et al., 1999b), 
knockdown of DSS1 significantly reduces HR in human cells, inhibition of the 
proteasome result in a smaller reduction on HR, suggesting DSS1 has a role in HR 
beyond proteolysis (Kristensen et al., 2010). 
 HR appears to be more reliant on proteasome activity than NHEJ. 
Gudmundsdottir et al observed that treatment with the proteasome inhibitor 
Epoxomicin in an ES cell line lead to a shift towards the error-prone single-strand 
annealing pathway from the error-free gene conversion pathway in the repair of 
repetitive elements (Gudmundsdottir et al., 2007). Similarly it has been observed that 
inhibition of the proteasome with MG132 and LC caused a reduction in HR-
dependent DSB repair and only had a modest effect on NHEJ (Murakawa et al., 
2007). Moreover Ku-70 deficient cells that have impaired NHEJ show reduced repair 
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kinetics in response to X-Ray induced DSBs when the proteasome is inhibited with 
MG132 treatment. Treatment of Hela cells with MG132 inhibits the formation of 
RAD51 foci and Brca1 foci in response to X-ray irradiation suggesting that the 
proteasome is involved in the early stages of HR, prior to the formation of the Brca2-
DSS1 complex (Murakawa et al., 2007). 
 Due to the need for the controlled assembly and degradation of protein 
complexes in order to execute successful DNA damage repair programs it is 
unsurprising that proteasomal degradation has been shown to be integral to many 
stages of this process.  
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1.4.3 UPS and Ageing  
 
 The accumulation of damaged and misfolded proteins is well documented 
during the ageing process. This loss of protein homeostasis has been suggested to 
effect the ageing process directly, as well as influence many age associated 
diseases (Lopez-Otin et al., 2013). The UPS is a key component of the proteostasis 
network that has been shown to decline in function with age. This dysfunction has 
been shown to occur at a number of levels such as a decreased expression of 
proteasomal subunits(Wooten et al., 2000), aberrant proteasome 
composition(Ferrington et al., 2005),  proteasome disassembly (Ferrington et al., 
2005) or inactivation via interaction with protein aggregates (Grune et al., 2004). This 
can set up a catastrophic cycle where reduced proteostasis results in increased 
aggregate formation which in turn can inhibit proteasomal degradation further.  This 
cycle was highlighted recently in a study by Andersson et al where they showed by 
enhancing protein disaggregation they could restore functional proteasome activity in 
aged yeast (Andersson et al., 2013). 
 A decline in proteasome function has been observed in many mammalian  cell 
types and tissues (Bulteau et al., 2000, Carrard et al., 2003, Chondrogianni et al., 
2003, Petropoulos et al., 2000, Wagner and Margolis, 1995, Bardag-Gorce et al., 
1999, Bulteau et al., 2002, Conconi et al., 1996, Husom et al., 2004, Keller et al., 
2000, Shibatani et al., 1996). Interestingly, a decline in proteasome function is also a 
common feature of cellular senescence (Chondrogianni et al., 2003). Furthermore, 
treatment of fibroblasts with proteasome inhibitors leads to a shortened replicative 
life span and the induction of s senescent like phenotype (Torres et al., 2006). In 
addition, transgenic mice with reduced proteasomal chymotrypsin-like activity have a 
reduced lifespan and exhibit a premature ageing phenotype as well as enhanced 
age-related metabolic disorders such as obesity and fat accumulation in hepatic cells 
(Tomaru et al., 2012).    
 Notably, there have been several reports that proteasome activity correlates 
with longevity in long lived animals such as the naked mole rat (Perez et al., 2009) 
and the giant clam (Ungvari et al., 2013). Interestingly, proteasome activity is also 
increased in particularly long lived humans. A study by Chondrogianni et al found 
that the levels of several proteasomal subunits, as well as proteasomal activity in 
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fibroblasts derived from centenarians was comparable to younger, rather than older 
control donors (Chondrogianni et al., 2000). 
 The link between proteasome activity and longevity has been further 
strengthened by studies taking a genetic approach. For example, ectopic expression 
of 19S proteasome subunits has been shown to extend lifespan in model organisms 
such as D. melanogaster and C. elegans. Overexpression of Rpn11 reduces the 
age-dependent reduction of 26S/30S proteasome activity and leads to an extension 
of lifespan in D. melanogaster. Additionally, increased Rpn11 levels are able to 
suppress expanded PolyQ-induced progressive neurodegeneration (Tonoki et al., 
2009). Similarly, In C. elegans overexpression of Rpn6 confers protection against 
toxic aggregates in PolyQ-disease models and extends lifespan under conditions of 
proteotoxic stress   (Vilchez et al., 2012). Interestingly, overexpression of the 20S 
proteasome subunit β5 in human fibroblasts leads to increased numbers of 
proteasomes and confers resistance to oxidative stress, delaying the onset of 
cellular senescence (Chondrogianni et al., 2005). Similarly, overexpression of 
another protein involved in proteasome assembly, the proteasome chaperone 
POMP, increases proteasome activity and protects against oxidative stress in human 
fibroblasts (Chondrogianni and Gonos, 2007).  
 Increasing evidence suggests that the functional decline of the proteasome 
and accumulation of damaged proteins are indeed determinants of the ageing 
process. Long-lived individuals (centenarians), as well as long lived model 
organisms positively correlate with increased functional proteasome activity. 
Moreover, genetic manipulations that enhance proteasome activity not only confer 
resistance to proteotoxicity and oxidative stress, they also extend lifespan.  These 
data, taken together, indicate that proteasomal activity plays a key role in stress 
resistance, DNA damage repair, cellular senescence and organismal ageing.  
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1.5 Autophagy 
 
 Like the UPS, autophagy is a cellular degradation pathway that has been 
closely linked to the maintenance of cellular homeostasis. Autophagy has also been 
implicated in stress resistance, DNA damage repair, cellular and organismal ageing. 
Autophagy translates from the Greek “Auto” meaning oneself and “Phagy” meaning 
to eat and describes catabolic cellular degradation pathways involving delivery of 
cargo to lysosomes. There are three main described autophagic pathways present in 
eukaryotic cells shown in Figure 1-5. These include: microautophagy (direct 
engulfment and degradation of portions of the cytoplasm via invagination of the 
lysosome (Mijaljica et al., 2011), chaperone-mediated autophagy (direct 
translocation of targeted proteins containing the KFERQ motif into the lysosome via 
the LAMP-2A receptor) and macroautophagy (formation of a double membrane 
around cytoplasmic proteins and organelles which seals to form organelles known as 
autophagosomes). These autophagosomes are then trafficked to lysosomes where 
they fuse to deliver their cargo for degradation by lysosomal enzymes (Bejarano and 
Cuervo, 2010). Since the discovery of autophagy-related (ATG) proteins in yeast, the 
machinery of autophagy has been dissected in great detail. A key breakthrough in 
understanding of the molecular machinery came from genetic studies in yeast in 
which 35 ATG genes have been identified. These are genes that are essential 
canonical autophagosome formation (Nakatogawa et al., 2009). 
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Figure 1-5: Schematic diagram of the three main forms of autophagy in 
mammalian cells. (A) Formation of double membrane vesicles that then travel along 
microtubules and fuse with the lysosome (Macroautophagy). (B) Invagination of the 
lysosomal membrane to engulf regions of the cytoplasm (Microautophagy). (C) 
Selective uptake of proteins containing KFERQ motif across the lysosomal 
membrane via LAMP-2A mediated by chaperones Hsc70 and LysHsc-70 
(Chaperone Mediated Autophagy) Abbreviations: hsc70: heat-shock cognate protein 
of 70 KDa, LAMP-2A: lysosome associate membrane protein type 2A. Figure 
adapted from (Hewitt et al., 2015).  
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1.5.1 Chaperone-mediated autophagy 
 
 Unlike the other forms of autophagy, CMA is an exclusively selective 
degradation process. As the name may suggest, CMA is aided by a protein 
chaperone called heat shock cognate protein (hsc70). The interaction of hsc70 with 
cytosolic protein substrates is mediated by a consensus pentapeptide motif KFERQ 
found in all CMA-targeted proteins (Figure 1C). Hsc70 alone or in complex with a 
protein substrate is able to bind to a plethora of co-chaperones through interactions 
that are thought to participate in specific substrate recognition, substrate delivery, 
protein unfolding and the final protein translocation across the lysosomal membrane. 
Delivery of the protein substrate to the lysosome is facilitated by binding to the 
cytosolic tail of the transmembrane protein, lysosomal-associated membrane protein 
2A (Lamp-2A). The substrate protein is then unfolded and transported into the lumen 
of the lysosome via a poorly understood mechanism. Following translocation the 
substrate is rapidly degraded by hydrolytic enzymes (Ravikumar et al., 2010). 
 The mechanisms that regulate CMA activation, substrate recognition, 
transport and translocation are not well understood. Evidence suggests, however, 
that regulation of LAMP-2A expression levels is particularly important for efficient 
CMA and indeed the level of lysosome-associated LAMP-2A directly correlates with 
CMA activity. Thus, induction of CMA by oxidative stress has been shown to induce 
LAMP-2A transcription and in CMA-activating conditions the protein half-life of 
LAMP-2A increases, thus enhancing the CMA response. In addition, during 
prolonged CMA activation, LAMP-2A can be transported from the lysosomal 
membrane into the matrix but can seemingly be retrieved from an intact pool of 
LAMP-2A and reinserted back into the lysosomal membrane, again ensuring a 
robust maintenance of CMA response (Cuervo and Dice, 2000b). 
  Interestingly, while only approximately 25 proteins have been identified as 
substrates for CMA, the targeting motif, KFERQ is relatively common in cytosolic 
proteins (approximately 30%). Proteins that have been confirmed to be CMA 
substrates participate in a range of cellular processes including glycolysis, 
transcription and proteasome-based protein degradation. CMA is therefore an 
important participant in the general turnover of proteins required to maintain cellular 
homeostasis. 
Chapter1. Introduction 
 
28 
1.5.2 Microautophagy 
 
Direct delivery of cytoplasmic contents, either by lysosomal membrane 
invagination or protrusion is referred to as microautophagy (Figure 1-5B). The 
specific regulatory mechanisms are poorly understood in mammalian cells but 
seminal work in yeast indicates that microautophagy can mediate degradation of 
cytoplasmic contents via both non-selective and selective mechanisms, reviewed in 
(Mijaljica et al., 2011). Indeed, direct lysosomal-engulfment of mitochondria and 
nuclear fragments have been observed in yeast and are referred to as 
micromitophagy (Li et al., 2012b) and micronucleophagy (Boya and Codogno, 2012), 
respectively. Since little is known about any specific regulators of microautophagy, 
the primary tool for investigating this process is electron microscopy, limiting the 
scope for experimentation. Despite this, the process of microautophagy was 
characterised to occur via five main steps: 1) invagination of the lysosomal 
membrane, 2) vesicle formation, 3) vesicle expansion, 4) vesicle scission and 5) 
vesicle degradation (Li et al., 2012b). Due to the poorly defined molecular 
mechanisms in mammalian cells microautophagy will not be discussed further in this 
chapter except to say that, in yeast models at least, it shares some key upstream 
regulators with macroautophagy including the autophagy-related Atg proteins and 
the potent negative regulator, target of rapamycin (TOR) (Li et al., 2012b). Future 
work will undoubtedly unravel the current mystery that is microautophagy and of 
particular interest will be to identify how common upstream regulators are able to 
influence multiple protein degradation pathways.  
 
1.5.3 Macroautophagy 
 
Macroautophagy is an evolutionarily conserved catabolic process involving the 
formation of double-membrane vesicles (autophagosomes) that engulf cellular 
macromolecules and organelles, which are finally transported along microtubules 
leading to fusion with lysosomes and degradation of their contents (Figure 1-6). It is 
responsible for what is often referred to as bulk degradation; it has the broadest 
range of substrates and is by far the best studied of all three autophagic pathways, 
often being referred to simply as autophagy. Macroautophagy occurs in all cells at 
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basal albeit varying levels and these basal levels are often reflective of cellular 
function and energy demands. The most well-known regulator of macroautophagy is 
the serine/threonine kinase mTOR as part of the macromolecular complex (in 
mammals called mTORC1), which is activated in nutrient-rich, low cellular stress 
conditions and promotes protein translation and cell growth. In these growth-
promoting conditions macroautophagy is largely suppressed. Cellular starvation 
(amino acids and growth factors), in addition to many other cellular stressors such as 
hypoxia and DNA damage, can lead to the inactivation of mTORC1 and 
subsequently activate macroautophagy. This up-regulation of autophagy facilitates 
the removal of unwanted or damaged cellular components and proteins freeing 
molecular building blocks and energy for other cellular processes.  
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1.5.4 Autophagic Machinery 
 
 
 
 
 
 
 
 
 
 
Figure 1-6: Schematic diagram of macroautophagy: Macroautophagy involves 
the sequestration of cytoplasmic contents, such as lipids, organelles and proteins 
into a double-membrane-bound organelle. These structures are called 
autophagosomes and they are transported along the microtubule network towards 
the perinuclear, lysosome-rich microtubule organising centre (MTOC). 
Autophagosomes fuse with lysosomes in a Rab7- and SNARE-dependent manner 
and deliver their contents for hydrolytic degradation. Macroautophagy induction is 
regulated by a number of autophagy related proteins and protein complexes which 
interact sequentially orchestrating the proper initiation, elongation and maturation of 
autophagosomes. Figure adapted from (Carroll et al., 2013). 
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The formation of phagophores (the precursor to autophagosomes) requires 
two protein complexes the Beclin1/Vps34 complex and the ATG1 (or ULK1) 
complex. The ULK1 complex is negatively regulated by mTOR (Jung et al., 2009), 
this is the major regulatory signal for autophagosome formation and will be 
discussed in further detail later in this chapter.  The origin of the autophagosomal 
membrane component is not fully known, however it is likely to come from either 
endoplasmic reticulum, mitochondria, Golgi or the cell membrane (Tooze and 
Yoshimori, 2010). 
The elongation of the double membrane structure, a crucial stage in 
autophagosome formation, involves two ubiquitination like reactions. Firstly, Atg7 
conjugates Atg12 to Atg5, these conjugates then interact non-covalently with Atg16 
to form a complex. The Atg12-Atg5-Atg16 complex associates with phagophores 
during autophagosome formation but dissociates at its completion. The role of this 
protein complex is not yet fully understood, however it is necessary for normal 
autophagosome formation (Lin et al., 2007). Genetic knockout of Atg5 leads to a 
complete abolition of autophagy, however the autophagic machinery is able to 
function even when Atg5-Atg12 conjugate levels are reduced by 90% (Hosokawa et 
al., 2007) indicating that only very low levels of Atg5-Atg12 are required for 
autophagy. Secondly, microtubule-associated protein 1 light chain 3 (LC3) is 
conjugated to the lipid phosphatidylethanolamine (PE) in the phagophore membrane 
by Atg7 and Atg3. Here it is converted from its soluble form LC3-I to its 
autophagosome associated form LC3-II (Yang and Klionsky, 2010).  Detection of 
LC3-II by microscopy or western blotting is often used to measure cellular autophagy 
(Mizushima et al., 2010). Phagophores then elongate and engulf cytoplasmic cargo. 
Following the formation of these LC3-II-positive vesicles (autophagosomes) they are 
trafficked along microtubules towards the late endosome or lysosome. Upon meeting 
the lysosome the two structures fuse and the autophagic cargo is delivered for 
degradation (Mizushima, 2007).  
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1.5.5 Selective Autophagy 
 
Macroautophagy was originally thought to be a non-specific bulk degradation 
pathway, however there is now strong evidence which suggests that autophagy can, 
in fact, be highly specific (reviewed in (Reggiori et al., 2012)). Autophagy has been 
shown to be involved in the selective turnover of many organelles including the 
endoplasmic reticulum (ER) (reticulophagy), peroxisomes (pexophagy), parts of the 
nucleus (nucleophagy), pathogens (xenophagy), protein aggregates (aggrephagy), 
ribosomes (ribophagy) and mitochondria (mitophagy) (Klionsky et al., 2007). This 
quality control role of autophagy requires that it is able to distinguish between 
functional and dysfunctional substrates. The molecular mechanisms underlying this 
substrate selection is relatively unknown. Similarly to the UPS, Ubiquitylation has 
been shown to play a role in this specificity by acting as a signal for selective 
autophagy (Kraft et al., 2010). 
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1.5.6 Regulation of Autophagy 
 
Given the large number of stimuli able to modulate autophagy it is 
unsurprising that numerous signalling pathways are involved in its regulation. One of 
the most important regulators of autophagy is the mTOR pathway.  
 
1.5.6 mTOR pathway 
 
 The mTOR pathway regulates a number of cellular functions such as cell 
growth, protein translation, lipid biogenesis, DNA synthesis, mitochondrial biogenesis 
and autophagy (Wullschleger et al., 2006). mTOR is an atypical serine/threonine 
kinase that exists in functional complexes: mTOR complex 1 (mTORC1) made up 
from the mTOR catalytic domain, regulatory associated protein of mTOR (raptor), G 
protein β-subunit-like protein (GβL), proline-rich Akt substrate of 40 kDa (PRAS40). 
mTORC1 is rapamycin sensitive and is the branch of the mTOR pathway resposible 
for the regulation of autophagy (Levine and Kroemer, 2009). mTOR complex 2 
(mTORC2) is composed of mTOR, rapamycin-sensitive companion of mTOR (rictor), 
GβL, SAPK-interacting protein 1(SIN1) and protein observed with rictor (PROTOR). 
mTORC2 is not believed to be a direct regulator of autophagy (Jung et al., 2010). 
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Figure 1-7: mTOR regulation of autophagy. The  phosphatidylinositol 3-kinase 
(PI3K)/mTOR pathway is activated by the binding of insulin or growth factors to cell 
surface receptors. Activated PI3K converts Phosphatidylinositol 4,5-bisphosphate 
(PIP2)  to Phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which recruits and 
activates Akt. Akt then inactivates TSC1/2 leading to activation of Rheb and 
mTORC1.  AMPK senses changes in the adenosine triphosphate (ATP)/ adenosine 
monophosphate (AMP) ratio and directly phosphorylates tuberous sclerosis 1 
(TSC1) tuberous sclerosis 2 (TSC2) activating it, which results in inactivation of 
mTORC1. Amino acids can activate mTORC1 via Rag GTPases and Rheb and 
supress autophagy. mTORC1 suppresses autophagy via phosphorylation-dependent 
inhibition of ULK1 and Atg13. Inhibition of mTORC1, such as that caused by 
rapamycin or starvation, leads to dissociation of mTORC1 from the ULK1-Atg13-200 
kDa FAK-family interacting protein (FIP200) complex resulting in a 
dephosphorylation-dependent activation of autophagy. 
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There are many different cellular signals that converge to modulate the 
mTORC1 pathway such as glucose, energy status, amino acids, growth factors and 
different forms of stress (Sarbassov et al., 2005). Amino acids and growth factors 
activate mTORC1 via Rag GTPases, these bind raptor and target mTOR to cellular 
compartments that contain its activator, small GTPase Rheb (Sancak et al., 2008). 
Further light was shone on this process when it was shown that amino acids induce 
recruitment of mTORC1 to lysosomal membranes via a trimetric complex known as 
Ragulator. This recruitment places mTORC1 in close proximity to membrane bound 
Rag GTPases with the Ragulator acting as a docking site, allowing the activation of 
mTOR via Rheb (Sancak et al., 2010). It has also been suggested that constitutive 
targeting mTORC1 to the lysosomal membrane eliminates sensitivity to amino acids 
(Sancak et al., 2010). This highlights this translocation event as an essential part in 
the regulation of mTORC1 by amino acids. 
Recently the autophagy adaptor protein p62 has been shown to be an integral 
part of the mTORC1 complex and is necessary to mediate amino acid signaling. p62 
interacts with mTOR and raptor in an amino acid dependent manner. Additionally, 
p62 is able to bind Rag proteins favoring the formation of the active Rag 
heterodimer. p62 co-localises with Rags at the lysosme and has been shown to be 
required for targeting mTORC1 to the lysosome membrane (Duran et al., 2011). 
The Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway is a 
major signalling cascade that feeds into mTORC1. Class 1a PI3K is activated by the 
binding of insulin and growth factors to cell surface receptors. Following this, the 
regulatory subunit facilitates activation of the p110 catalytic subunit by direct 
interaction with phosphotyrosine residues of activated receptors. Once activated, 
PI3K converts the plasma membrane lipid phosphatidylinositol-4,5-bisphosphate 
(PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3), wherein pleckstrin 
homology (PH) domain proteins such as AKT and phosphoinositide-dependent 
kinase 1 (PDK1) are recruited to the plasma membrane (Cantley, 2002). Activation 
of PI3K leads to the recruitment and activation of AKT which in turn phosphylates 
and deactivates TSC2. TSC2 inhibits mTOR through Rheb (Ras homolog enriched in 
brain). Once TSC2 is inactivated, Rheb is maintained in its GTP-bound state leading 
to the activation of mTOR (LoPiccolo et al., 2008). 
MTORC1 can also act as a sensor for changes in cellular energy via AMP-
activated kinase  (AMPK) (Meijer and Codogno, 2006). AMPK senses changes in the 
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ratio between ATP and AMP and directly phosphorylates TSC2 facilitating the 
subsequent additional phosphorylation by glycogen synthase kinase 3 (GSK-3) 
resulting in an inhibition of mTORC1 signaling (Inoki et al., 2006).   
 Activation of mTORC1 leads to phosphorylation of two downstream effectors: 
p70 S6 Kinase (p70S6K) and translation initiation factor 4E binding protein-1 
(4EBP1) at Thr389/Thr421/Ser424 and Thr37/Thr46, respectively (Han et al., 1995). 
This phosphorylation leads to activation of cell growth and protein translation. The 
activity of mTORC1 can be inhibited by rapamycin, an antibiotic originating from 
Streptomyces hygroscopicus. In mammalian cells rapamycin exerts its effect by 
forming a complex with the immunophilin FK506-binding protein of 12 kDa 
(FKBP12). This stabilises the mTOR-raptor interaction and inhibits mTOR kinase 
activity (Kim et al., 2002). Neither p70s6K or 4EBP1 are directly involved in the 
regulation of autophagy, which will be expanded upon on the following section. 
1.5.7 mTOR regulation of autophagy 
 
Activation of mTORC1 is the main negative regulator of autophagy 
(Sarbassov et al., 2005) (Figure 1-7). Inhibition of mTORC1 by rapamycin is a potent 
inducer of autophagy. Nutrient deprivation also activates autophagy via stabilisation 
of the mTOR-raptor complex. This activation is thought to serve to recycle 
intracellular components and provide an alternative source of amino acids 
(Ravikumar et al., 2010). The importance of the up-regulation of autophagy as an 
alternative means of supplying cellular energy is highlighted in Atg5 -/- mice. Mice 
lacking Atg5 are autophagy deficient and are unable to survive the neonatal 
starvation period and die shortly after birth (Kuma et al., 2004). Atg5 -/- mice are only 
able to survive early embryogenesis due to maternally inherited Atg5. Eliminating 
maternal Atg5 protein with oocyte-specific Atg5-knockout results in embryonic 
lethality (Tsukamoto et al., 2008). The exact mechanism for which autophagy is 
required is not yet understood, however it has been suggested that it could be 
needed to meet the high demand for amino acids required for protein synthesis at 
this early stage in embryogenesis (Tsukamoto et al., 2008).  
  
Experiments initially carried out in yeast began to shine light onto the 
mechanisms linking TOR signalling to autophagy. It is thought that Atg1 and the 
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Atg1-Atg13-Atg17 complex act downstream of TOR to regulate autophagosome 
formation (Kamada et al., 2000). More recently studies have identified some of the 
key molecular components acting downstream of mTORC1 in the regulation of 
autophagy in mammalian cells. Similar to yeast, the ULK1/2-Atg13-FIP200 complex 
is involved in the initiation of autophagy downstream of mTORC1 (Jung et al., 2009).  
Under nutrient rich conditions autophagy is inhibited by direct interaction of mTOR 
with the ULK1/2-Atg13-FIP200 complex and mTORC1 dependent phosphorylation of 
Atg13 and ULK1, which results in a reduction in kinase activity. Conversely, following 
starvation, mTOR dissociates from the complex resulting in a reduction of mTOR 
dependent phosprolyation of Atg13 and ULK1. This causes a dephosphorylation-
dependent increase in kinase activity of ULK1 resulting in ULK1 mediated 
phosphorylation of Atg13 and FIP200 leading to an induction of autophagy (Jung et 
al., 2010, Kim et al., 2011, Egan et al., 2011).  
 
 1.5.8 mTOR-independent regulation of autophagy  
 
 The first study to show mTOR independent regulation of autophagy was 
published by Sakar et al in 2005, where they show that autophagy is negatively 
regulated by intracellular inositol and inositol 1,4,5-trisphosphate (IP3) levels (Sarkar 
et al., 2005). This pathway is initiated by G protein coupled receptor activation of 
phosopholipase C (PLC), this hydrolyzes PIP2 to form IP3 and diacylglycerol (DAG) 
(Berridge, 1987). IP3 is then able to bind to its receptors (IP3R) on the endoplasmic 
reticulum (ER), causing the release of stored calcium, activating a large number of 
cellular responses (Berridge et al., 2003). Autophagy can be induced by a number of 
inositol-lowering agents, this activation is dependent on downstream levels of IP3 as 
pharmacological interventions that raise levels of IP3 such as myo-inositol or an 
inhibitor of prolyl oligopeptidase prevent the induction of autophagy (Sarkar et al., 
2005). Moreover, direct reduction of IP3 such as that caused by over-expression of 
cytosolic IP3 kinase A, which phosphorylates IP3 to inositol 1,3,4,5-tetrakisphosphate 
(IP4), induces autophagy (Williams et al., 2008). IP3R has been shown to regulate 
the Beclin 1 complex and Xestospongin B, an IP3R antagonist, disrupts the 
interaction of Beclin 1 and IP3R/Bcl-2 complex causing the induction of autophagy 
(Vicencio et al., 2009)  
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1.5.9 Regulation of autophagy by ROS 
  
Aberrant levels of reactive oxygen species (ROS) are a common intracellular 
stress that leads to the induction of autophagy.  Starvation, a potent inducer of 
autophagy, has been shown to increase ROS in an PI3K-dependent manner, whilst 
treatment with antioxidants reduces the ability of starvation to induce autophagy 
(Scherz-Shouval et al., 2007). ROS has been suggested to affect autophagy directly 
through interaction with Atg4. It has been shown that oxidation of a conserved 
cysteine residue in  position 81 of Atg4 inhibits its catalytic activity preventing the 
cleavage of LC3 from the autophagosomal membrane thus promoting lipidation of 
LC3 and inducing autophagy (Scherz-Shouval et al., 2007). Interestingly the down 
regulation of ROS with antioxidants causes a down regulation of basal autophagy, 
consistent with ROS playing a positive regulatory role on autophagy (Scherz-
Shouval and Elazar, 2011)   
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1.5.10  Autophagy Adaptor Proteins 
 
Targeting of substrates for selective degradation via autophagy usually 
requires specific cargo-recognising adaptor molecules. These adaptor molecules 
serve to couple substrates with LC3 in pre-autophagosomal membranes.  There are 
a number of different adaptor molecules involved in the targeting of different 
substrates, however common to all is the ability to interact with ubiquitinated 
substrates and  LC3 (Johansen and Lamark, 2011).  
1.5.10.1 p62 
 
p62 also known as sequestosome 1 (SQSTM1), A170 or ZIP is a 
multifunctional protein induced in response to a number of cellular stresses. It serves 
as an autophagy adaptor selectively targeting polyubiquitinated proteins for 
degradation (Pankiv et al., 2007). It has also been shown to shuttle ubiquitinated 
substrates for degradation via the proteasome (Seibenhener et al., 2004), thus, 
playing a central role in cellular protein homeostasis. p62 has also been shown to act 
as part of many signalling pathways (Sanz et al., 1999, Sanz et al., 2000a, Joung et 
al., 1996). Mutations, the sqtsm1 (p62) gene have been linked to a number of 
diseases, such as: Paget’s disease of bone (Laurin et al., 2002, Hocking et al., 
2002), familial and sporadic ALS (Teyssou et al., 2013). Interestingly recent research 
has shown dysregulation of p62 is common in many age-related pathologies such as 
neurodegeneration and cancer.  
Structure  
sqtsm1 (p62) gene is highly conserved among vertebrates. The human 
sqtsm1 (p62) gene is located on chromosome 5q35 and is comprised of 16Kb of 
genomic DNA. Sqtsm1 contains 8 exons that encode a 440 amino acid protein. 
There are two protein isoforms of p62 arising from three mRNA variants. Protein 
isoform1 (440aa) is encoded by transcript variant 1 while protein isoform2 (356aa) is 
encoded by transcripts variant 2 and 3 which have the same coding sequence which 
lacks a portion of the 5’coding region compared to transcript variant 1 resulting in a 
slightly shorter N terminus in isoform2 compared to isoform1. Transcript variants 2 
and 3 only differ slightly in their 5’UTR. Differences in the function and expression of 
these isoforms are not yet fully understood but are beginning to be investigated. A 
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recent paper from the Handa Laboratory suggests that Isoform1 is protective against 
oxidative stress while Isoform2 is transcriptionally active it is translationally inactive.    
(Wang et al., 2014). p62 has many conserved  domains that mediate its multiple 
cellular functions (NCBIGeneID:8878) (Figure 1-1-8). 
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Figure 1-1-8: Schematic representation of domain structure of p62: p62 consists 
of: an N-terminal Phox and Bem1 (PB1) domain (which mediates interaction with: 
protein kinases (aPKC, MEK5, MEKK3), NBR1 and oligomerisation), a zinc finger 
(ZnF) domain (which mediates interaction with RIP1), a (TRAF6) binding (TB) 
domain, two nuclear localization signals (NLS) and one Nuclear Export Signal (NES) 
(which mediate shuttling of p62 in and out of the nucleus), LC3 interacting region 
(LIR), KEAP1-interacting region (KIR) and a Ubiquitin Association (UBA) domain 
responsible for binding to ubiquitin. 
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The N-terminal Phox and Bem1 (PB1) domain (aa 20–102) allows p62 to 
interact with other PB1 containing proteins as well as to oligomerise (Lamark et al., 
2003). The PB1 domain of p62 mediates interactions of p62 with several protein 
kinases such as atypical protein kinase C (aPKC) (Joung et al., 1996) and the MAPK 
kinase MEK5 (Lamark et al., 2003)-one of the ways in which p62 participates in 
signal transduction cascades. Moreover, PB1-mediated oligomerisation has been 
shown to be central to the role of p62 in the selective degradation of protein 
substrates via autophagy (Itakura and Mizushima, 2011, Pankiv et al., 2007). p62 
has also been shown to interact with the autophagy adaptor NBR1 via its PB1 
domain (Kirkin et al., 2009).  
The C-terminal Ubiquitin Association (UBA) domain (aa 389–434) is 
necessary for p62 to bind to ubiquitinated proteins and organelles (Seibenhener et 
al., 2004, Vadlamudi et al., 1996, Geisler et al., 2010). The UBA functional domain is 
a motif of 45 amino acids which is conserved among proteins with the ability to bind 
to ubiquitin (Ub) (Hofmann and Bucher, 1996). The structure of the UBA has been 
elucidated using nuclear magnetic resonance and shows a compact three-helix 
bundle, with a hydrophobic surface on one side which is the proposed site for its 
interaction with Ub (Dieckmann et al., 1998, Bertolaet et al., 2001). p62 has an 
increased affinity for lysine 63 (K63) poly-ubiquitin chains over other forms of 
ubiquitination (Seibenhener et al., 2004). K63 linkage is believed to promote the 
formation of protein inclusions as well as target them for degradation predominantly 
via autophagy (Tan et al., 2008). This view however has been challenged by the 
Layfield laboratory where K63 affinity was not observed. Instead they observe 
equivalent affinity of p62 for K63 and K48 poly-ubiquitin chains (Long et al., 2008). 
The affinity of p62 for ubiquitin can be modulated by the phosphorylation of the UBA 
on Ser-403 by Casein Kinase II (CK2), increasing its binding to poly-ubiquitin and 
promoting the formation of p62 inclusion bodies. These p62-rich inclusion bodies or 
“sequestosomes” have been proposed to serve as signalling hubs and can be 
cleared by autophagy (Matsumoto et al., 2011).  
p62 contains a zinc finger (ZnF) domain (aa 122–167) that primarily facilitates 
the involvement of p62 in a number of cytoplasmic signalling cascades. The ZZ 
domain is necessary for the binding of p62 to the receptor-interacting protein 1 
(RIP1) kinase in the TNF receptor (TNF-R) complex. This binding allows the 
signalling of TNF-R through protein kinase C (PKC) and the activation of nuclear 
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factor-kappaB (NFB) (Sanz et al., 1999). Aside from mediating the role of p62 in a 
number of cytoplasmic signalling cascades the ZZ domain has also been implicated 
in the association of p62 with a number of transcription factors in the nucleus such 
as the chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) 
(Marcus et al., 1996) and has been suggested to stimulate transcription through the 
SV40 enhancer (Rachubinski et al., 1999) 
p62 binds to TRAF6 via the TNFα receptor-associated factor 6 (TRAF6) 
binding (TB) domain. This p62-TRAF6 interaction is required for NFB signalling 
from the interleukin 1 receptor (IL-1R) (Sanz et al., 2000b) and nerve growth 
factor  receptor (NGF-R) (Wooten et al., 2000). Following stimulation, p62 binds 
TRAF6 via its TB domain and aPKC via its PB1 domain, serving as a scaffold that 
brings these proteins into close spatial proximity which facilitates kinase activation. 
The presence of two nuclear localization signals (NLS) and one Nuclear 
Export Signal (NES) was first reported by Pankiv et al. (Pankiv et al., 2010). They 
observed that p62 shuttles rapidly between the cytoplasm and the nucleus and that 
upon inhibition of nuclear export p62 lead to an accumulation of polyubiquitinated 
proteins in promyelocytic leukemia (PML) bodies. They also observed that nuclear 
p62 contributed to the formation of proteasome-containing degradative 
compartments (Pankiv et al., 2010). It was also previously suggested that p62 may 
enter the nucleus by binding other NLS containing proteins such as aPKC (Geetha 
and Wooten, 2002), The authors infer the presence of a NES signal as p62 
accumulates in the nucleus in response to inhibition of exportin 1 with Leptomycin B 
treatment. They also claim that p62 does not contain its own NLS. In light of more 
recent work by Pankiv et al. it may be necessary further study whether p62 is able to 
enter the nucleus bound to another NLS containing protein, independently of its own 
NLS domain.     
 The LC3 interacting region (LIR) (aa 321–342) facilitates the interaction 
between p62 and LC3, a key component of the autophagosome membrane. This 
domain is key to the function of p62 as an autophagy adaptor protein, and is required 
for the degradation of p62, by autophagy (Pankiv et al., 2007). Interestingly, it has 
been shown that p62 is still able to localise to the nucleation point of 
autophagosomal membranes in the absence of the LIR domain. This interaction has 
instead been shown to be dependent on the PB1 domain and oligomerisation 
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(Itakura and Mizushima, 2011). It is however possible that this occurs due to PB1 
dependent interactions with other LIR domains containing proteins such as NRB1.   
The Kelch-like ECH-associated protein (Keap1) interacting region (KIR) (aa 
346–355) mediates the association of p62 with Keap1 (Jain et al., 2010, Komatsu et 
al., 2010, Lau et al., 2010). The binding of p62 to Keap1 occurs on a site essential 
for Keap1 to bind nuclear factor (erythroid 2)-like 2 (Nrf2). This binding interrupts the 
repressor function of Keap1 on Nrf2 leading to its activation. Although the affinity of 
p62 for Keap1 is lower than that of Nrf2 (Komatsu et al., 2010), inhibition of 
autophagy and over expression of p62 have both been shown to sequester Keap1 
leading to the activation of Nrf2 (Jain et al., 2010, Komatsu et al., 2010). The ability 
of p62 to bind and sequester Keap1 also requires the PB1 domain and the ability of 
p62 to form oligomers (Jain et al., 2010). 
 
1.5.10.2 Regulation of intracellular levels of p62  
 
Transcriptional regulation 
 
Nrf2 is one of the main players in the transcriptional regulation of p62. Nrf2 is 
a member of basic leucine zipper (bZIP) family of transcription factors. Nrf2 is a key 
regulator of the antioxidant response and upon increased oxidative stress 
translocates to the nucleus where it binds to the antioxidant-responsive element 
(ARE motif) located in the p62 promoter to induce expression of p62 mRNA (Jain et 
al., 2010). p62 is a positive regulator of Nrf2 and this sets up a positive feedback 
loop in which p62, through activation of Nrf2, is able to drive its own transcription 
(Jain et al., 2010). Additionally, analysis of the 5’-flanking region of the p62 promoter 
has revealed binding sites for numerous transcription factors, such as NF-κB, Ets-1 
AP-1, and SP-1 (Vadlamudi and Shin, 1998). Expression of p62 has indeed been 
shown in response to transcription other than that induced from Nrf2 with p62 
expression increasing very rapidly (30 mins - 2 hours) in response to stimuli such as 
calcium, interleukin 3 (IL-3) and phorbol 12-myristate 13-acetate (PMA) (Lee et al., 
1998).  Interestingly, RAS-transformed fibroblasts have been shown to have high 
levels of p62 mRNA expression, which is reduced upon invalidation of the AP-1 
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binding site present upstream on the p62 promoter. These findings suggest that p62 
is regulated at the transcriptional level by the Ras/MEK/ERK1/2 pathway via the AP-
1 domain in its promoter (Duran et al., 2008). p62 has also been shown to be 
transcriptionally regulated downstream on JNK/c-Jun pathway in chronic 
myelogenous leukemia (CML) cells (Puissant and Auberger, 2010, Puissant et al., 
2010). The exact molecular mechanism, however, by which the JNK/c-Jun pathway 
elicits this effect on p62 transcription is still unknown.  
  
Post translational regulation  
 
As mentioned previously, p62 is a substrate for degradation by autophagy via 
its LIR domain-mediated interaction with the autophagosomal membrane (Pankiv et 
al., 2007). As a result, the intracellular levels of p62 can be greatly influenced by 
changes in autophagic flux. Thus, pro-autophagic stimuli such as starvation, hypoxia 
and treatment with autophagy inducing drugs lead to a decrease in intracellular p62. 
Similarly, inhibition of autophagy leads to an accumulation of p62. As such, 
intracellular levels of p62 are often used in the assessment of autophagic flux 
(Klionsky et al., 2012). Similarly, p62 has been shown to be a proteasomal substrate 
(Seibenhener et al., 2004) and so stimuli that modulate proteasomal activity could 
also influence intracellular levels of p62. 
 
1.5.10.3 p62 as a Signalling Molecule 
  
p62 was initially identified as an interacting partner of Lck-tyrosine kinase and 
atypical protein kinase C (αPKC) (Joung et al., 1996, Puls et al., 1997). Following its 
identification, p62 has been shown to participate in a number of signalling pathways. 
p62 has been show to serve as a scaffold where its function is to bring together two 
or more components of a signaling pathway for example the ZZ domain of p62 binds 
active RIP1 kinase and PB1 domain binds protein kinase C λ/ι (PKC λ/ι) in TNF-R 
signalling. Thus, upon stimulation of TNF-R p62, PKC λ/ι and RIP1 form a complex 
facilitating NFB activation. Disruption of the ZZ domain or reduced p62 expression 
is sufficient to impair TNFα-mediated NFkB activation (Sanz et al., 1999). p62 plays 
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a similar scaffold role in activation of  NFkB downstream of interleukin-1β receptor 
(IL-1βR) (Sanz et al., 2000b) and the nerve growth factor receptors TrkA and p75NTR 
(Wooten et al., 2000). Here p62 binds to the ubiquitin ligase TRAF6 via its TB 
domain along with interleukin-1 receptor-associated kinase (IRAK). PKC λ/ι is then 
recruited to this complex where it binds to the PB1 domain of p62 and is 
phosphorylation by IRAK leading to its activation (Sanz et al., 2000b, Mamidipudi et 
al., 2002). p62 plays further roles in IL-1β and NGF signal transduction aside from 
acting as a scaffold, with the UBA domain and PB1 domain of p62 having been 
shown to be necessary for the oligomerisation and self-ubiquitination of TRAF6 
(Wooten et al., 2005). Moreover, p62 has been shown to act as a link between two 
NGF receptors, TrkA and p75NTR. The formation of this bridge facilitates the 
ubiquitination of TrkA via TRAF6, a process required for both receptor internalisation 
(Geetha et al., 2005) as well as turnover via the proteasome (Geetha et al., 2008). 
Unsurprisingly, it has been shown that in IL-1 signalling intracellular levels of p62 can 
modulate signal intensity through IL-1βR. As a result, increased degradation of p62 
via the proteasome or autophagy lead to a dampening in IL-1 signalling causing an 
anti-inflammatory effect. This mechanism was first identified in Atg16L1-/- cells. Lee 
et al discovered that Atg16L1 is able to modulate levels of p62 via the proteasome 
and autophagy. Atg16L1 is essential for neddylation of Cul-3 (Cullin 3) and its 
activation. The Cul-3 complex has E3 ubiquitin ligase activity responsible for 
targeting p62 for proteasomal degradation. Therefore knock-out of Atg16L1 leads to 
a build up of p62 as a result of decreased autophagy and reduced degradation via 
the proteasome (Lee et al., 2012b). As well as impacting on IL-1 signalling the 
interaction of p62 with Cul-3 has been shown to stimulate the extrinsic apoptosis 
pathway. Here active Cul-3 is recruited to the death-inducing signalling complex 
(DISC) where it facilitates that addition of poly-Ub chains to caspase 8. Next, p62 
facilitates aggregation of Ub-tagged caspase-8 leading to its auto-catalytic cleavage 
and activation (Jin et al., 2009).  
p62 has also been implicated in amino acid sensing through mTOR. This is 
mediated through interaction of p62 with raptor, a key component of the mTORC1 
complex, enabling its translocation to the lysosome (Duran et al., 2011). This is 
thought to facilitate interaction of mTOR with the Rag family of small GTPases 
(Sancak et al., 2010). It has been shown that TRAF6 is also important to this 
process. TRAF6 is involved in recruiting mTORC1 to the lysosome and mediates the 
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K63-linked ubiquitination of the mTOR subunit of the complex allowing optimal 
activation by amino acids (Linares et al., 2013). Knockdown of TRAF6, similar to p62 
reduced proliferation and transformation-rate in cancer cells as well as increasing 
autophagic flux. This could be rescued by the expression of a constitutively active 
RagB mutant. Thus, p62 acts as a scaffold upstream of Rag proteins specifically 
regulating components involved in mTORC1 signalling (Linares et al., 2013, Duran et 
al., 2011). Recently, it was shown that phosphorylation of p62 at T269/S272 is 
critical to amino acid sensing through mTORC1 (Linares et al., 2015). The authors 
report that p62 is phosphorylatedvia a cascade that includes MEK3/6 and p38 and 
requires interaction with MEKK3 via its PB1 domain. This phosphorylation proceeds 
the recruitment of TRAF6 and the ubiquitination and activation of mTOR described 
previously (Linares et al., 2013). Importantly, mTORC1 can be activated through a 
number of different inputs. Amino acid sensing is the only known input to require p62 
and so activation via insulin for instance can occur independently of p62 status 
(Duran et al., 2011).  
p62 has been shown to activate an anti-oxidant response via its interaction 
with the Keap1-Nrf2 pathway (Komatsu et al., 2010). The Keap1-Nrf2 pathway is one 
of the major cellular antioxidant pathways (Itoh et al., 1999). Keap1 is a  negative 
regulator of the antioxidant response element through its interaction with 
transcription factor Nrf2 (Itoh et al., 1999). In physiological conditions Nrf2 is 
sequestered in the cytoplasm via a strong noncovalent interaction with Keap1 
homodimers. Keap1 then recruits Cul-3 leading to the ubiquitination of Nrf2 and its 
degradation by the proteasome (Cullinan et al., 2004, Furukawa and Xiong, 2005). 
Under oxidative conditions Keap1 is oxidised and undergoes a conformational 
change inhibiting its interaction with Nrf2, thereby inhibiting its degradation 
(Wakabayashi et al., 2004). This allows free Nrf2 to enter the nucleus where it is able 
to activate the transcription of a number of genes involved in ROS scavenging, DNA 
repair and mitochondrial function (Motohashi and Yamamoto, 2004). 
p62 can lead to the activation of Nrf2 in the absence of oxidative stress. Here, 
p62 binds to Keap1 via its KIR domain preventing its inhibitory effect on Nrf2 (Lau et 
al., 2010). This interaction with p62 has also been shown to lead to the degradation 
of Keap1 via autophagy (Fan et al., 2010). The interaction between p62 and Keap1 
is much weaker than that between Keap1 and Nrf2, therefore it has been suggested 
that p62 will only affect this pathway when it reaches supraphysiological levels, such 
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as those that occur due to inhibition of autophagy. Interestingly, there is a small 
portion of Keap1 that is constitutively bound by p62 (Copple et al., 2010) suggesting 
that there may be other influences such as post-translational changes to either p62 
or Keap1 that may regulate this process (Bitto et al., 2014). 
All of these findings show that p62 plays a role in multiple signalling pathways 
placing it at the heart of the maintenance of cellular homeostasis.   
1.5.10.4 p62 and Protein Homeostasis 
 
One of the most studied cellular functions of p62 is its role in protein 
homeostasis.  This is a function that came to light with the discovery of its UBA 
domain (Seibenhener et al., 2004, Vadlamudi et al., 1996). p62 has been shown to 
facilitate the selective autophagy of proteins (Pankiv et al., 2007), organelles (Geisler 
et al., 2010) and bacteria (Zheng et al., 2009). These substrates are usually targeted 
for autophagy through tagging with with poly-ubiquitin chains (K63 or K27 
linkages) and association with the UBA domain of p62. These p62 bound substrates 
then form aggregates mediated by oligomerisation of p62 with other molecules of 
p62, or other PB1 domain-containing proteins. These p62-substrate aggregates are 
referred to as sequestosomes and are targeted to autophagosomes via the LIR 
domain of p62, where they are degraded (Pankiv et al., 2007). As well as facilitating 
the formation of aggregates, p62 is also able to bind to pre-existing protein inclusions 
such as mutant huntingtin aggregates (Bjorkoy et al., 2005). The formation of these 
inclusions is greatly enhanced by phosphorylation of UBA domain on serine 403, a 
modification that increases the affinity of p62 for polyubiquitin linkages (Matsumoto 
et al., 2011). The ability of p62 to form oligomers is essential for its ability to target 
aggregates to the initiation point of the autophagosomal membranes, a process 
essential for efficient engulfment of these substrates (Itakura and Mizushima, 2011). 
These data suggest that p62 plays more than just an adaptor function, linking 
substrates to the autophagosomal membrane and places it as an active player in the 
autophagy process (Komatsu et al., 2007). As well as being able to target 
ubiquitinated substrates for degradation via autophagy, p62 has also been shown to 
facilitate the autophagic clearance of non ubiquitinated aggregates via interaction 
with is PB1 domain (Watanabe and Tanaka, 2011).     
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As well as its role in autophagy p62 has been implicated in targeting 
ubiquitinated proteins to the proteasomal degradation pathway. Selection of which 
degradation pathway is chosen is thought to depend on posttranslational 
modification such as ubiquitin linkage. Interestingly, p62 is able to interact with the 
proteasome via its PB1 domain and knockdown of p62 can impair the degradation of 
proteasomal substrates (Seibenhener et al., 2004, Pankiv et al., 2010, Geetha et al., 
2008). Furthermore, p62 contains two PEST sequences and is itself target for 
proteasomal degradation via Cul-3 mediated ubiquitination (Lee et al., 2012b). 
Interestingly, levels of p62 appear to play an important role in regulation of 
proteasomal degradation with reduction (Seibenhener et al., 2004) or an 
accumulation (Korolchuk et al., 2009) of p62 leading to an impairment of 
proteasomal degradation. This apparent dual role in the regulation of proteasomal 
degradation is dependent on intracellular levels of p62, while single molecules of p62 
are able to bind to proteasomal substrates and target them for degradation, when 
levels of p62 increase beyond a certain threshold, large oligomers begin to form and 
proteasomal substrates become sequestered within them. These aggregates are 
themselves too large to be degraded via the proteasome, however, it has been 
suggested that the formation of aggregates comprised of p62 and proteasomal 
substrates, may be a route by which proteins classically regarded as substrates of 
the proteasome become targets for  degradation by autophagy (Bitto et al., 2014).  
1.5.10.5 p62 and the DDR 
 
As discussed above, autophagy has been shown to affect DNA damage 
response and repair. One of the hypothesized mechanisms is through its regulation 
of cellular levels of p62. Thus, Bae and Guan have shown that in addition to a 
marked increase in p62 levels inhibition of autophagy (through the knock-out of 
FIP200) results in impaired repair of DNA damage induced by IR, Camptothecin and 
Etoposide (Bae and Guan, 2011). Knockdown of p62 in cells lacking FIP200 with 
shRNA restored DNA damage repair in response to CPT as measured by H2A.x 
foci. Moreover, p62 knock-down also rescued cell survival. Similarly, p62 knock-
down partially rescued cell viability and DNA repair in response to IR- and 
Etoposide-induced damage (Bae and Guan, 2011). It has also been suggested that 
the increased levels of ROS seen in autophagy deficient cells may mediate 
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increased levels of DNA damage (Mathew et al., 2007b). However, treatment with 
the antioxidant NAC did not rescue deficient DNA damage repair in FIP200 KO 
MEFs compared to wild-type (Bae and Guan, 2011). These results suggest that the 
effect of autophagy knockdown on DNA damage repair is at least in part due to 
increased levels of p62 and can occur independently of ROS. However, the exact 
mechanism by which p62 can affect DNA damage repair is not yet understood. 
Although p62 is mainly located in the cytoplasm, the discovery of nuclear-
cytoplasmic shuttling along with interaction between p62 and PML bodies within the 
nucleus (Pankiv et al., 2010) could provide an interesting avenue of research when 
trying to elucidate its role in the DDR. PML bodies have been implicated in DNA 
damage especially the orchestration of homologous recombination (Yeung et al., 
2012).   
1.5.10.6 p62 in Disease   
Cancer 
 
As described above p62 is involved in several signalling pathways including 
NFB and Ras/Raf/MAPK and mTOR. These are signalling pathways that are 
commonly modified during tumour transformation and help promote proliferation 
migration and invasion of tumour cells. This, combined with the role of p62 in the 
regulation of autophagy (Duran et al., 2011), place p62 as a potential player 
in carcinogenesis. However, the exact contribution of p62 in tumour progression is 
still poorly understood, this is in part due to its wide range on cellular functions and 
depends on its involvement in pro-oncogenic signalling coupled with its role in both 
pro and anti-tumorigenic autophagy.  
The transformation of cells requires them to reprogram metabolic pathways to 
escape cell death and acquire new invasive properties. Autophagy has long been 
known to be dysregulated during carcinogenesis (Mathew et al., 2007a). Yet, the 
exact role for autophagy in this process is still poorly understood with autophagy 
having been reported to have both pro and anti-tumorigenic activity. During the 
initiation of tumour growth autophagy helps cancer cells overcome metabolic stress, 
protecting against low O2 and nutrients that occur due to reduced perfusion in the 
absence of vascularization (Degenhardt et al., 2006). Therefore, in the early stages 
of tumour development it is thought autophagy plays a pro-tumorigenic role. 
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However, during the later stages of tumour development loss of autophagy is 
thought to lead to increased levels of ROS as well as damaged organelles which, in 
turn, results in an increase in the rate of DNA mutations and loss of genome stability 
(Mathew et al., 2007b). Furthermore, this decreased autophagy leads to an increase 
in intracellular p62. 
Accumulation of p62 has been seen in many different cancer types such 
as non-small-cell lung carcinoma (NSCLC) (Inoue et al., 2012) and breast cancer 
(Thompson et al., 2003). Levels of p62 have also been shown to correlate with a 
poor prognosis (Inoue et al., 2012) or increased severity (Rolland et al., 2007) of 
cancer in a clinical context. p62 is able to influence tumour progression 
independently from its role in autophagy. As described previously, p62 plays a role in 
a number of signalling pathways. Many of these interactions have been shown to be 
key to the role of p62 in cancer development and progression. Increased synthesis 
of p62, as a result of NF-B activation downstream of constitutive Ras activation, has 
been observed in ductal pancreatic adenocarcinoma cells. Here, p62 through its 
interaction with TRAF6, serves to amplify Ras activation setting up a positive 
feedback loop (Ling et al., 2012). Similar p62-dependent activation of NF-B 
signalling has been observed in lung cancer, Here this activation is thought to elicit 
an antioxidant response leading to inhibition of deleterious ROS (Duran et al., 2008). 
Interestingly, high levels of p62 and related MAPK activation have been observed in 
a subset of aggressive glioblastoma, with inhibition of p62 leading to a reduction in 
mortality and invasiveness of tumour cells (Galavotti et al., 2013). 
p62 has also been observed to play a pro-tumorigenic role through its 
activation of the mTOR pathway (Duran et al., 2011). Knock-down of p62 using 
shRNA has been shown to inhibit the growth of tumour cells with hyper-activated 
mTOR (Duran et al., 2011). p62 has also been shown to be necessary for the 
development of tumours in Tsc2+/- mice (Parkhitko et al., 2011). Similarly, 
knockdown of p62 lead to increased survival in mice injected with (TSC2-/-) MEFs 
(Parkhitko et al., 2011). These results highlight the activation of mTOR via p62 as a 
key pro-tumorigenic event. 
There are also data suggesting that p62 may play a tumour suppressive 
function in some contexts, particularly during mitosis (Linares et al., 2011). Here, 
they show that phosphorylation of p62 by cyclin-dependent kinase 1 (CDK1) at T269 
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and S272 is an important regulator of levels cyclin B1 and CDK1 activity which are 
necessary to properly control entry and exit from Mitosis. Lack of this 
phosphorylation leads to a more rapid exit from mitosis, resulting in increased 
proliferation and tumorigenesis following Ras-induced transformation (Linares et al., 
2011).  
Taken together these studies highlight the importance of p62 during cancer 
development, with p62 playing an apparent dual role in tumorigeneses, both 
dependent and independent of its role in autophagy. Further understanding of the 
involvement of both p62 and autophagy in the context of tumorigenesis will no doubt 
provide novel avenues for drug development and cancer treatment.    
 
Neurodegeneration 
 
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD) and Huntington’s disease (HD) are characterized by the buildup of 
protein aggregates in the brain. Different proteins are responsible for the aggregates 
seen in each disease but the presence of p62 associated with these aggregates is a 
common feature of many proteinopathies (Kuusisto et al., 2001). The presence of 
p62 in these aggregates was originally believed to be required for their formation 
(Kuusisto et al., 2002). However, more recently, p62 has been shown to associate 
with protein inclusions following their formation (Bjorkoy et al., 2005) , in the case of 
AD, p62 is responsible for the degradation of Tau via the proteasome (Babu et al., 
2005). In agreement with p62 playing a protective role in AD, mice lacking p62 show 
many AD associated characteristics such as age-associated accumulation of K63-
tagged tau, neuronal cell death, increased anxiety and reduced short term memory 
(Ramesh Babu et al., 2008). Interestingly, levels of p62 are reduced in AD brains 
compared to control. This is thought to occur due to oxidative damage to the 
promoter region of p62 (Du et al., 2009a), a process which has been shown to 
increase with age and is a common feature of many neurodegenerative diseases 
(Du et al., 2009b). 
Both oxidative stress and mitochondrial dysfunction are common features of 
neurodegenerative diseases (Lin and Beal, 2006) particularly in PD (Geisler et al., 
2010, Narendra et al., 2008). p62 has been suggested to play a role in the 
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maintenance of mitochondrial homeostasis, (Geisler et al., 2010, Narendra et al., 
2010) as well as antioxidant defense through its role in the Keap1-NRF2 pathway 
(Lau et al., 2010). A loss of p62 has been shown to correlate with a reduction in Nrf2 
activity in neurons of those affected by neurodegeneration (Ramsey et al., 2007). 
Interestingly, an Nfe2l2 haplotype that confers increased transcriptional activity of 
Nrf2 appears to have a protective effect against the development of PD (von Otter et 
al., 2010). Similarly, expression of Nrf2 in a Drosophila melanogaster model of PD 
protects against neurodegeneration (Barone et al., 2011). These data show that p62 
can have a protective effect on neurodegeneration both through its role in the 
clearance of pathogenic protein aggregates as well as its role in maintenance of 
mitochondrial homeostasis and antioxidant defence.  
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1.5.11 Autophagy and Apoptosis 
 
 The connection between autophagy and apoptosis and other forms of 
cell death is a growing area of research. Autophagy and apoptosis are regulated by 
common stimuli and signalling pathways (Figure 1-9). 
 
Figure 1-9: Crosstalk between apoptosis and autophagy. Autophagy and 
apoptosis are controlled by overlapping signalling pathways and show a degree of 
mutual inhibition. Sustained induction of apoptosis leads to a caspase 8 mediated 
cleavage of Beclin 1 generation N and C fragments inhibiting their ability to induce 
autophagy. The C-terminal fragment translocates to mitochondria sensitizing the cell 
to pro-apoptotic signals. Although caspase-mediated cleavage of Atg5 and Beclin 1 
has an inhibitory effect on autophagy, caspase 3-mediated cleavage of Atg 4D 
generates a fragment with increased autophagic activity. Autophagy can also inhibit 
apoptosis by degrading active caspase 8.  
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As described earlier, Beclin1 is essential for the formation of autophagic 
vesicles Beclin1 is known to interact with Bcl-2, a key regulator of apoptosis as well 
as another anti-apoptotic protein from the Bcl family, Bcl-xL, Bcl-2/Bcl-xL not only 
inhibits apoptosis by binding pro-apoptotic proteins Bax and Bak, it also plays a role 
in the inhibition of autophagy through the binding of Beclin 1 (Pattingre et al., 2005). 
This interaction was shown to occur via the Bcl-2 homology 3 (BH3-only ) domain on 
Beclin 1 (Feng et al., 2007). Conversely it has been shown that disruption of the 
interaction between Beclin 1 at the BH3 domain and Bcl-2 leads to an induction of 
autophagy (Maiuri et al., 2007). Activation of c-Jun N-terminal kinase 1 (JNK1) has 
been shown to phosphorylate Bcl-2 and cause it to dissociate from Beclin1, 
highlighting another mechanism by wich stress can activate autophagy (Wei et al., 
2008). Despite BH3- only proteins of the Bcl-2 family being well know inducers of 
autophagy and apoptosis, Beclin 1, which contains this domain, does not activate 
apoptosis even when overexpressed and autophagy is active (Boya and Kroemer, 
2009). Instead, Beclin 1 has been shown to offer cytoprotection to several apoptotic 
stimuli including starvation, suggesting an anti-apoptotic role for Beclin 1 (Boya and 
Kroemer, 2009).  
Caspases are cysteine aspartyl proteases that play a pivotal role in the 
execution of apoptotic cell death. Activated caspases cleave a large number of 
proteins usually resulting in inactivation through removal of regulatory domains (Yi 
and Yuan, 2009). Interestingly, caspases can cleave Beclin 1 during sustained 
exposure to pro-apoptotic stimuli, resulting in a loss of its pro-autophagic capacity 
(Wirawan et al., 2010) Atg5 and Atg4D can also be cleaved by caspases in response 
to apoptosis, the cleavage product of Atg5 is thought to interact with Bcl-2 proteins at 
mitochondria and help to induce cell death by apoptosis (Yousefi et al., 2006).  
Unlike cleavage of Atg5 and Beclin 1 that inhibits autophagy, cleavage of Atg4D 
generates a fragment that increases autophagic activity. This fragment has, 
however, been shown to have a cytotoxic effect independent from activation of 
autophagy thought to correlate with its recruitment to mitochondria (Betin and Lane, 
2009).  Thus, caspase-mediated cleavage of the autophagy components Atg5, 
Atg4D and Beclin 1 may serve to amplify the apoptotic programme through the 
mitochondrial pathway. 
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Recent work has identified Atg12, an essential autophagy protein, as a 
potential point of cross-talk between autophagy and apoptosis. In work by Rubinstein 
et al it was shown that Atg12 is a positive mediator of apoptosis, with knockdown of 
Atg12 leading to an inhibition of Bax activation and cytochrome c release. 
Additionally, it was shown that over-expression of Atg12 reduced the anti-apoptotic 
activity of Mcl-1 (Rubinstein et al., 2011). The cross-talk between autophagy and 
apoptosis highlights the importance of autophagy in determining cell-fate in response 
to stress. 
1.5.12 Autophagy and the DDR 
 
Despite autophagy being a cytoplasmic process and DNA damage occurring 
in the nucleus, there is a growing body of evidence suggesting a link between the 
two processes. It has been observed that activation of autophagy occurs following 
the induction of DNA damage by a number of different of genotoxic agents 
(Katayama et al., 2007, Abedin et al., 2007, Yao et al., 2003). Autophagy has been 
shown to play a cytoprotective role in response to DNA damage, with inhibition 
leading to increased cell death (Liu et al., 2015, Elliott and Reiners, 2008, Apel et al., 
2008, Amaravadi et al., 2007). Furthermore, inhibition of autophagy has been shown 
to lead to increased genome instability (Zhao et al., 2012, Katayama et al., 2007) 
suggesting a cytoprotectective role for autophagy in response to DNA damage. 
Conversely, the activation of autophagy in response to DNA damage has also been 
show to lead to cell death when canonical apoptosis pathways are impaired (Kim et 
al., 2005, Assuncao Guimaraes and Linden, 2004). The exact role of autophagy in 
the DDR is still not fully understood however has been a great area of interest in 
recent years. 
 
Activation of autophagy following DNA damage 
 
 The exact mechanisms by which autophagy is activated in response to DNA 
damage are still being debated. It has been shown that autophagy is activated in a 
PARP-1 dependent manner following DNA damage induced by doxorubicin (Munoz-
Gamez et al., 2009). The enzyme PARP-1 (poly [ADP-ribose] polymerase 1) is 
activated in response to DNA damage. This enzyme converts β-nicotinamide 
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adenine dinucleotide (NAD+) into polymers of poly(ADP ribose) and plays a role in 
nuclear homeostasis. Once hyper-activated in response to DNA damage, PARP-1 
causes depletion in NAD+ and ATP, eventually leading to energy crisis and cell 
death (Ha and Snyder, 1999). Here it has been suggested that autophagy is 
activated in response to reduced intracellular ATP and serves a protective function 
against energy stress. Indeed, inhibition of autophagy in this context has been 
shown to lead to increased cell death (Munoz-Gamez et al., 2009, Huang and Shen, 
2009).  
Another means by which autophagy has been shown to be activated 
downstream of a DDR is through p53 (Crighton et al., 2006, Kang et al., 2009, Feng 
et al., 2005). The exact mechanism of p53-dependent activation of autophagy is not 
fully understood. It has been shown to be independent of the transcriptional activity 
of p53: through AMPK and TSC1/2 activation leading to long term inhibition of 
mTORC1 (Feng et al., 2005). As well as dependent on the transcriptional activity of 
p53:  through p53 mediated expression damage-regulated autophagy modulator 
(DRAM) encoded lysosomal protein that leads to increased autopahgy (Crighton et 
al., 2006). Additionally, autophagy has also been shown to be induced in response to 
expression of tumour suppressor ARF in both a p53-dependent and p53-
independent manner (Abida and Gu, 2008). Although activation of p53 can induce 
autophagy it has also been shown that p53 can also have an inhibitory effect on 
autophagy (Tasdemir et al., 2008). Autophagy has also been how to be activated 
downstream of phosphorylated ATM, a key step in the initiation of the DDR. Here 
ATM activates TSC2 via AMPK to inhibit mTORC1 and activates autophagy 
(Alexander et al., 2010). These results highlight p53 as a bilateral regulator of 
autophagy. It has been suggested that activation of autophagy in response to low 
levels of DNA damage may assist in DNA repair through the degradation of 
damaged proteins and organelles by freeing cellular energy to be used in the repair 
process. However, on the flip side of this if the damage is too severe or is unable to 
be repaired then the prolonged activation of autophagy may help to accelerate cell 
death in a p53-dependent manner (Crighton et al., 2006).  
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Autophagy and DNA repair  
 
More recently it has been suggested that autophagy may have a more direct 
effect on DNA damage repair. There have been results showing that inhibition of 
autophagy leads to a decreased repair capacity in response to DNA damage agents 
(Bae and Guan, 2011, Liu et al., 2015). In the paper by Bae and Guan, autophagy is 
inhibited by the genetic knock out of 200 kDa FAK-family interacting 
protein (FIP200), an essential component of the mammalian autophagy machinery 
leading to a reduced DNA damage repair capacity. The exact mechanism  is not 
explored however they do suggest that it is in part due to increased levels of p62 
found in autophagy compromised cells and independent of increased levels of ROS 
(Bae and Guan, 2011). More recently a paper from Kevin Ryan’s group in Glasgow 
showed that loss of autophagy through an inducible knock-out of Atg7 leads 
specifically to an inhibition of homologous recombination through the enhanced 
proteasomal degradation of checkpoint kinase 1 (Chk1) (Liu et al., 2015). They 
report that cells lacking autophagy have a higher proteasome activity that results in a 
reduction in both phosphorylated and total levels of Chk1. Downstream analysis of 
homologous recombination via quantification of RAD51 foci or using the reporter 
plasmid described in (Pierce et al., 1999) show a reduction in this repair pathway in 
cells lacking autophagy.       
1.5.13 Autophagy and Senescence 
  
Autophagy and senescence are both activated in response to various cell stressors 
such as radiation, chemotherapy and oxidative stress (Katayama et al., 2007, Yao et 
al., 2003, von Zglinicki et al., 2005).  The relationship between the two, however, is 
poorly understood with some reports suggesting a direct involvement of autophagy in 
the progression of senescence (Young et al., 2009) and others suggesting that 
inhibition of autophagy is a key driver of senescence (Kang et al., 2011). 
 A number of papers have provided data to suggest a collateral induction of 
senescence and autophagy. An increase in autophagosomes and senescence-
associated β-galactosidase (Sen-β-Gal) activity has been observed in ageing 
fibroblasts (Gerland et al., 2003). Markers for both autophagy and senescence have 
been observed in the bile ducts of patients with primary biliary cirrhosis, along with 
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biliary epithelial cells in mice treated with DNA damaging agents such as hydrogen 
peroxide and Etoposide, senescent endothelial cells as well as senescent human 
dental pulp (Sasaki et al., 2012, Sasaki et al., 2010, Patschan et al., 2008, Li et al., 
2012a). These observations however are merely correlative and do not address the 
question whether autophagy and senescence are linked or interdependent 
responses. 
 One of the first studies carried out to test a potential direct relationship 
between autophagy and senescence was carried out by Young et al in human 
fibroblasts (Young et al., 2009). Here the authors suggest that oncogene-induced 
senescence could be dependent on the activation of autophagy as pharmacological 
and genetic interference with autophagy caused suppression in senescence. 
However, the conclusion from this work is that inhibition of autophagy delays but 
does not abrogate senescence, with senescence eventually achieving identical 
levels in cells with and without autophagy. Moreover, the authors also showed that 
inhibition of autophagy could not rescue the development of senescence supporting 
the idea that autophagy can accelerate oncogene induced senescence in fibroblasts, 
but once initiated the development of senescence is independent of autophagy.  The 
mechanism by which increased autophagy could accelerate senescence is not yet 
understood. It has been suggested that the up-regulation of autophagy could provide 
the cell with a supply of energy in anticipation of the permanent cell cycle arrest seen 
in senescence (Gewirtz, 2013). 
 Other studies have also reported a decrease in senescence with the inhibition 
of autophagy (Singh et al., 2012, Mosieniak et al., 2012). Similarly, others report an 
increase in autophagy with the induction of senescence (Maddodi et al., 2010, 
Capparelli et al., 2012), however it has yet to be conclusively proven that the two are 
functionally connected.  
Both autophagy and senescence are believed to serve cytoprotective 
functions in response to stress.  Autophagy and senescence are regulated by 
overlapping signalling pathways such as p53 and mTOR. This makes the study of 
the role of autophagy in senescence difficult as interventions intended to modulate 
autophagy could have a direct effect on senescence itself. One challenge is that the 
suppression of autophagy in cells undergoing senescence causes an increase in the 
population of apoptotic cells and so what appears to be an increase in the 
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percentage of senescent cells is actually due to cell loss through apoptosis 
(Thorburn, 2008). 
 
1.5.14 Autophagy and Ageing 
 
It has been well documented that there are age-associated changes in 
autophagy pathways. This is due to many factors, such as an increased load of 
damaged and misfolded proteins, as well as dysfunctional organelles (Martinez-
Vicente et al., 2005). These changes are believed to occur due to an increase in 
oxidative stress, as well as changes in regulatory factors. Age-related decline in 
macroautophagy and CMA activity has been observed (Cuervo and Dice, 2000a, 
Vittorini et al., 1999). It is thought that this decreased activity in both of these 
degradation pathways could contribute, at least in part, to the accumulation of 
damaged proteins and organelles and help contribute to a loss of homeostasis and 
aberrant stress responses in ageing cells. 
 
Age-dependent Changes in Autophagy Pathways 
  
 Changes in macroautophagy with age are accompanied by a number of 
morphological changes to the lysosomal system. These include an expansion of the 
cellular acidic compartment, an accumulation of autophagic vacuoles and a build-up 
of undegraded material in the lumen of the lysosome known as lipofuscin (Cuervo 
and Dice, 2000b). A decline in autophagy with age has been previously observed 
and has been suggested to contribute to cellular ageing (Terman, 1995, Vittorini et 
al., 1999, Lipinski et al., 2010).  
In contrast to macroautophagy, there have been no age-associated 
morphological changes in the subset of lysosomes able to perform CMA (Cuervo 
and Dice, 2000c). Functional analyses, however, have shown that both substrate 
binding and translocation across the lysosomal membrane is greatly impaired in 
lysosomes taken both from organs from aged animals and senescent cells. These 
functional changes in the CMA pathway have been attributed to an age-dependent 
decrease in LAMP-2A on lysosomal membranes (Cuervo and Dice, 2000a). This 
gradual decline in LAMP-2A levels begins at middle age, although the decline in 
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function is temporarily offset by an increase in the number of lysosomes recruited to 
perform CMA. This compensatory increase in the number of lysosomes containing 
Hsc70 is only transient and, eventually, a functional decline in CMA becomes 
apparent (Cuervo and Dice, 2000a).  
 This age related reduction on LAMP-2A is not caused by a reduction in 
transcription, synthesis or the lysosomal trafficking of LAMP-2A. Instead it is thought 
to be caused by a reduction of the stability of LAMP-2A in the lipid membrane of the 
lysosome. The exact mechanisms underlying this drop in stability are unclear, 
however, changes in the lipid composition of the lysosomal membrane have been 
observed with age (Rodriguez-Navarro et al., 2012). It is possible that this disrupts 
the dynamics of LAMP-2A within this system and could contribute to the reduced 
levels of this receptor seen in old lysosomes. 
 Additional work is required in order to fully elucidate the changes that occur in 
autophagy with age. There is increasing evidence that manipulation of autophagy 
can have an impact on longevity, as well as have beneficial effects on many age 
associate pathologies.  
Manipulation of Autophagy Impacts on Lifespan 
 
 Many studies designed to investigate mechanisms which impact on ageing 
and longevity, have identified pathways that modulate autophagy. One of the first 
identified and reproducible interventions able to extend lifespan was calorie 
restriction (CR). The life-span promoting effects of CR are evolutionary conserved 
and have been observed in yeast, worms (C. elegans), flies (D. melanogaster) and 
rodents (Fontana et al., 2010). The increase in lifespan seen with CR is, at least, in 
part, due to autophagy as deletion or mutation of autophagy proteins inhibits the life 
span extension seen in CR (Rubinsztein et al., 2011, Hansen et al., 2008). 
Treatments that activate autophagy, such as rapamycin and resveratrol, have also 
been shown to increase lifespan (Wood et al., 2004, Harrison et al., 2009). Similarly, 
interventions that down-regulate autophagy have been shown to have a negative 
effect on longevity and lead to an accelerated ageing phenotype (Hansen et al., 
2008). Interestingly, it has been shown that short term DR, an intervention 
associated with life span extension, causes an increase in the turnover of 
mitochondria (Miwa et al., 2008). It was recently shown that overexpression of Atg5 
in mice leads to an increase in autophagy and extension of lifespan. Moreover, 
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MEFs isolated from these Atg5 transgenic mice showed a marked resistance to 
oxidative stress-induced cell death. This resistance was reduced when autophagy 
was inhibited with either 3-MA or Baf (Pyo et al., 2013). These data suggest that an 
up-regulation of autophagy or prevention of its decline could decrease the 
accumulation of damaged macromolecules and organelles and improve longevity. 
1.6 Dietary Restriction as a modulator of longevity 
Dietary restriction (DR), reduced calorie intake without causing malnutrition, 
was first shown to extend lifespan almost 80 years ago (McCay et al., 1989, 
McDonald and Ramsey, 2010) since then it has been shown to extend lifespan in 
many model organisms (Guarente and Kenyon, 2000) as well as reduce the 
progression of age-associated diseases, reviewed in (Masoro, 2002) . These factors 
led DR to be one of the most commonly studied interventions when trying to uncover 
the mechanisms of organismal ageing. The exact mechanisms by which DR elicits 
this effect on lifespan are not yet fully understood, however, it is well known that DR 
reduces the accumulation of oxidatively damaged molecules that occurs with age in 
rodents reviewed in (Walsh et al., 2014). This effect could be down to a reduction in 
the rate at which ROS is generated in animals under DR (Miwa et al., 2014, Sanz et 
al., 2005) or an increase in the activity of protective pathways such as antioxidant 
defenses (Walsh et al., 2014) and repair pathways (Haley-Zitlin and Richardson, 
1993). Interestingly, even animals subjected to short term DR show lower levels of 
DNA damage as measured by H2A.X foci compared to AL (Ad-Libitum) (Wang et al., 
2010). DR has also been shown to reduce the levels of damaged proteins in mice 
and rats (Sohal et al., 1994, Aksenova et al., 1998, Youngman et al., 1992). 
Moreover, life extension by DR has been shown to require autophagy (Rubinsztein 
et al., 2011, Jia and Levine, 2007). In mice DR has been shown to activate 
autophagy (Bergamini et al., 2003)  through the activation of either AMPK or 
SIRT1 (Kim et al., 2011) as well as increase expression of proteasome 26S subunit, 
ATPase 3 (Psmc3) proteasome regulatory particle base subunit (Rpt5), a subunit of 
the 19s proteasome, as well as proteasome activator proteasome activator subunit 1 
(PSME1) (Lee et al., 1999). Taken together,  these data show correlations between 
DR and a reduction in various forms of cellular damage, however we are still yet to 
fully understand the exact contribution of these changes to increasing longevity.   
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1.7 Aims 
 
Although autophagy has been shown to be an important determinant of longevity, 
the mechanisms by which autophagy is involved in the ageing process have not yet 
been fully identified. Recent studies have suggested a role for autophagy in the DNA 
damage response and repair; however the underlying processes are not yet 
understood. The general aim of this thesis is to understand the role of autophagy in 
DNA damage repair and to test if crosstalk between these two processes is a feature 
of normal ageing. 
 
 
Specific aims 
 
1.To investigate the role of autophagy in DNA damage repair. 
 
2.To investigate the role of the autophagy adaptor p62 in DNA damage repair.  
 
3.To investigate the contribution of interactions between p62 and DNA damage 
during ageing. 
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2. Chapter 2. Material and Methods 
2.1 Materials 
2.1.1 Cell lines  
 
Prokaryotic cell lines 
 
α-select GOLD Efficiency chemically competent cells (Bioline #BIO-85027) 
were used for non-lentivirus constructs. NEB Stable competent E.coli (High 
Efficiency) (New England BioLabs #C3040) were used for lentivirus constructs. 
Eukaryotic cell lines 
 
Human cell lines 
Human embryonic lung MRC5 fibroblasts and HeLa cells were obtained from 
ECACC (European Collection of Cell Cultures) (Salisbury, UK) and HEK 293FT were 
purchased from Life Technologies #R700-07). 
Mouse cell lines 
p62 knock-out p62-/- and wild type p62+/+ mouse embryonic fibroblasts (MEFs) 
(Komatsu et al., 2007) were kindly provided by Dr. Eiji Warabi of the University of 
Tsukuba. Autophagy-related protein 5 (Atg5)-deficient Atg5−/− and wild-type Atg5+/+ 
MEFs (Kuma et al., 2004) and M5-7 MEFs (Hosokawa et al., 2007) were kindly 
provided by Dr Noboru Mizushima (Tokyo Medical and Dental University). The M5-7 
cell line is a cell line derived from Atg5−/− MEFs, here Atg5−/− MEFs have been 
coupled with a Tet-off system, allowing an inducible knock out of Atg5 when Dox is 
present. M5-7s have the benefit over Atg5−/− MEFs as they allow the study of acute 
autophagy knock out. This is advantageous as cells have less time to adapt to the 
lack of autophagy and as the cells are the same at the beginning of an experiment 
there is less impact of clonal differences between cells with and without autophagy.  
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Cloning 
 
For lentiviral expression full length wild type FLAG-tagged p62 was subcloned into 
the pLENTI6/V5-DEST vector using EcoRI and XhoI (NEB). Briefly, FLAG-p62 and 
pLENTI6/V5-DEST vector were digested with EcoRI and XhoI prior to gel purification 
(QIAquik GEL Extraction Kit (Qiagen)). The vector was dephosphorylated by calf 
intestinal alkaline phosphatase (Fermentas) and the ligation with FLAG-p62 was 
carried out using T4 DNA Ligase (New England BioLabs). Cloning was performed by 
Gisela Otten (Newcastle University). 
mCherry-53BP1c for lentiviral expression was carried out as follows: a 2.7 kb C-
terminal portion of 53BP1 (53BP1c), was excised from pAcGFP-53BP1c (Nelson et 
al., 2009) using BamHI and XhoI and ligated into pENTR2B (Invitrogen) to create 
pENTR2B-53BP1c. The sequence for mCherry fluorescent protein was amplified via 
PCR from pRSETB-mCherry (Shaner et al., 2004), incorporating SalI sites at both 
ends and a 5 amino acid linker at the 3' end. This product was ligated into 
pENTR2B-53BP1c SalI site in frame 5' of 53BP1c. A correct, sequence verified clone 
was then recombined into pLenti6-UbC/V5-DEST using LR Clonase following the 
manufacturer's instructions (Invitrogen) to produce pLenti6-mCherry-53BP1c. 
Cloning was performed by Dr James Wordsworth (Newcastle University).  
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2.1.2 Antibodies 
Table 2.1: Primary antibodies for Immunofluorescence on cells 
    Primary  antibodies  
Protein Host Dilution Reference/Manufacturer 
p62 Guinea pig 1:200 Progen #GP-62-C 
53BP1 Rabbit 1:200 CST #4937 
p62 Rabbit 1:1000 MBL #PM045 
Rad51 Rabbit 1:1000 Millipore #ABE257 
p62 Mouse 1:1000 BD Laboratories #610832 
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Table 2.2: Secondary antibodies for Immunofluorescence on cells 
 
Secondary antibodies 
     
Protein Species Host Dilution Reference/Manufacturer 
Anti-mouse 
Fluorescein-
conjugated 
AlexaFluor 488 
Mouse Goat 1:4000 A21042 -Invitrogen  
Anti-mouse 
Fluorescein-
conjugated 
AlexaFluor 594 
Mouse Goat 1:4000 A21044 - Invitrogen 
Anti-mouse 
Fluorescein-
conjugated 
AlexaFluor 647 
Mouse Goat 1:4000 A21238 - Invitrogen 
Anti-rabbit 
Fluorescein-
conjugated 
secondary 
antibody 
AlexaFluor 488 
Rabbit Goat 1:4000 A21212 - Invitrogen 
Anti-rabbit 
Fluorescein-
conjugated 
AlexaFluor 594 
Rabbit Goat 1:4000 A21213 - Invitrogen 
Anti-rabbit 
Fluorescein-
conjugated 
AlexaFluor 647 
Rabbit Goat 1:2000 A21244 - Invitrogen 
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Table 2.3: Primary antibodies for Western Blotting 
 
Primary antibodies for Western Blotting 
     
Protein Host Dilution Reference/Manufacturer 
Atg5  Rabbit  1:1000 Sigma #A0856 
CHD4  Rabbit  1:1000 Active Motif #39290 
Chk1  Rabbit  1:500 CST #2360 
FLAG M2  Mouse  1:2000 Sigma #F1804 
GAPDH   Rabbit 1:10000 CST #5174 
GFP Chicken 1:2000 Abcam #ab13970   
LC3B   Rabbit  1:1000 CST #3868  
p21   Rabbit  1:1000 CST #2947 
p53 Rabbit  1:1000 CST #9282 
p62  Guinea pig   1:1000 Progen #GP-62-C 
PARP   Rabbit  1:1000 CST #9284 
p-Chk1 
(Ser345)  Rabbit  1:1000 CST #2348 
p-p53 (Ser15)  Rabbit  1:1000 CST #9284  
Filamin A Rabbit 1:1000 CST #4762 
RAD51 Rabbit 1:1000 Millipore #ABE257 
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Table 2.4:  Secondary antibodies for Western Blotting 
 
Secondary antibodies for Western Blotting 
     
Protein Species Host Dilution Reference/Manufacturer 
Goat anti-
rabbit IgG -
HRP 
conjugated 
Rabbit Goat 1:5000 A0545 - Sigma  
Goat anti-
mouse IgG -
HRP 
conjugated 
Mouse Goat 1:5000 A2554 - Sigma  
Rabbit  anti-
Guinea Pig 
IgG -HRP 
conjugated 
Guinea 
Pig 
Rabbit 1:2500 P 0141 - Dako 
Goat anti-
chicken IgG -
HRP 
conjugated 
Chicken Goat 1:5000 ab97135 Abcam 
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Table 2.5: Primary antibodies for Immunostainings on Mouse Tissues 
Primary antibodies 
     
Protein Species Host Dilution Reference/Manufacturer 
γ-H2A.X(Ser139) 
Human 
Mouse 
Rabbit 1:200 #9718 - CST 
p62 
Human 
Mouse 
Guinea 
Pig 
1:100 #GP-62-C – Progen 
 
 
Table 2.6: Secondary antibodies for Immunostainings on Mouse Tissues 
Secondary antibodies 
     
Protein Species Host Dilution Reference/Manufacturer 
Anti-guinea pig 
Fluorescein-
conjugated 
secondary antibody 
AlexaFluor 594 
Guinea 
pig 
Goat 1:2000 A11076 - Invitrogen 
Anti-rabbit Vectastain 
(biotinylated) 
Rabbit Goat 1:4000 PK4001 –Vector lab 
Fluorescein Avidin 
DCS 
  1:500 
A-2011 - Vector 
Laboratories 
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2.1.3 Cell Culture  
 
Table 2.7:  Reagents for Cell Culture 
     
Reagent Manufacturer Reference  
Trypsin-EDTA Solution  Sigma   T3924 
Penicillin-Streptomycin Sigma   P4333 
Mycoalert Detection Kit Lonza LT07-218 
L-Glutamine Solution  Sigma   G7513 
Dulbecco’S Modified Eagle’S Medium 
(DMEM) 
Sigma   D5796 
Dimethyl Sulfoxide (DMSO) Sigma   D2650 
20 X PBS New England Bio 9808 
10% Heat Inactivated Foetal Bovine Serum  BioSera NA 
 
  
Chapter 2. Materials and Methods 
 
71 
Table 2.8: Cell Treatments 
     
Reagent Manufacturer Reference  
Bafilomycin A1  Enzo  BML-CM110-0100 
Blasticidine Sigma   15202 
Etoposide  Sigma   E1383 
G418 Sigma   A1720 
Leptomycin B  Cell Signalling  9676 
Polybrene  Sigma   107689 
Puromycin 
ThermoFisher 
Scientific 
 A11138 
Rapamycin Sigma   R8781 
Tetracycline hydrochloride Sigma   079K1498 
Z-Leu-Leu-Leu-al (MG132) Sigma   C2211 
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Table 2.9: Cell Culture Consumables 
     
Reagent Manufacturer Reference  
 CryoTube Vials 
ThermoFisher 
Scientific 
377267 
0.6ml 'Crystal Clear' Microcentrifuge Tube, 
2 x 500 
Star labs E1405-0600 
1.5 microcentrifuge tubes  Star labs S1615-5500 
12-well plate Fisher TKB-100-110R 
15ml Centrifuge Tube, Conical (Sterile), 
Loose 
Star labs E1415-0200 
175cm² TC treated flask with filter cap Greiner-Bio one 661175 
2.0ml 'Crystal Clear' Microcentrifuge Tube, 
1 x 500 
Star labs E1420-2000 
24 well plates Fisher TKB-100-115H 
50ml Centrifuge Tube, Conical (Sterile), 
Loose 
Star labs E1450-0200 
6-well plates Fisher 11825275 
75cm2 TC treated flask with filter cap Greiner-Bio one 658175 
Acrodisc® Minispike syringe filters Sigma   Z260444-1PAK 
Acryl Aquaclean 
WAK-Chemie 
Medical GmbH 
WAK-AQA-250-50L 
Bijou sample container, plain label Sigma   Z645346-700EA 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
ThermoFisher 
Scientific 
10075371 
Coverglass 13mm/0.16mm VWR 631-0150 
glass pasteur pipettes 230mm VWR 612-1702 
serological pipettes 10ml Sarstedt 86.1254.001 
serological pipettes 25ml Sarstedt 86.1685.001 
serological pipettes 5ml Sarstedt 86.1253.001 
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2.1.4 Plasmid Prep  
 
Table 2.10: Plasmid Prep Reagents 
     
Reagent Manufacturer Reference  
Agarose 
ThermoFisher 
Scientific 
BP1356-500 
Alpha-Select Bronze Efficiency Bioline BIO-85025 
Ampicillin Sigma   A5354 
Burner Bunsen Natural Gas 13mm SLS BUR3000 
Cell culture dish treated with vents sterile 
polystyrene non-pyrogenic 
ThermoFisher 
Scientific 
10075371 
Glass spreaders Sigma  S4522-6EA 
Kanamycin  Sigma  K0254 
LB Agar Miller 
ThermoFisher 
Scientific 
10734724 
LB Broth Miller Powder 
ThermoFisher 
Scientific 
10638013 
Molecular Grade RNase-free water 
ThermoFisher 
Scientific 
B-003000-WB-100 
NEB stable competent E.coli (high 
efficiency) 
New England Bio C3040H 
peqGREEN Peqlab 37-5000 
PureYield™ Plasmid Midiprep System Promega A2492 
S.O.C. Medium 
ThermoFisher 
Scientific 
15544-034 
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2.1.5 Transfections 
Table 2.11:  Transfection Reagents 
     
Reagent Manufacturer Reference  
Lipofectamine™ 2000 Transfection Reagent  
ThermoFisher 
Scientific 
11668019 
OptiMEM 
ThermoFisher 
Scientific 
11058021 
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2.1.6 Lentiviral Vectors 
Table 2.12: Plasmid Lentiviral Vectors 
    
        
Insert 
Expression 
Vector 
Packging 
Vectors 
Packaging 
Cells 
Selection 
Selection 
conc 
Maintenance 
conc 
Target 
Cells 
FLAG-p62 pLenti6 
3rd Gen 
(GAG pLP1, 
VSV-
pLP/VSVG, 
REV pLP2) 
HEK293FT blasticidin 8 μg/ml 4 μg/ml 
p62
-/-
 
MEFs 
mCherry-
53BP1 
pLenti6 
3rd Gen 
(GAG pLP1, 
VSV-
pLP/VSVG, 
REV pLP2) 
HEK293FT blasticidin none none 
p62
+/+
  
p62
-/- 
MEFs 
Empty pLenti6 
3rd Gen 
(GAG pLP1, 
VSV-
pLP/VSVG, 
REV pLP2) 
HEK293FT blasticidin 8 μg/ml 4 μg/ml 
p62
-/-
 
MEFs 
Atg5 
shRNA 2 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin none none MRC5 
Atg5 
shRNA 3 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin none none MRC5 
Atg5 
shRNA 4 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin none  none MRC5 
Atg5 
shRNA 5 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin none none MRC5 
GFP 
shRNA 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin 2μg/ml 0.5μg/ml MRC5 
p62 
shRNA 3 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin 2μg/ml 0.5μg/ml MRC5 
p62 
shRNA 4 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin 2μg/ml 0.5μg/ml MRC5 
p62 
shRNA 5 
pLKO-puro 
2nd Gen 
(VSV-G 
HIV-1) 
HEK293FT puromycin 2μg/ml 0.5μg/ml MRC5 
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2.1.7 Plasmids  
 
pEGFP-p62, pEGFP-PB1p62, pEGFP- -ΔUBAp62 constructs 
were previously published (Bjorkoy et al., 2005, Pankiv et al., 2010, Lamark et al., 
2003). FLAG-p62 was kindly provided by Robert Layfield (University of Nottingham, 
Nottingham, UK) (Najat et al., 2009). pLKO-puro GFP was kindly provided by Dr 
Simon Wilkinson (Edinburgh Cancer Research Centre, University of Edinburgh). 
mCherry-53BP1 was kindly provided by Dr Glyn Nelson (Newcastle University, 
Newcastle) pG-AcGFP-53BP1c  has been described previously (Nelson et al., 2009). 
Filamin A-GFP was kindly provided Dr Aragay (Institut de Biologia Molecular de 
Barcelona) 
 
2.1.8 siRNA  
Table 2.13: siRNA 
ON-TARGETplus SMARTpool siRNA from Dharmacon 
     
Protein siRNA Reference/Manufacturer 
Non-targeting 
ON-TARGETplus Non-Targeting 
control pool siRNA 
# D-001810-10 Dharmacon 
 
p62 
ON-TARGETplusSqstm1 
siRNA 
L-047628-01-0005- 
Dharmacon 
FLNA ON-TARGETplusFlna siRNA 
L-058520-01-0005 - 
Dharmacon 
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2.1.9 Cell fractionation  
Table 2.14: Cell Fractionation Reagents  
     
Reagent Manufacturer Reference  
20 x PBS New England Bio 9808 
Calcium chloride 1M solution Sigma   21115 
IGEPAL® CA-630 (NP40) Sigma   I3021 
Magnesium chloride 1M solution 
ThermoFisher 
Scientific 
AM9530G 
Phosphatase inhibitor cocktail 100X  
ThermoFisher 
Scientific 
1861280 
polyoxyethylene sorbitan (Tween-20) Sigma   93774 
Sodium chloride Sigma   S7653 
Trisma base Sigma   T1503 
Triton X-100  Sigma   T8787 
4x Laemmli Buffer   
20% SDS solution 
ThermoFisher 
Scientific 
AM9820 
Bromophenol Blue Sigma   B0126 
Glycerol Sigma   G5516 
β-mercaptoethanol (BME) Sigma   M3148 
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2.1.10 Immunofluorescence  
 
Table 2.15: immunofluorescence in Cells Reagents 
     
Reagent Manufacturer Reference  
20 x PBS New England Bio 9808 
Bovine Serum Albumin Sigma   5482 
Gelatin from cold water fish skin Sigma   G7041 
Microscope slide ground edges, twin frosted 
ThermoFisher 
Scientific 
FB58628 
Prolong Gold 
ThermoFisher 
Scientific 
P36935 
 
 
Table 2.16: immunofluorescence in Tissues Reagents 
     
Reagent Manufacturer Reference  
CyStain UV Ploidy (DAPI) Partec 05-5001  
Ethanol 
ThermoFisher 
Scientific 
 E/0650DF/17 
Histoclear 
National 
Diagnostics 
HS-200 
Microscope slide ground edges, twin frosted 
ThermoFisher 
Scientific 
FB58628 
Normal Goat Serum Blocking Solution Vector Lab S-1000 
Trisodium citrate  Sigma   S1804 
Vectashield mounting medium  Vector Lab H-1200 
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2.1.11 Immunoblotting  
 
Table 2.16: Materials for Western Blotting 
     
Reagent Manufacturer Reference  
N,N,N’,N’-Tetramethylethylenediamine 
(TEMED)  
Sigma   T9281 
20x PBS New England Bio 9808 
20% SDS solution 
ThermoFisher 
Scientific 
AM9820 
2xLaemmli buffer Biorad 1610737 
Acrylamide-Bis acrilamide Severn Biotech 20-2100-10  
Ammonium persulphate (APS) Sigma   A3678 
Bovine serum albumin (BSA) Sigma   A2153 
Clarity western ECL substrate Biorad 170-5061 
DC Protein Assay Kit  Biorad 500-0112 
Gel loading tips Starlabs 1022 0600 
Glycine Sigma   G8898 
Immobilon-P polyvinylidene difluoride 
(PVDF) 0.45µM membrane  
Milipore IPVH00010 
Marvel non-fat dry milk powder  Asda NA 
Methanol Sigma   32213 
Phosphatase inhibitor cocktail 100X  
ThermoFisher 
Scientific 
1861280 
Polyoxyethylene sorbitan (Tween-20) Sigma   93774 
Ponceaux  Sigma   P2395 
Precision Plus Protein™ Dual Color 
Standards 
Biorad 610374 
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Restore# PLUS Western Blot Stripping 
Buffer 
ThermoFisher 
Scientific 
46430 
Thick blotting paper  VWR 732-0594 
Trisma base Sigma   T1503 
β-mercaptoethanol (BME) Sigma   M3148 
Triton X-100  Sigma   T8787 
4x Laemmli Buffer   
20% SDS solution 
ThermoFisher 
Scientific 
AM9820 
β-mercaptoethanol (BME) Sigma   M3148 
Glycerol Sigma   G5516 
Bromophenol Blue Sigma   B0126 
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2.1.12 Comet Assay  
 
Table 2.17: Reagents for Comet Assay 
     
Reagent Manufacturer Reference  
10x TBE  
ThermoFisher 
Scientific 
AM9863 
20x PBS New England Bio 9808 
Agarose Sigma   A0169 
Agarose, low gelling temperature Sigma   A9414 
Dimethyl sulfoxide Sigma   D8418 
Ethylenediaminetetraacetic acid (EDTA) Sigma   E6758 
Sodium chloride Sigma   S7653 
Sodium hydroxide Sigma   795429 
Superfrost™ Plus Adhesion Slides 
ThermoFisher 
Scientific 
10143352 
SYBR® Gold Nucleic Acid Gel Stain 
ThermoFisher 
Scientific 
S-11494 
Trisma base Sigma   T1503 
Triton X-100  Sigma   T8787 
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2.1.13 Immunoprecipitation  
 
Table 2.18: Reagents for immunoprecipitation 
     
Reagent Manufacturer Reference  
Buffer 
  
Triton X-100  Sigma   T8787 
Trisma base Sigma   T1503 
Sodium chloride Sigma   S7653 
Polyoxyethylene sorbitan (Tween-20) Sigma   93774 
Magnesium chloride 1M solution 
ThermoFisher 
Scientific 
AM9530G 
Calcium chloride 1M solution Sigma   21115 
Beads   
ANTI-FLAG M2 Affinity Gel Sigma   A2220 
Anti-FLAG M2 Magnetic Beads Sigma   M8823 
Recombinant protein A Sepharose  Generon PC-A5 
Gel-stain   
Sodium thiosulfate Sigma   13481 
Sodium carbonate Sigma   451614 
Silver nitrate Sigma   209139 
GelCode Blue stain reagent 
ThermoFisher 
Scientific 
10608494 
Formaldehyde solution Sigma   F8775 
Acetic acid Sigma   320099 
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2.2 Methods 
2.2.1 Cell Culture 
 
All cells were grown in DMEM (Dulbecco’s Modified Eagle’s Medium, Sigma) 
supplemented with 10% heat-inactivated FCS (Foetal Calf Serum, Biosera), 5% 
penicillin/streptomycin (Invitrogen) and 2 mM L-glutamine (Sigma) in a humidified 
atmosphere containing 5% CO2 at 37°C. Autophagy was abolished in M5-7 MEFs by 
treating with 1 μg/ml tetracycline for at least four days. HEK293FT were maintained 
in 500 µg/ml G418 (Sigma #A1720) prior to transfection.  
2.2.1.2 Cryogenic storage 
 
Exponentially growing adherent cells were trypsinised (when at ~70% confluence)  
with Trypsin-EDTA (Sigma).Trypsin was neutralized with the addition of pre-warmed 
media and cells centrifuged at 150g for 3 minutes at room temperature. The 
supernatant was removed and cells were re-suspended in Foetal Calf Serum (FCS) 
containing 10% (v/v) dimethyl sulfoxide (DMSO) at a density of 1x106 cells/ml. Cell 
suspension was immediately transferred to cryo-vials in one ml aliquots (containing 
1x106 cells) and placed in a Mr. FrostyTM Cryo freezing container filled with 
isopropanol (Thermo Scientific). Cells were placed @ -80°C for 24h to allow slow 
freezing, before being transferred to liquid nitrogen for long term storage. 
 
2.2.1.3 Resuscitation of frozen cells 
 
Cryo-vials containing cell suspension were removed from liquid nitrogen and 
placed in a water bath @ 37°C to thaw (1-2min). Thawed cell suspension was 
immediately added to pre-warmed media and seeded. Cell culture media was 
replaced 24h following to remove DMSO and cell debris.  
2.2.1.4 Calculating cell density and population doublings 
 
Cell concentration was calculated using a Fuchs Rosenthal haemocytometer 
(VWR International, UK) where 20 µL of trypsinised cells suspension was analysed 
under a standard microscope (DMIL, Leica Microsystems, UK). The average of three 
counts of 8 squares is equivalent to the number of cells x104/mL. This allowed the 
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calculation of the total number of cells by multiplying the volume of cell suspension 
(mL) with the cell concentration (cells/mL). For human primary cell lines the 
population doubling (PD) was calculated using the following equation: PD)=X+Ln( 
N1/N2)/Ln2 
 
where, PD = population doublings 
  X   = previous PD 
N1 = number of cells harvested 
N2 = number of cells seeded 
 
For immortalised cell lines cells were tracked by recording the dilution factor 
and the number of passages.  
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2.2.2 Over-expression Vectors 
2.2.2.1 Bacterial Transformation  
 
All bacterial transformations for transiently expressed plasmids were performed 
using α-select GOLD Efficiency chemically competent cells (Bioline, #BIO-85027) 
according to supplier’s instructions. Briefly,  10 µL of cells were thawed on wet ice. 2 
µL of DNA solution was added and cells were mixed and incubated for 30 min on wet 
ice. Tubes were placed at 37°C for 30 seconds and then incubated on wet ice for a 
further 2 min. Transformation reactions were then diluted in 500 µL SOC medium 
(Invitrogen, 15544-034). SOC Medium: 2% Tryptone, 0.5% Yeast Extract, 0.4% 
glucose, 10mM NaCl, 2.5mM KCl, 10mM MgCl2 & 10mM MgSO4. Tubes were then 
incubated at 37°C for 1h while shaking. Cells were then spread on agar selection 
plates containing lysogeny broth (LB) medium plus ampicillin/kanamycin.Plates were 
incubated overnight at 37°C. Individual colonies were then grown overnight in 100mL 
selective LB. DNA was purified using PureYield Plasmid Midiprep System (Promega, 
#A2492) as described by manufacturer. 
 
Bacteria transformations for lentiviral plasmids was performed in NEB stable 
Competent E. coli (High Efficiency)(New England BioLabs, #C3040H) 
Transformation process was as above although overnight incubation at 37°C was 
replaced with incubation at 30°C for 24 hours. DNA was purified using PureYeild 
Plasmid Midiprep System (Promega, #A2492). 
 
Transformed bacteria stocks  
 
Glycerol stocks were made from 500μL LB containing transformed bacteria mixed 
with 500μl 80% glycerol, then snap frozen in liquid nitrogen and stored at -80oC.  
2.2.2.2 Transfection and Transduction Protocols  
 
Transfection 
Cells were transfected using polyethylenimine (PEI) as described in (Segura et al., 
2010) or Lipofectamine 2000 (Life Technologies #11668) according to the 
manufacturer’s protocols for 24h prior to lysis or fixation. 
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Transduction 
Lentivirus particles were generated in HEK293FT following the manufacturer's 
protocol (Life Technologies). HEK293FT cells were seeded in antibiotic-free medium 
supplemented with 0.1 mM MEM non-essential amino acids (Invitrogen) and then co-
transfected with lentiviral expression vectors and 2nd or 3rd generation packaging 
system plasmids. After 24 hours, media was replaced with fresh media without 
antibiotics. 48 hours after transfection, viral transduction was performed by 
transferring media from HEK293FT cells 70% confluent in the presence of 6 μg/ml 
Polybrene (Sigma). Media containing virus was replaced after 24 hours with fresh 
media containing antibiotic for selection of transduced cells. Media was replaced 
every 2-3 days for 10-12 days by keeping the antibiotic selection. Transduced MEFs 
were then maintained in lower levels of selection antibiotic until seeding for 
experimental purposes. 
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2.2.3 Induction of DNA Damage 
 
2.2.3.1 X-Ray Irradiation 
 
 DNA damage was induced using X-ray irradiation (X-Rad 225, 
Precision X-Ray INC, N-BRANFORD, CT USA) with doses as indicated (0.25-20Gy). 
Media was changed immediately after irradiation to prevent further damage form 
residual free radical generated by IR. 
 
2.2.3.2 Etoposide 
 
 DNA damage was also induced using the topoisomerase inhibitor 
Etoposide. Cells were treated with doses and times as indicated (0.01-1µM). Media 
containing Etoposide was then removed, cells were washed with warm PBS and 
media was replenished. Cells were then left to recover for time indicated.    
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2.2.4 Treatments of cells in tissue culture: 
2.2.4.1 Rapamycin 
 
mTORC1 inhibition was used as a means to stimulate autophagy. mTORC1 
was inhibited by treating cells with 100nM Rapamycin (Sigma, #R8681)  immediately 
after irradiation.  
2.2.4.2 Bafilomycin A1 
 
Autophagic flux was inhibited by treatment with Bafilomycin A1 (Enzo, #BML-
CM110-0100) at 100-400nM as indicated, for 440 min, or the duration of the 
experiment as indicated. 
2.2.4.3 Leptomycin B 
 
Cells were incubated with 20nM Leptomycin B (CST, #9676) for 1-4 hours as 
indicated to inhibit nuclear protein export. 
2.2.4.4 MG132 
 
Proteasomal inhibition was achieved by treatment of 10μM MG132 (Sigma, 
#C2211) for 4 hours. 
2.2.4.5 N-Acetyl-Cysteine (NAC) 
 
Cell were treated with 5µM NAC immediately after X-Ray Irradiation 
2.2.5 Knock down by small interfering RNA 
 
Cells were transiently transfected with ON-TARGETplus SMARTpool siRNA 
against mouse p62 (#18412), FLNA (L-012579-02) and non-targeting SMARTpool 
siRNA (D-001810-04) purchased from Dharmacon. Final siRNA concentrations of 
100nM were used for 96 hours for silencing and transfections were carried out using 
Lipofectamine 2000 (Life Technologies, #11668) as per company instructions. 
Knockdown efficiency was measured by western blot analysis. 
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2.2.6 Mice 
 
2.2.6.1 Mice Groups, Treatments and Housing 
 
All mice were inbred C57BL/6 (Harlan, Blackthorn UK). Mice were housed in same-
sex cages in groups of 4 to 6 (56 × 38 × 18 cm, North Kent Plastics, Kent, UK) and 
individually identified by an ear notch. Mice were housed at 20 ± 2°C under a 12 h 
light/12 h dark photoperiod with lights on at 7.00 am. The diet used was standard 
rodent pelleted chow (CRM (P); Special Diets Services, Witham, UK) for ad libitum 
(AL)-fed mice and the same diet, but as smaller pellets were offered to dietary 
restricted (DR) mice. DR mice were offered 60% of AL intake (calculated based on 
average food intake in 90 control AL mice between 5 and 12 months of age) as one 
ration at 9.30 am daily. All mice were fed AL until 3 months of age and then split into 
AL or DR groups, matched for body mass and food intake.  
 
2.2.6.2 Mouse tissue collection and preparation 
 
Tissues were collected during necropsy and fixed with 4% formaldehyde 
aqueous solution (VWR; Cat. Number 9713.9010) and paraffin embedded for 
histochemical analysis. Parts of the tissues were also snap-frozen in liquid nitrogen 
and stored at -80oC for biochemical analysis. 
 
2.2.6.3 Tissues provided by collaborators 
 
Paraffin embedded tissue sections of the small intestine from AhCre; APC f/wt 
mice ages 27weeks were kindly provided by Masashi Narita (Cancer research UK 
Cambridge Institute) 
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2.2.7 Cell fractionation 
 
Cellular fractionation was carried out as in (Suzuki et al., 2010).  Briefly, 6x105 cells 
were seeded on 10 cm dishes 48 hours prior to collection. Cells were washed in ice-
cold PBS, scrapped in 1 ml ice-cold PBS and centrifuged for 10 seconds at 13,000 
rpm at 4˚C. The supernatant was aspirated and cells were resuspended (triturated 5 
times) in 1 ml ice-cold 0.1% NP40 in PBS. 200 µL was collected in a fresh tube 
(whole cell sample). Samples were centrifuged again for 10 seconds at 13,000 rpm 
at 4˚C and supernatant, which represents the cytoplasmic fraction, was collected in a 
fresh tube. The pellet was resuspended (triturated once) in 1 ml ice-cold 0.1% NP40 
in PBS. Samples were centrifuged for 10 seconds at 13,000 rpm at 4˚C, supernatant 
was discarded and the nuclear pellet was processed as described below.  
For Immunoblot: Whole cell samples and cytoplasmic fractions were mixed 3:1 with 
4x Laemmli sample buffer, sonicated using a microprobe for five seconds on ice and 
boiled at 100°C for 5 minutes in the presence of 2.5% β-ME (beta mercaptoethanol). 
Nuclear pellets were resuspended in 200 µL 1x Laemmli sample buffer, sonicated 
using a microprobe for 5 seconds on ice and boiled at 100°C for 5 minutes in the 
presence of 2.5% β-ME then centrifuged for 10 minutes at 13,000 rpm at 4˚C and 
transferred to a new tube. 
For immunoprecipitation: The nuclear pellets were resuspended in 200 µL IP buffer 
(50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2, 1 mM CaCl2, 0.1% Tween 20, 
0.5% Triton-X100 and 2x Halt Protease & Phosphatase inhibitor cocktail (Thermo 
Scientific, #1861280)). The samples were sonicated using a microprobe for 5 
seconds centrifuged for 10 minutes at 13,000 rpm at 4˚C and transferred to a new 
tube. Immunoprecipitation was performed as described below.  
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2.2.8 Live cell imaging 
 
p62-/- and p62+/+ MEFs, stably expressing mCherry-53BP1c  were seeded on a 35 
mm glass bottomed dish (IWAKI) 48 hours prior to treatment. Cells were irradiated 
with 0.25 Gy X-Ray irradiation and immediately transferred to the heated, XLmulti S1 
humidified stage (95% air, 5% CO2) of a Zeiss CellObsever spinning disk confocal 
for imaging.  Images were captured using a 561 nm laser and 40 × 1.3NA objective 
(Zeiss) driven by Axiovision software (v4.8.1, Zeiss, Cambridge, UK). Z-stacks 
encompassing the entire cell were taken every 10 minutes for 8 hours. Foci were 
tracked using Cell/Vesicle function in Imaris (Bitplane, Oxford Instruments). 
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2.2.9 Immunostainings 
 
2.2.9.1 Immunofluorescence staining on fixed cells 
 
Fixation 
Cells grown in coverslips were fixed in 500µL of 2% formaldehyde in PBS 
(VWR, 9713.9010) for 8 minutes at room temperature. Paraformaldehyde was 
removed and cells were washed twice with PBS. Coverslips were stored in PBS at 
4oC (short term) or -80oC (long term). Cells were defrosted/washed once in PBS 
before beginning staining procedure. 
 
Permeabilisation 
Cells were incubated for 45 minutes at room temperature with 500µL PBG-
Triton (0.2% cold water fish gelatine, 0.5% BSA and 0.5% Triton in PBS). 
 
Immunofluorescence staining 
Cells were incubated for 45 minutes in primary antibody (diluted in PBG –
Triton) with gentle agitation or overnight at 4oC without gentle agitation. Cells were 
washed twice with PBG-Triton for 5 minutes. Cells were incubated for 45 minutes 
with fluorophore-conjugated secondary antibody (1/2000) diluted in PBG–Triton and 
then washed three times with PBS for 5 minutes. Cells were washed 3 times in PBS 
before mounting cells on slides using ProLong® Gold Antifade Mountant with DAP 
(ThermoFisher Scietific, P36935) 
 
2.2.9.2 Immunostainings on paraffin embedded tissues 
 
Dewax and Hydration 
Paraffin tissue sections of 3µm thickness were deparaffinised by incubating 
for 10 minutes in Histoclear (National Diagnostics; Cat. Number HS-200) X2 and 
rehydrated in graded concentration of ethanol solutions: 100% (2x 5 minutes), 90% 
(5 minutes), 70% (5 minutes) and H2O (10 minutes). 
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Antigen Retrieval  
Antigens were retrieved by incubating tissues sections in 0.01M citrate buffer 
pH6.0 (29.41g of trisodium citrate in 1L of distilled water, pH6.0) in the microwave: 
high power (800W) for 5 minutes until boiling followed by 10 minutes at medium 
power (400W). Tissue sections were cooled by incubating for 20 minutes on wet ice. 
Tissue sections were then washed twice in H2O for 10 minutes. 
 
Immunofluorescence staining 
Tissue sections were incubated in blocking buffer (goat IgG, #S1000, Vector Lab) for 
30-60 minutes at room temperature. Tissue sections were further blocked with 
Avidin/Biotin (Vector Lab, # SP-2001) for 15 minutes. Primary antibody (rabbit 
H2A.X 1:200 in blocking buffer, CST, #9718) was applied overnight at 4°C. Slides 
were washed three times with PBS and incubated for 30 minutes with secondary 
antibody (Vector Lab, #PK-4001). Sections were washed three times with PBS and 
incubated with Fluorescein Avidin DCS (1:500 in PBS, Vector Lab, #A-2011) for 20 
minutes. Sections were washed three times with PBS and incubated for 30 minutes 
with blocking buffer. Second primary antibody (guinea pig p62 1:100 in blocking 
buffer, Progen, #GP-62-C) was applied overnight at 4°C (note antibodies were 
incubated sequentially). Slides were washed three times with PBS and incubated for 
30 minutes with secondary antibody (anti guinea pig Alexa Fluor® 594 1:2000, 
Molecular Probes #A-11076 ). Sections were stained with DAPI for 5-10 minutes and 
mounted in Vectashield mounting medium (Vector Lab, # H-1200).  
2.2.9.3 Microscopy 
 
Cells were imaged with a Leica DM 5500B Widefield Microscope through an HCX PL 
APO 100x/1.40-0.70 or oil HCX PL APO 40x/1.25 oil objective using a Leica DFC 
360 FX camera. Alternatively, for co-localisation and live cell imaging analyses, 
images were captured using a Zeiss CellObsever spinning disk confocal microscope 
equipped with: CSUX1 spinning disk confocal head (Yokogawa), and Quant EM 
CCD (Photometrics), using a 405, 488 and 561 nm lasers and 63× 1.4NA objective 
(Zeiss) driven by Axiovision software (v4.8.1, Zeiss, Cambridge, UK). 
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2.2.10 Protein expression analysis 
 
2.2.10.1 Protein Extraction 
 
Cells were washed with ice cold PBS and then lysed with ice cold 
Radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1% NP40, 0.5% 
NaDoC, 0.1% SDS, 50 mM Tris pH 7.4 and 1x phosphatase and protease inhibitors 
cocktail (Thermo Scientific, 78442) by scraping using a rubber cell scraper. Samples 
were then collected into 1.5 mL microcentrifuge tubes and immediately stored at -
80oC (alternatively samples could be immediately used for protein quantification and 
further analysis). 
 
2.2.10.2 Protein quantification 
 
Cell lysates were defrosted on wet ice before being centrifuged for 10 minutes at 
16,000g at 4oC. Protein quantification was performed using a colorimetric Bio-Rad 
DC Protein Assay (Bio-Rad; Reagent A Cat. Number 500-0113, Reagent B Cat. 
Number 500-0114, Reagent S Cat. Number 500-0115) according to the 
manufacturer’s instructions. Absorbance was measured using a Fluostar Omega 
plate reader (BMG Labtech) Protein concentration of each sample was calculated 
and normalised by mixing adjusted volumes of protein lysate and loading buffer [950 
µL of 2xLaemmli buffer (Bio-Rad; Cat. Number 161-0737) plus 50 µL of β-
mercaptoethanol (Sigma, M6250) or (4x Laemmli 8% SDS, 40% glycerol, 240mM 
Tris pH6.8, 10% β-mercaptoethanol). Protein denaturation was achieved by 
incubating samples at 100°C for 5 minutes. Samples were immediately placed on ice 
after denaturation. At this stage denatured samples were either stored at -20oC or 
used immediately for western blotting. 
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2.2.10.3 Western blotting 
 
Electrophoresis 
Acrylamide gels were prepared as following:  
 
1. A resolving gel was prepared according to size of the proteins of interest and 
poured into a cassette (Invitrogen, NC2015 or NC2010). 1ml of water was 
added on top of gel to insure a straight edge (see Table 3.6 for gel preparation)  
5% gels: > 250 kDa 
8% gels: 250-120 kDa 
10% gels: 120-40 kDa 
12% gels: 40-15 kDa 
15% gels: < 20 kDa 
  
2. After the resolving gel has polymerised, a 5% acrylamide staking gel was 
prepared, poured into the cassette and allowed to polymerize (see Table 
2.19 for gel preparation). 
3. Gels were placed in a XCell SureLockTM Mini-Cell Electrophoresis System 
(Invitrogen) and Tris-Glycine running buffer (250µM Tris, 1.92mM Glycine 
and 0.1% SDS) was added. Samples were loaded into wells along with a 
Protein standard (Bio-Rad, 161-0374) and electrophoresis was performed 
at 120V, 35mA for 90 minutes. 
 
Table 2.19:  Acrylamide gels for Western Blotting analysis 
1Gel  5% 8% 10% 12% 15% Stacking 
Sterile H2O 6.8ml 5.1ml 4ml 3.3ml 2.3ml 3.4ml 
30% Acrylamide 1.7ml 2.6ml 3.3ml 4ml 5ml 830ul 
1.5M Tris pH 8.8 (1M Tris 
pH 6.8 (Stacking)) 
2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 630ul 
10% SDS 100ul 100ul 100ul 100ul 100ul 50ul 
10% Ammonium 
Persulphate 
100ul 100ul 100ul 100ul 100ul 50ul 
TEMED 8ul 4ul 4ul 4ul 4ul 5ul 
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Protein transfer to membrane 
 
Following electrophoresis gels were removed from cassettes and Proteins were 
transferred to a 0.45 µm polyvinylidene difluoride (PVDF) membrane (Millipore, 
IPVH00010). Between transfer pads (VWR, 732-0594) soaked in transfer buffer 
(250µM Tris, 1.92mM Glycine). Transfer was performed using the Trans-Blot® SD 
Semi-Dry Transfer Cell (BioRad) at 17 volts for 45-60min. The membrane was then 
stained with Ponceaux (Sigma, P2395) solution (0.5% Ponceaux and 5 % Acetic 
Acid in H2O) for detection of protein bands to check transfer and allow trimming and 
cutting of the membrane prior to antibody incubation. 
 
Immunoblotting 
 
Following transfer membranes were washed one in PBS then incubated for 1 
hour in blocking buffer (5% Fat free dry Milk (Marvel) in 0.05% PBS-Tween) at room 
temperature on a shaker. The membrane was the incubated overnight at 4oC while 
shaking gently in primary antibody diluted in 5% Milk in 0.05% PBS-Tween (5% BSA 
in 0.05% PBS-Tween for antibodies against phosphorylated proteins). Membrane 
was washed 3 times in PBS before incubation with the secondary antibody diluted in 
5% Milk in 0.05% PBS-Tween for 1 hour at room temperature while shaking gently. 
Membranes were washed 3 times with PBS followed by a 3 minutes wash in 0.05% 
PBS-Tween at room temperature while shaking gently, before a final 3 washes in 
PBS. 
 
 Chemiluminescence and evaluation 
Blots were incubated in ClarityTM Western ECL substrate (Bio-Rad, 170-5060) for 5 
minutes. The blot was visualised using Fuji film Intelligent Dark box II and Image 
Reader Las-4000 Software. Protein standard was used to confirm protein of interest 
by size comparison. ImageJ analysis software was used to quantify the integrated 
density of signal on the blot. Densitometry quantification of the protein of interest of 
calculated after Background subtraction and normalisation to a loading control. 
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2.2.11 Comet Assay 
 
Comet assay (single cell gel electrophoresis) is a method for analysing DNA 
strand breaks in eukaryotic cells. Cells are embedded in an agarose gel on top of 
microscope slides. These gels are then lysed in buffer containing detergent and a 
high salt concentration. This results in the formation of nucleoids of supercoiled 
DNA. Slides are then subjected to electrophoresis and DNA is stained and visualised 
by fluorescent microscopy. DNA Loops that contain breaks are able to migrate from 
the nucleoid toward the anode giving rise to a comet like appearance. The intensity 
of the comet “tail” relative the “head” (nucleoid body) reflects the number of breaks. 
 
Figure 2-1: Example of a Comet assay image. Area under the graph (green) is the 
comet head, orange is the comet tail  
 
Cells were trypsinised and centrifuged at 1600rpm, supernatant was removed 
and cells were resuspended in 500μl 10% DMSO in FBS. Cells were then frozen at -
80°C in in a Mr. FrostyTM Cryo freezing container filled with isopropanol (Thermo 
Scientific, #5100-0001). Cells were placed at -80°C and allowed to slow freeze, cells 
were then removed and stored at -80°C until required. Cells were defrosted on wet 
ice then washed in cold PBS and centrifuged at 4°C at 1600rpm for 5 mins. 
Supernatant was removed and cells were resuspended in 0.7% LMP agarose at 
37°C to a concentration of 2 x 105 cells/ml. 70μl of cell/agarose mix was placed on 
slides coated in 1% agarose between a cover-slip, care was taken to avoid bubbles. 
Slides were then placed at 4°C for 10 mins to allow the gel to set. Cover slips were 
removed and the slides were placed in lysis buffer (2.5M NaCl, 100nM EDTA, 10nM 
Tris, 250nM NaOH 10% DMSO, 1% Triton X-100) for 1h at 4°C. Slides were then 
washed twice in cold PBS.  
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Alkaline Comet 
Slides were places for 40 mins in alkaline buffer (300mM NaOH, 1mM EDTA) 
at 4°C to denature DNA. Samples were subjected to electrophoresis for 30 minutes 
at 25V at 4°C in alkaline buffer. 
 
Neutral Comet  
Samples were subjected to electrophoresis for 30 minutes at 25V at 4°C in 
Tris-borate EDTA (TBE) buffer.  
 
Visualisation 
After slides were washed 2x in cold PBS, 500μl of 1000x Sybr Gold 
(Invitrogen) in TBE buffer was added to each gel and slides were incubated for 40 
mins in a dark humid chamber. Slides were washed 2x in MilliQ water and allowed to 
dry. Samples were imaged using an Olympus BX51 widefield microscope with 
Olympus UPlanFL 20x/0.50 air objective. Comets were scored using Comet assay IV 
(Perceptive Instruments Ltd., Haverhill, Suffolk, United Kingdom). Each experiment 
was run on 2 separate gels and an average reading for the two gels was quantified. 
2.2.12 Immunoprecipitation 
 
Cells were seeded 6×105 in a 10 cm dish and transfected as described above 24 
hours later. Following another 24 hours, nuclear fractions were prepared as 
described above. 
For FLAG-tagged protein: lysates were incubated with pre-washed and equilibrated 
anti-FLAG M2 magnetic beads (Sigma Aldrich, #M8823) for two hours at 4°C with 
constant rotation. Beads were washed twice with lysis buffer and the pulled-down 
protein was eluted from the beads by incubation with 25 µl 0.2 M glycine-HCl, pH 
2.5, for 10 minutes at room temperature. Eluent was neutralised by the addition of 
2.5 µl Tris-HCl, pH 8.8. The samples were then mixed with sample buffer and boiled 
at 100°C for five minutes in the presence of 2.5% β-ME before being subjected to 
SDS-PAGE and immunoblot. 
For GFP-tagged protein: lysates were incubated with 3 µl anti-GFP rabbit serum (Life 
Technologies, #A-6455) for one hour at 4°C with constant rotation. Lysates were 
then incubated with 20 µl pre-washed Protein A Sepharose beads (Generon, #PC-
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A5) for 1 hour at 4°C with constant rotation. Beads were then washed twice in IP 
buffer, mixed with sample buffer and boiled at 100°C for 5 minutes in the presence of 
2.5% β-ME. Samples were centrifuged for 10 minutes at 13,000 rpm at 4°C and 
transferred to a new tube. Samples were then subjected to SDS-PAGE and 
immunoblot. 
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2.2.13 Mass Spectrometry 
 
Immunoprecipitation was carried out as described above. Gel was then stained using 
Coomassie and bands present in IP and absent in control were excised. Excised 
bands were digested in-gel and the resulting tryptic peptides analysed by LC-MSMS 
using an Orbitrap XL (Themo Scientific) coupled to a nanoAcquity (Waters). MSMS 
data was acquired in a top 6 DDA fashion and raw files were processed in Proteome 
Discover v1.4 using the Sequest search engine against a Uniprot human database 
(downloaded 030314, 68,710 entries). CAM cysteine was set as a fixed modification 
with oxidised methionine and deamidated asparagine/glutamine as potential variable 
modifications. FDR calculations were performed using Percolator with peptides 
filtered to 0.01 FDR. Mass spectrometry analyses were performed by Dr. Robin 
Antrobus at Cambridge Institute for Medical Research. 
2.2.14 Statistical analyses 
 
Two-tailed, paired or unpaired Student’s t-tests were carried out on experimental 
data from at least three individual experiments using Excel. A one-way Anova was 
used for multiple comparisons between groups using Sigma Plot. 
 
2.2.15 Ethics statement 
 
Ethical approval was granted by the LERC Newcastle University, UK. The 
work was licensed by the UK Home Office (PPL 60/3864) and complied with the 
guiding principles for the care and use of laboratory animals. 
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3. Chapter 3. The Effects of Autophagy on DNA Damage Repair 
 
Autophagy is known to play a central role in cellular homeostasis, with 
impaired autophagy being implicated in many human diseases (Levine and Kroemer, 
2008).  Autophagy has been shown to be a potent tumor suppressor, with autophagy 
defects being common in many forms of cancer (Gozuacik and Kimchi, 2004, Kung 
et al., 2011). However, the exact mechanisms by which autophagy confers 
protection against transformation are still unclear. Autophagy defects have been 
shown to lead to genomic instability (Karantza-Wadsworth et al., 2007) and inhibition 
of autophagy has previously been suggested to suppress DNA repair (Liu et al., 
2015, Bae and Guan, 2011, Robert et al., 2011). In this chapter I further explore the 
link between autophagy and the ability of cells to repair DNA. 
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3.1 Cells Lacking Autophagy Have a Decreased DNA Repair Capacity 
 
To investigate the effect of autophagy on DNA repair, DNA damage was 
induced in Atg5−/ − and Atg5+/+ MEFs using 1Gy of X-Ray irradiation. Atg5 is part of 
the Atg5-12/Atg16L1 complex that is essential for the formation of autophagosomes.  
Atg5−/− MEFs are unable to form autophagosomes, rendering these cells autophagy 
deficient (Figure 3-1). Similarly, M5-7 MEFs are a cell line where the knockdown of 
Atg5 is under the control of a tetracycline promoter (Tet). The advantage of an 
inducible knock-down cell system is that it reduces clonal differences between cell 
lines and the period where cells are able to adapt to the lack of autophagy.  DNA 
damage was assessed using immunostaining for 53BP1 across a 480 minute time 
course.  It was found that Atg5-/- MEFs show a reduced rate of repair, judged by an 
increased number of 53BP1 foci at later time points, compared to Atg5+/+  
(autophagy competent) MEFs (Figure 3-2A-B). Similarly, M5-7 MEFs treated with Tet 
to abolish expression of Atg5, showed a reduced repair capacity compared to non-
treated controls (Figure 3-2C-D). The differences in M5-7 MEFs shown in (Figure 
3-2C) are less pronounced than those seen in the Atg5 MEFs shown in (Figure 3-2B). 
The reason for this difference is not clear, however M5-7 –Tet cells showed reduced 
basal levels of both LC3 and the Atg5-Atg12 complex compared to Atg5+/+   (Figure 
3-2 E). This suggests a slight suppression of autophagy even in the absence of 
Tetracycline treatment and could explain the larger differences seen in the Atg5 cell 
lines compared to the M5-7 cells. This could be a result of antibiotics present in the 
FCS used in the culture media. Overall, these results indicate that MEFs lacking 
autophagy show a slower recovery from X-ray induced DNA damage, suggesting a 
possible role for autophagy in the DDR. 
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Figure 3-1: Deletion of Atg5 leads to a loss of autophagy. (A) Schematic 
representation of the initiation of autophagy, showing that loss of Atg5 results in a 
loss of functioning autophagy. (B) Representative western blot showing Atg5/12 and 
LC3 II levels in Atg5+/+ and Atg5-/- MEFs treated with and without 400nM Bafilomycin 
A1 for 440 min prior to collection. 
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Figure 3-2: Cells lacking autophagy have a reduced repair capacity in 
response to X-Ray irradiation. Representative images (A) and quantification (B) of 
the mean number of 53BP1 foci in Atg5+/+ and Atg5-/- MEFs 0-480 minutes after 1Gy 
X-Ray irradiation. (C-D) M5-7 MEFs were treated with tetracycline (Tet) to induce 
knock-out of Atg5. Mean number of 53BP1 foci was quantified (C). Representative 
images of 53BP1 foci 0-480 minutes after 1Gy X-Ray irradiation are shown in (D). 
Representative western blot showing Atg5/12 and LC3 II levels in Atg5+/+, Atg5-/- and 
M5-7 MEFs with and without Tetracycline (Tet). Scale bar 10 µm; n=3; Error bars 
represent S.E.M. 
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In addition to DNA damage, X-Ray irradiation induces damage to other 
cellular components such as proteins and lipids (Carugo and Djinovic Carugo, 2005). 
Having shown that cells lacking autophagy show an increased sensitivity to X-Ray 
induced DNA damage it was important to confirm that these effects were DNA 
damage specific and not due the accumulation of a different type of cellular damage.  
This is especially important in light of the role of autophagy in the recycling of many 
damaged proteins and macromolecules.  In order to investigate this, Etoposide was 
used to induce DNA damage.  Etoposide induces double strand breaks via the 
inhibition of topoisomerases (Pommier et al., 2010), these are enzymes that cleave 
DNA to allow the rearrangements required for sufficient access of the transcription 
machinery. Their inhibition results in the enzyme being held at the site of cleavage 
resulting in improper resolution and generation of double strand breaks (DSB).  
Here, Atg5−/ − and Atg5+/+ MEFs were treated with 1µM Etoposide for 120 
minutes. Cells were either fixed immediately after treatment or washed and allowed 
to recover for 300 min, then were fixed and stained with antibody against 53BP1 
( Figure 3-3A). Results shown in  Figure 3-3B indicate that treatment with Etoposide 
induced similar levels of damage in Atg5+/+ and Atg5-/- MEFs. However, following 5 
hours recovery Atg5-/- MEFs showed significantly more DNA damage. These results 
confirm that cells lacking autophagy are indeed more sensitive to DNA damage. 
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 Figure 3-3: Cells lacking autophagy have a reduced repair capacity in 
response Etoposide. DNA damage was induced in Atg5+/+ and Atg5-/- MEFs by 120 
minute incubation with Etoposide and, where indicated, followed by a 300 minute 
recovery period. Representative images are shown in (A) and the mean number of 
53BP1 foci was quantified (B). Scale bar 10 µm; n=3; Error bars represent S.E.M; 
NS: not significant, * p<0.05, ** p<0.01, *** p<0.001. 
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3.2 The effect of autophagy on the DDR is independent of ROS  
 
Cells lacking autophagy have been shown to have higher levels of ROS. 
These are a group of reactive molecules including: superoxide anion (O2
•−), hydroxyl 
radical (OH•) and hydrogen peroxide (H2O2) that are generated as part of normal 
oxygen metabolism, primarily in mitochondria. Autophagy is involved in the 
degradation of mitochondria (mitophagy), and inhibition of autophagy has been 
shown to contribute to an increase in both dysfunctional mitochondria and ROS (Pua 
et al., 2009). ROS play an important role as signalling molecules in the cell. 
However, if levels of ROS are elevated they can lead to oxidative stress, causing 
damage to proteins, lipids and DNA. For this reason, it was important to assess the 
potential contribution of ROS in the differences in 53BP1 foci kinetics seen between 
Atg5+/+ and Atg5-/- MEFs.  
To test whether the increase in DNA damage seen in cells lacking autophagy 
was ROS dependent, Atg5+/+ and Atg5-/- MEFs were exposed to 1Gy of X-ray 
irradiation, treated with and without antioxidant N-acetyl-cysteine (NAC) and fixed 
every hour for 8h following IR. Cells were then stained with antibody against 53BP1 
and DDF quantified by microscopy. Results shown in Figure 3-4 indicate that 
treatment with NAC had no effect on the number of DNA damage foci in Atg5+/+ and 
Atg5-/- MEFs following 1Gy IR. The concentration of 5mM NAC has however, been 
shown to reduce ROS in response to the higher dose of 10Gy in these cells (Correia-
Melo, 2014). These data suggest that the differences seen in Atg5+/+ and Atg5-/- 
MEFs are not ROS dependent, however it still remains for us to measure ROS in this 
system.  
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Figure 3-4: Treatment with NAC does not rescue DNA damage phenotype. 
Quantification of the mean number of 53BP1 foci in Atg5+/+ and Atg5-/- MEFs with and 
without 5mM NAC 0-480 min after 1Gy X-Ray irradiation. n=3; Error bars represent 
S.E.M. 
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3.3 The effect of Atg5 knock-out on DDR is independent of other lysosomal 
degradation pathways 
 It has been recently suggested the CMA may be involved in the regulation of 
DNA damage repair through the selective degradation of Chk1 (Park et al., 2015). It 
has also been suggested that autophagy is able to occur in the absence of Atg5 
(Nishida et al., 2009). It was therefore important for us to assess if there was any 
additive effect of other lysosomal degradation pathways in DNA damage repair in 
Atg5-/- MEFs. Here, lysosomal degradation was inhibited (Figure 3-5A) with treatment 
of Atg5-/- MEFs with 400nM Bafilomycin A1 (Baf) (Yamamoto et al., 1998). Atg5-/- 
MEFs were exposed to 1Gy of X-ray irradiation, treated with and without Baf and 
fixed every hour for 8h following IR. Cells were then stained with an antibody against 
53BP1 and DDF quantified by microscopy. Quantification shown in (Figure 3-5B) 
indicates that block of lysosomal degradation with Baf had no further effect on DNA 
damage repair in Atg5-/- MEFs. These data suggest that CMA as well as Atg5/7 
independent autophagy have no effect on DNA damage repair following low dose IR.  
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Figure 3-5: Block of lysosomal degradation with Baf has no further effect on 
DNA damage than genetic knockout of autophagy in Atg5-/- MEFs. (A) 
Schematic representation of the action of Bafilomycin A1 which inhibits V-H 
ATPases present in the lysosomal membrane leading to deacidification and an 
inhibition of the fusion of autophagosomes. (B) Quantification of the mean number 
of 53BP1 foci Atg5-/- MEFs with and without 400nM Baf 0-480 min after 1Gy X-Ray 
irradiation. n=3; Error bars represent S.E.M. 
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3.4 Knockdown of p62 rescues Decrease in DNA Repair Capacity in Autophagy 
Deficient Cells 
 
Assuming that ROS is not responsible for increased levels of DNA damage in 
autophagy null cells, we decided to look at autophagy adaptor proteins as a potential 
link between these two spatially separate cellular processes. The autophagy adaptor 
protein p62 has previously been suggested to play a role in DNA damage repair 
(Bae and Guan, 2011). In order to further understand the extent of the contribution of 
p62 to the differences seen in DNA damage between autophagy deficient MEFs, p62 
was knocked down using siRNA in Atg5+/+ and Atg5-/- MEFs expressing a 53BP1-
GFP reporter.  Cells were then exposed to 1Gy of X-Ray irradiation and fixed at 5 
and 300 minutes following IR as well as non-IR control. Cells were stained with 
antibody against p62 and 53BP1 foci were analysed by microscopy (Figure 3-6A). 
The knockdown efficiency was tested by immunoblot for p62 as shown in Figure 
3-6B. Data in (Figure 3-6C) show that knockdown of p62 rescues the increased DDF 
seen in Atg5-/- MEFs as well as reduces the number of DDF at 5h following IR in 
Atg5+/+ MEFs. These results suggest that differences in DDF in autophagy deficient 
cells are dependent on p62. 
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Figure 3-6: Knockdown of p62 in autophagy deficient cells rescues the delay in 
DNA damage repair. Atg5+/+ and Atg5-/- MEFs treated with control or p62 siRNA 5 
and 300 min after 1Gy X-Ray irradiation. (A-C) Representative images of GFP-
53BP1 foci are shown in (A). Blot showing scrambled control (Sc) and p62 siRNA in 
Atg5+/+ and Atg5-/- MEFs (B). Quantification of the mean number of GFP-53BP1 (C). 
Scale bar 10 µm; n=3; Error bars represent S.E.M; NS: not significant, * p<0.05, ** 
p<0.01, *** p<0.001.    
  
Chapter 3. The Effects of Autophagy on DNA Damage Repair 
 
113 
 
3.6 The effect of knockdown of Atg5 on DDR Downstream Signalling 
 
Having established that cells with compromised autophagy have a slower 
DNA damage repair kinetic compared to those without, as measured by 53BP1 foci 
(Figure 3-2 &  Figure 3-3), I investigated whether downstream DNA damage 
signalling was being affected as a result of autophagy inhibition. For this, it was 
necessary to knock down Atg5 in primary cells, as downstream signalling is possibly 
disrupted in Atg5-/- MEFs as a result of the SV40 immortalisation process (Boichuk et 
al., 2010). Here, MRC5 human fibroblasts were transduced with shRNA against Atg5 
as a means of inhibiting autophagy. The Atg5 knockdown efficiency of cell lines 
derived from chosen virus titre is shown in (Figure 3-7A) following 2 cell passages (to 
allow cells to recover from transduction), indicating successful Atg5 knockdown by 
shRNA#1 and 5. These results indicate a modest effect on LC3II levels; this is in 
agreement with the observation made in (Hosokawa et al., 2007) that only very low 
levels of Atg5 are required for functional autophagy. Next, we wanted to investigate 
the effect of Atg5 knockdown on signalling downstream of a DDR. Here, MRC5 
human fibroblasts that are stably expressing shRNA against Atg5 were exposed to 
1Gy of X-Ray irradiation and collected at time points 5min-8h following IR.  Samples 
were then run on SDS-PAGE electrophoresis and immunoblot analysis was carried 
out for PARP, p62, p-p53, p21, p16 and loading control GAPDH. Results shown in 
Figure 3-7B indicate an increase in p62 in cells expressing shRNA against Atg5. 
Similarly, there was also a trend for an increase in p-p53 and p21 expression in Atg5 
shRNA expressing cells. These results are consistent with data shown previously 
indicating that impaired autophagy impacts on DDF repair kinetics (Figure 3-2& 
Figure 3-3). As it was planned to assess senescence in these Atg5 shRNA-
expressing cells, they were not subject to Puromycin selection so that an accurate 
record of population doubling could be kept. Comparison of the levels of LC3II with 
and without Bafilomycin A1 treatment allows gauging of the basal rate of autophagic 
flux. Results shown in Figure 3-7C indicate that Atg5 shRNA is in fact having little 
effect of autophagic flux following successive cell passages, suggesting that 
expression of shRNA had been lost. Another attempt was made to generate these 
cell lines using higher virus titres with the hope of achieving a greater knockdown of 
autophagy. Interestingly, cells expressing Atg5 shRNA in this instance ceased to 
Chapter 3. The Effects of Autophagy on DNA Damage Repair 
 
114 
 
proliferate following transduction which precluded follow up experiments.  It is 
possible that inhibition of autophagy has led to a premature induction of senescence 
in these cells as previously reported in (Kang et al., 2011).  
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Figure 3-7: Downstream DDR in MRC5 fibroblasts transduced with shRNA 
against Atg5. Western blots (A) showing Atg5-12, LC3 II and loading control 
GAPDH in chosen virus volume (2ml Virus media in a total of 4ml). Western blots (B) 
showing PARP, p62, p-p53, p21, p16 and loading control GAPDH in MRC5 
fibroblasts transduced with GFP-shRNA (control) of Atg5 shRNA as indicated 
following 1Gy X-ray irradiation at time points 5min-8h. Western blots (C) showing 
p62, LC3 II and loading control GAPDH in chosen virus volume (2ml Virus media in a 
total of 4ml) with and without 4h 400nM Bafilomycin A1 treatment.  
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3.6 Discussion 
 
 Despite several recent studies that explore the role of autophagy in the DDR 
few have directly tested the role of autophagy on DNA damage repair (Liu et al., 
2015, Bae and Guan, 2011, Robert et al., 2011). Liu et al conclude that there is no 
difference in the rate of DNA repair between autophagy compromised and wt cells 
(Liu et al., 2015). Here, autophagy is abolished through inducible knock out of Atg7. 
DNA damage is measured by immunofluorescence analysis of H2A.X before, 1 h 
and 8 h after 10Gy ionizing radiation. In this work, the authors report the complete 
resolution of H2A.X foci 8h following 10Gy irradiation. Our group and others have 
observed an average of 30 DDF in MEFs at 1 day following 10 Gy X-ray irradiation 
(Hewitt et al., 2012, Rodier et al., 2011), as well as foci that persist up to 10 days 
following IR. The striking difference between the numbers observed in the study from 
Liu et al and ours suggests a relatively low sensitivity in the assay used by others to 
detect DNA damage foci.H2A.X is also measured by western blot from whole cells 
lysed in RIPA buffer. Data from our group (not shown) indicates that samples from 
MRC5 human fibroblasts lysed in RIPA buffer before or 1h, 6h, and 12h following 
exposure to 20Gy X-Ray irradiation are positive for H2A.X only at 1h and 6h but not 
12h. When compared to analysis of DNA damage foci at the same time points 
(Hewitt et al., 2012, Passos et al., 2010) it can be seen that measurements of DDR 
using western blotting is extremely insensitive. DNA damage is also measured by 
Comet assay and data is presented as % of cells with Comet tail.  Again, the authors 
report no significant differences between the levels of DNA damage between ATG7 
null and wt MEFs following, in this instance, treatment with Etoposide. Quantification 
of Comet assay as % of cells with Comet tail is a very crude analysis and results 
show low levels of damage. This, again, suggests inadequate sensitivity in this 
analysis. Authors then go on to report increased proteasome activity in ATG7 null 
MEFs, which results in increased degradation of Chk1, resulting in an inhibition of 
homologous recombination. They also measure NHEJ using reporter plasmids 
described in (Seluanov et al., 2004) and report no difference between ATG7 null and 
wt MEFs. Taken together, it is surprising that an inhibition of HR and no change in 
NHEJ does not lead to a difference in levels of double strand break repair in cells 
lacking autophagy and further point to a lack of sensitivity in the methods used to 
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assess damage. Authors do report an increased level of DNA damage in cells 
lacking autophagy when NHEJ is inhibited at 4h and 8h following treatment with 
Etoposide, as measured by COMET assay (Liu et al., 2015).  
Contrary to the study from Liu et al 2015, Bae and colleagues describe that 
inhibition of autophagy by FIP200 deletion impairs DNA damage repair (Liu et al., 
2015). In this study, similarly to Liu et al, high doses of DNA damaging drugs or 
10Gy of irradiation is used to induce damage. Damage is assessed by COMET 
assay, immunostaining and western blot for H2A.X (Bae and Guan, 2011). The 
difference between both studies could be due to a more sensitive analysis of DNA 
damage carried out by Bae et al. In their study the authors detected H2A.X positive 
cells using higher magnification at 24h following 10Gy IR in FIP200 deleted cells. 
They are also able to detect a much more robust induction of H2A.X, as measured 
by western blot. This could be a result of different sample preparation. Here, cells 
were lysed directly in boiling sample buffer, giving a more complete lysis, which is 
especially important when trying to assess hard-to-extract histones and preserves 
phosphorylation. It should be noted that 10Gy IR is sufficient to cause cell death as 
concluded by this study (Bae and Guan, 2011) and others (Jo et al., 2015). Similarly 
Liu et al used 10Gy IR to induce DNA damage, however they report a much reduced 
induction of cell death (Liu et al., 2015). Induction of apoptosis can lead to false 
positive results when using Comet assay to assess DNA damage induction as 
shown by (Choucroun et al., 2001). There are a number of mechanisms by which 
apoptotic cells would appear to have increased DNA damage, as measured by % of 
tail vs head. It is known that DNA intercalators that are commonly used to visualise 
Comets such as ethidium bromide and syber gold also recognise RNA (Tuma et al., 
1999). As apoptosis is an active process leading to changes in protein synthesis 
(Clemens et al., 2000), it is possible that changes in levels of mRNA in these cells 
could lead to incorrect  scoring of Comet tails. Moreover, the chromatin degradation 
occurring at the beginning of apoptosis (Walker et al., 1995) could lead to further 
migration of stretched DNA into the Comet tail. Comet tails may result due to nuclear 
blebbing and the formation of micronuclei that are also common to apoptotic cells. 
Interestingly, work done by our group and others has suggested a role for autophagy 
in the degradation of micronuclei (Ivanov et al., 2013, Rello-Varona et al., 2012). We 
have also seen that 10Gy of irradiation is sufficient to lead to the generation of 
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micronuclei in Atg5-/- MEFs, presenting another potential confound when using 
Comet assay to assess autophagy dependent differences in DNA repair using high 
doses of IR. Contrary to a potential overestimation of DNA damage seen using 
Comet assay, cell death can lead to an underestimation of DNA damage when using 
markers such as H2A.X measured by microscopy. This is because cells that contain 
higher level of DNA damage are eliminated from your analysis, as they detach during 
the fixation and staining process.  
Autophagy status has been heavily implicated in cell survival and execution of 
cell death pathways (Marino et al., 2014), therefore the use of DNA damaging agents 
at doses able of inducing cell death is inappropriate to elucidate the effect of 
autophagy on the kinetics of DNA damage repair itself. 
As well as inducing cell death, 10Gy X-ray irradiation is also able to induce 
cellular senescence in MEFs (Hewitt et al., 2012). This induction of senescence is 
associated with the presence of long lived DNA damage foci (Hewitt et al., 2012, 
Rodier et al., 2011, Fumagalli et al., 2012), as well as the constant generation and 
repair of transient DNA that arise due to mitochondrial ROS generation (Passos et 
al., 2010). The role of autophagy in mitochondrial turnover (Lee et al., 2012a) could 
indeed influence DNA damage in this context, independent of any role in DNA 
damage repair. Consistently, knockout of Atg7 in the hematopoietic system of mice 
resulted in an accumulation of mitochondria, ROS generation and DNA damage 
(Mortensen et al., 2011). Similarly, hepatocytes from Atg5 mosaic knockout mice 
show increased numbers of swollen mitochondria as well as DNA damage 
(Takamura et al., 2011). This makes the study of direct effects of autophagy on DNA 
damage repair extremely challenging in using these models. Interestingly, autophagy 
status may influence the execution of the senescent phenotype (Gewirtz, 2013) 
presenting the problem that differences seen in DNA damage may result from the 
effect of autophagy on the senescence process rather than DNA damage repair 
itself. 
It is possible that the effect of autophagy in processes such as cell death and 
senescence are mediated, in part, by changes in DNA damage repair. However in 
this thesis to avoid the possible confounding influences of these processes, DNA 
damage repair was studied in the context of low level damage induction.  
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Results presented in this chapter show that cells lacking autophagy due to 
knockout of ATG5 show an impaired repair kinetics of 53BP1 foci compared to wt 
cells when exposed to 1Gy of irradiation.  As discussed, M5-7 MEFs were used to 
help confirm that this result was due to the absence of autophagy and not due to 
clonal differences between MEFs derived from separate animals. It should be noted 
that these cells must be cultured for 4 days in the presence of Tet to completely 
abolish autophagy. This is because only very low levels of Atg5 are required for 
basal autophagy (Hosokawa et al., 2007). It would be interesting to study the effect 
of an acute inhibition of autophagy in the context of DNA damage as both Atg5-/- and 
M5-7 MEFs cells have impair autophagy prior to induction of DNA damage. This is 
something that will be discussed further in the coming chapters.  
Whole cell X-ray irradiation leads to the damage of many cellular components 
such as lipids, proteins and DNA. As we are hoping to assess the effect of 
autophagy, a protein degradation pathway, on DNA repair capacity. It is important to 
account for the possibility that differences in foci repair kinetics between Atg5+/+ and 
Atg5-/- MEFs may arise due to differences in the clearance of other cellular damage 
other than DNA damage, which may itself influence DNA repair processes. 
Therefore, damage induced by the topoisomerase inhibitor Etoposide was also 
assessed. These results indicated that, similar to X-ray IR, cells lacking autophagy 
had a reduced repair capacity compared to wild type cells. These data suggest that 
the differences seen in DDF following induction of DNA damage result from 
differences between Atg5+/+ or Atg5-/- MEFs in DNA repair pathways and not as a 
result of damage to other cellular macromolecules. 
Data presented above suggest that the differences in DNA damage foci repair 
kinetics following 1Gy X-ray irradiation are not dependent on ROS as treatment with 
5mM NAC had no significant effect on repair kinetics in Atg5+/+ or Atg5-/- MEFs. It 
should be noted, however, that levels of intracellular ROS were not assessed in this 
experiment. Nevertheless, treatment of fibroblasts with 2.5mM NAC has previously 
been shown to be sufficient to reduce levels of ROS following 20Gy X-Ray IR  as 
well as in Atg5+/+ or Atg5-/- MEFs following 10Gy X-Ray IR (Correia-Melo, 2014). 
Therefore, it could be expected that this treatment would be sufficient to supress 
ROS in response to 1Gy IR, however further studies would be required to confirm 
these assumptions. 
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Recently, it was suggested that CMA may play a role on DNA damage repair 
(Park et al., 2015). In this paper, similar to those published by 2 other groups (Liu et 
al., 2015b, Bae and Guan, 2011a) high levels of DNA damaging agents were used 
and reduced cell viability was observed, again leading to possible confounding 
effects when assesing DNA damage. The authors propose that CMA is responsible 
for the regulated degradation of Chk1, concluding that inhibition of CMA leads to an 
accumuation of Chk1 in the nucleus resulting in a prolonged cell cycle arrest and 
DNA damage response (Park et al., 2015). For that reason, it was important to 
assess the potential role of CMA on DNA repair in our system. My results indicate 
that inhibition of lysosomal degradation, inclusive of CMA, by treatment with 
Bafilomycin A1 lead to no further change in DNA damage foci kinetics. These data 
suggest that CMA is not having an effect on DNA damage repair in response to low 
level radiation. It is possible that CMA is inhibited in Atg5-/- MEFs and so treatmennt 
with Bafilomycin A1 had no further effect, however inhibition of macroautophagy by 
Atg5 knockdown has in fact been shown to lead to an increase in the activity of CMA 
(Wang et al., 2008). Although unlikely, further investigation would be required to rule 
out the effects of CMA in this process.   
There have also been studies that show an Atg5/7-independent alternative 
macroautophagy pathway (Nishida et al., 2009). Here, authors describe the 
formation of autophagosomes that are devoid of the classical autophagosome 
marker LC3 II that are generated in a Rab9-dependent manner in both Atg5-/- and 
Atg7-/- MEFs (Nishida et al., 2009). It is possible that this pathway could be 
upregulated in Atg5-/- MEFs and influencing DNA damage repair. This possibility was 
ruled out along with the contribution of CMA as treatments with Bafilomycin A1 in 
Atg5-/- MEFs had no effect on the rate of DNA damage repair, suggesting that other 
lysosomal degradation pathways such as Atg5/7-independent autophagy were not 
important in this context.  
It should also be noted that Atg5 has been shown to be involved in a number 
of processes independently of its function in autophagy such as: immunity to 
intracellular pathogens in macrophages via its role in recruiting IFN-γ-inducible p47 
GTPase IIGP1 (Irga6) to the vacuole membrane (Zhao et al., 2008) and late 
endosome and lysosome biogenesis (Peng et al., 2014).  Atg5 has also recently 
been shown to play an important role in the induction of mitotic catastrophe through 
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its interaction with survivin, thereby inhibiting the correct formation of the 
chromosome passenger complex (Simon and Friis, 2014) (Maskey et al., 2013). This 
effect of Atg5 occurs in the nucleus and is independent of autophagy. This mitotic 
catastrophe was induced in response to sub-lethal treatment with anti-cancer drugs 
such as: Etoposide and cystplatin for 24-48 hrs. It is possible that this role for Atg5 
could lead to confounding results when studying the role of autophagy in DDR using 
Atg5 KO as a means of autophagy ablation. However, Simon and Friis suggest that 
the effect of Atg5 on mitotic catastrophe occurs independently of DNA damage 
(Simon and Friis, 2014). The induction of mitotic catastrophe is less likely to be 
relevant when using more acute treatments (2h to induce DNA damage). Moreover, 
it would be expected that increased mitotic catastrophe would lead to an increase in 
DNA damage in Atg5+/+ MEFs. Although my data suggests a link between inhibition 
of autophagy to a decreased repair of DNA damage foci, further experiments should 
be conducted using another genetic approach to inhibit autophagy such as knockout 
of Atg7 when assessing DNA damage repair in response to 1Gy X-ray IR. Indeed, 
another reason for the discrepancy with Liu et al is that they have used an Atg7 KO 
while in our experiments we used an Atg5 KO. 
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4. Chapter 4. Phenotypic characterisation of the role of p62 in the DDR 
 
In the previous chapter, we demonstrated that cells lacking autophagy have a 
reduced clearance of 53BP1 foci following induction of damage by both X-ray 
irradiation and Etoposide treatment (Figure 3-2& Figure 3-3). These data are in 
agreement with (Bae and Guan, 2011). It has previously been observed by our group 
(Korolchuk group, unpublished data) and others that cells lacking autophagy have 
higher levels of reactive oxygen species, especially when cells are exposed to 
extrinsic stressors (Sun et al., 2013, Kurihara et al., 2012). Reactive oxygen species 
have long been known to induce DNA damage (Kurihara et al., 2012). However our 
data indicate that treatment with NAC, a potent antioxidant, had little effect on 53BP1 
foci kinetics in our experimental system, suggesting that ROS were not responsible 
for autophagy-dependent differences in DDF kinetics. Previous studies have 
suggested a link between the accumulation of p62 in autophagy compromised cells 
and an increase in DNA damage (Bae and Guan, 2011). Results shown in the 
previous chapter show that siRNA knockdown of p62 in both autophagy 
compromised and wt cells does indeed lead to a reduction in 53BP1 foci. Similarly, 
inhibition of autophagy in primary fibroblasts lead to increased expression of p62 and 
increased levels of p21 and p-p53 following X-ray irradiation. These data suggest a 
possible link between p62 and DNA damage repair. The aim of this next chapter is to 
further investigate the role of p62 in DNA damage repair.  
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4.1 p62-/- MEFs show a decreased number of DDF following Induction of DNA 
damage 
 
To assess the role of p62 in the DDR p62+/+ and p62-/- MEFs were irradiated 
with 1Gy of X-ray irradiation and fixed every hour for 8h following IR. Cells were then 
stained with antibody against 53BP1 and DDF quantified by microscopy. p62 levels 
were assessed by immunoblotting (Figure 4-1A) and loss of p62 in p62-/-  MEFs 
confirmed. Results shown in Figure 4-1B-C indicate that p62-/- MEFs have a reduced 
number of DDF compared to p62+/+ MEFs. These results suggest a possible negative 
role for p62 in the repair of DNA damage. In order to further understand DNA 
damage foci dynamics live-cell imaging was performed in p62+/+ and p62-/- MEFs 
stably expressing mCherry-53BP1 following 0.25Gy X-Ray irradiation, allowing the 
tracking of individual foci lifespan. A lower dose of 0.25Gy was used instead of 1Gy 
like previous experiments to facilitate the accurate tracking of individual foci. Results 
shown in Figure 4-1D-E indicate that p62-/- MEFs have an increased rate of foci 
resolution compared to p62+/+ MEFs. These data support those seen in fixed cells 
and also help distinguish between foci that are generated by the initial dose of 
irradiation from those that occur at later time points due to the formation of new 
DSBs. 
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Figure 4-1: Cells lacking p62 have a faster DNA damage repair kinetic. (A) 
Representative immunoblot showing p62 and GAPDH in p62-/- and p62+/+ MEFs. (B-
C) p62-/- and p62+/+ MEFs stably expressing mCherry-53BP1 were exposed to 
0.25Gy X-ray irradiation and 53BP1 foci kinetics were monitored by live cell imaging 
for 300 min. Representative images are shown in (B), the nucleus is marked by 
dotted white border. (C) Kaplan-Meier plot showing the survival of individual 53BP1 
foci in p62-/- and p62+/+ MEFs following irradiation. Note that 0.25Gy was used to 
induce low frequency of DDF and facilitate accurate tracking of foci P=0.003. 
Representative images (D) and quantification (E) of the mean number of 53BP1 foci 
in p62-/- and p62+/+ MEFs 0-480 min after 1Gy X-Ray irradiation. Scale bar 10 µm; 
n=3; Error bars represent S.E.M; NS: not significant, * p<0.05, ** p<0.01, *** 
p<0.001.    
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Having shown that knockout of p62 results in an increased rate of DNA repair 
in live and fixed cells following X-Ray induced DNA damage, I wanted next to 
confirm this result using an alternative, more specific means of inducing DNA 
damage. Here, p62+/+ and p62-/- MEFs were treated with 1µM Etoposide for 120 min. 
Cells were either fixed immediately after treatment or washed and allowed to recover 
for 300 min, then were fixed and stained with antibody against 53BP1 (Figure 4-2A). 
Results shown in (Figure 4-2B) indicate that treatment with Etoposide induced 
similar levels of damage in p62+/+ and p62-/- MEFs. However, following 300 min 
recovery, p62+/+ MEFs showed significantly more DNA damage. These results 
confirm that cells lacking p62 repair DNA damage faster. 
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Figure 4-2: Cells lacking p62 have an increased repair capacity in response 
Etoposide. DNA damage was induced in p62-/- and p62+/+ MEFs by 120 min 
incubation with Etoposide and, where indicated, followed by a 300 min recovery 
period. Representative images are shown in (A) and the mean number of 53BP1 foci 
was quantified (B). Scale bar 10 µm; n=3; Error bars represent S.E.M; NS: not 
significant, * p<0.05, ** p<0.01, *** p<0.001. 
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Next, in order to answer whether the differences in DNA damage seen in 
p62+/+ and p62-/- MEFs were dependent on autophagy, p62+/+ and p62-/- MEFs were 
treated with Baf rendering cells autophagy deficient. p62+/+ and p62-/- MEFs were 
pre-treated with 100µM Baf for 180 min in order to block autophagy and allow 
sufficient accumulation of p62. Cells were then exposed to 1Gy of X-Ray irradiation 
and cell lysates were collected at 5 min and 300 min following IR as well as non-IR 
control. The block of autophagy was confirmed by immunoblotting for LC3 (Figure 
4-3A) as well as p62 (Figure 4-3B). These results confirm an accumulation of both 
LC3II and p62 following treatment with Baf in p62+/+ MEFs and LC3II in p62-/- MEFs 
indicating a block in autophagy. 
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Figure 4-3: The effect of Bafilomycin A1 treatment on autophagy.  Immunoblot 
analyses showing the levels of LC3 (A) and p62 (B) in p62+/+ and p62-/- MEFs 
following treatment with 100M Bafilomycin A1 following 1Gy X-Ray irradiation as 
shown. n=3; Error bars represent S.E.M.   
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Following confirmation of autophagy inhibition (Figure 4-3) as above, p62+/+ 
and p62-/- MEFs were pre-treated with 100µM Baf for 180 min. Cells were then 
exposed to 1Gy of X-Ray irradiation and fixed at 5 min and 300 min following IR as 
well as non-IR control. Cells were stained with antibody against 53BP1 and DDF 
were analysed by microscopy (Figure 4-4A-B). 
Here, inhibition of autophagy with Baf causes an increase in 53BP1 foci 300 
minutes following 1Gy X-Ray irradiation in p62+/+ but not p62-/- MEFs (Figure 4-4B), 
indicating that decreased repair capacity seen in autophagy-compromised cells is 
dependent on p62. 
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Figure 4-4: Inhibition of autophagy with Bafilomycin A1 treatment affects DNA 
damage repair in a p62-dependent manner. Representative images (A) and 
quantification (B) of the mean number of 53BP1 foci in p62-/- and p62+/+ MEFs 5 min 
and 300 min following 1Gy X-Ray irradiation and treatment with 100M Bafilomycin 
A1. Scale bar 10 µm; n=3; Error bars represent S.E.M; NS: not significant, * p<0.05, 
** p<0.01, *** p<0.001. 
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4.2 Reintroduction of p62 returns frequency of DDF to wild type level 
 
Having established that p62-/- MEFs have a reduced number of DDF following 
IR compared to their wt counterparts (Figure 4-1A-E) and (Figure 4-2A-B), I 
determined the effect of reintroducing p62 on DDR as differences between p62+/+ 
and p62-/- MEFs could be partly due to clonal differences independent of p62.  
Here p62+/+ and p62-/- MEFs were transfected with p62-GFP or GFP empty 
vector (control). Cells were then exposed to 1Gy of X-Ray irradiation and then fixed 
at 5h following IR as well as a non-IR control. Cells were stained with antibody 
against 53BP1 and DDF analysed by microscopy (Figure 4-5A-B). Results shown in 
Figure 4-5B demonstrate that re-introduction of GFP-p62 in p62-/- MEFs increases 
the number of 53BP1 foci back to the levels seen in p62+/+ transfected with GFP-
control. Overexpression of GFP-p62 in p62+/+ MEFs also significantly increased the 
number of 53BP1 foci 300 min following irradiation (Figure 4-5B). These results 
show that differences in DNA damage foci seen between p62+/+ and p62-/- MEFs are 
indeed dependent on p62. 
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Figure 4-5: The effect of overexpression or reintroduction of GFP-p62 into 
p62+/+ and p62-/-  MEFs. Representative images (A) and quantification (B) of 53BP1 
foci 300 min after irradiation of p62-/- and p62+/+ MEFs transfected overnight with 
GFP-control or GFP-p62. Scale bar 10 µm. n=3; Error bars represent S.E.M; NS: not 
significant, * p<0.05, ** p<0.01, *** p<0.001. 
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4.3 p62-/- MEFs show a decreased number of DSBs but not SSBs following 
induction of DNA damage 
  
Data shown in (Figure 4-1A-E) and (Figure 4-2A-B) indicate that cells lacking 
p62 have a quicker resolution of 53BP1 foci following induction of DNA damage than 
wild-types with both X-Ray irradiation and Etoposide treatment, respectively. 
Although 53BP1 has been shown to aggregate at DSBs and quantification of DNA 
damage foci is thought to serve as a good approximation for the number of DSBs 
(Panier and Boulton, 2014) the measurement of DNA damage foci is not a direct 
measure of DNA damage lesions. This can be done using the Comet assay. The 
general principle is that neutral Comet can be used to detect DSBs in cells while 
alkaline Comet may be used to detect both DSBs and SSBs. This will be discussed 
further later in this chapter. 
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 In order to assess the role of p62 on DNA single stranded lesions, an alkaline 
Comet assay was performed on p62+/+, p62-/- and p62-/-+FLAG-p62 cell lines 
following Etoposide treatment for 120 min. Cells were either collected immediately 
after treatment or washed and allowed to recover for 300 min. The p62-/-+FLAG-p62 
cell line was generated as it allows to separate the effect of p62 knock out from any 
clonal differences that may be present between p62+/+ and p62-/- MEFs. 
The Immunoblot shown in Figure 4-6A shows the successful reintroduction of 
p62 in the p62-/-+FLAG-p62 cell line, however it must be noted that the expression 
levels of p62 are markedly lower than in p62+/+ MEFs.  Results presented in Figure 
4-6B-C show a significant induction of DNA damage following Etoposide of around 
80% tail intensity in all cell lines. These data indicate that there is no difference in 
damage induction in p62+/+, p62-/- and p62-/-+FLAG-p62 cell lines in response to 
Etoposide treatment. Results shown in (Figure 4-6B-C) show equivalent levels of 
DNA damage around 40% tail intensity in all cell lines at 300 min following Etoposide 
treatment suggesting that there is no difference in resolution of DNA damage in 
p62+/+, p62-/- and p62-/-+FLAG-p62 cell lines in alkaline conditions.  
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Figure 4-6: Measurement of SSBs in p62+/+, p62-/- and p62-/-+FLAG-p62 MEFs 
using alkaline Comet assay. (A) Immunoblot analyses showing the levels of p62 in 
p62+/+, p62-/- and p62-/-+FLAG-p62 cell lines. Note that transgenic FLAG-p62 is 
expressed at lower levels than endogenous protein. (B-C) p62+/+, p62-/- and p62-/-
+FLAG-p62 following the induction of DNA damage with Etoposide for 120 min either 
followed with or without a 300 min recovery period (in the absence of Etoposide). 
Representative images of alkaline Comet analysis shown in (B) whilst % tail intensity 
is quantified in (C). Scale bar 40 µm. n=3; Error bars represent S.E.M; NS: not 
significant, * p<0.05, ** p<0.01, *** p<0.001. 
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In order to assess DSBs more specifically, neutral Comet assay was 
performed on p62+/+, p62-/- and p62-/-+FLAG-p62 cell lines following Etoposide 
treatment for 120 min. Cells were either collected immediately after treatment or 
washed and allowed to recover for 300 min. 
Results shown in Figure 4-7A-B (like in Figure 4-6B-C) show a significant 
induction of DNA damage following Etoposide of around 35% tail intensity in all cell 
lines that there is no difference in induction of double stranded DNA damage in 
p62+/+ and p62-/- MEFs in response to Etoposide treatment. Results shown in Figure 
4-7B indicate a significantly reduced tail intensity of around 17% in p62-/- MEFs 
compared to 30% in p62+/+ MEFs, at 300 min following Etoposide treatment, 
indicating like 53BP1 foci shown in Figure 4-1A-E and Figure 4-2A-B that there is 
increased resolution of DSBs in p62-/- compared to p62+/+ MEFs. Interestingly, there 
is also increased tail intensity in p62-/-+FLAG-p62 MEFs when compared to p62-/- 
MEFs, however the difference is not statistically significant. This is likely due to the 
relatively low levels of p62 expression seen in p62-/-+FLAG-p62 MEFs when 
compared to p62+/+ MEFs (Figure 4-6A). 
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Figure 4-7: Measurement of DSBs in p62+/+, p62-/- and p62-/-+FLAG-p62 MEFs 
using neutral Comet assay. (A-B) p62+/+, p62-/- and p62-/-+FLAG-p62 following the 
induction of DNA damage with Etoposide for 120 min either followed with or without 
a 300 min recovery period (in the absence of Etoposide). Representative images of 
neutral Comet analysis shown in (A) and % tail intensity is quantified in (B). Scale 
bar 40 µm. n=3; Error bars represent S.E.M; NS: not significant, * p<0.05, ** p<0.01, 
*** p<0.001. 
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4.4 The Effect of p62 Knockdown on DDR Downstream Signalling 
 
Having established that cells lacking p62 have an increased DNA damage 
repair kinetic compared to wild type cells, as measured by 53BP1 Foci and neutral 
Comet (Figure 4-1&Figure 4-5), I intended to investigate the impact of p62 on 
downstream DNA damage signalling. For this it was necessary to knock down p62 in 
primary cells as downstream signalling is possibly disrupted in p62+/+ and p62-/-  
MEFs as a result of the SV40 immortalisation process (Boichuk et al., 2010). Here, 
MRC5 human fibroblasts were transduced with shRNA for p62.  Optimisation of 
shRNA transduction is shown in Figure 4-8. Lentivirus containing shRNA #s 3,4 and 
5 was produced in HEK293FT cells and used at virus titres of 1,2,and 4ml of viral 
media in a total of 4ml. Knockdown of p62 is shown in Figure 4-8A-B and normalised 
to GFP shRNA (control) (Figure 4-8B). It can be seen from Figure 4-8A-B that 
transduction with p62 shRNA lead to a 70-80% knockdown of p62 at the optimal 
virus titre of 2ml of viral media in a total of 4ml, as measured by immunoblot. The 
p62 knockdown efficiency of cell lines derived from chosen virus titre is shown in 
Figure 4-8C and quantified in Figure 4-8D following 2 cell passages (to allow cells to 
recover from transduction) indicating successful selection and maintenance for p62 
shRNA expressing cells. 
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Figure 4-8: Optimisation of p62 shRNA transduction in MRC5 fibroblasts. (A) 
Western blots and quantification showing p62 and loading control GAPDH for 
different Virus titres 1, 2 and 4ml of viral media in a total of 4ml. (B) Quantification 
from (A) normalised to GFP control shRNA. Western blots (C) and quantification (D) 
showing p62 and loading control GAPDH in p62 shRNA stable cell lines. 
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Following the successful generation of p62 shRNA-expressing cell lines, next 
we wanted to investigate the effect of p62 knockdown on the downstream DDR. 
Here, MRC5 human fibroblasts that are stably expressing shRNA against p62 were 
exposed to 1Gy of X-Ray irradiation and collected at time points 5min-8h following IR.  
Samples were then run on SDS page electrophoresis and immunoblot analysis was 
carried out for p53, p62, p-p53, p21, p-Chk1, Chk1 and loading control GAPDH.  
Western blots shown in Figure 4-9A indicate successful knockdown of p62, and also 
indicate that levels of p62 are unchanged across the 8h time course following IR.  
Quantification shown in Figure 4-9B show a trend for p62 shRNA-expressing cells to 
have reduced levels of p21 2h and 5h following 1 Gy IR, however these differences 
are not statistically significant. Similarly, induction of p-p53 is reduced in p62 shRNA-
expressing cells but, again, results are not statistically significant. There were no 
differences between cells with and without p62 shRNA when comparing pChk1 and 
total Chk1 levels following IR (Figure 4-9D-E). It would be interesting to repeat these 
experiments using a higher dose of IR in order to ascertain if there are any p62-
dependent differences in downstream DDR. 
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Figure 4-9: Downstream DDR in MRC5 fibroblasts transduced with shRNA 
against p62.  Representative western blots (A) showing p62, p53, p-p53, p21, Chk1, 
p-Chk1 and loading control GAPDH in MRC5 fibroblasts transduced with GFP-
shRNA (control) of p62 shRNA as indicated following 1Gy X-ray irradiation at time 
points 5min-8h. Quantification of p21 is shown in (B), p-p53/p53 in (C), p-Chk1 in (D) 
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and total Chk1 in (E). n=3; Error bars represent S.E.M.. Done in collaboration with Dr 
Bernadette Carol. 
4.7 Discussion 
 
While previous studies, as well as the previous chapter, have suggested that 
p62 may mediate autophagy dependent differences in DNA damage repair (Bae and 
Guan, 2011), the role of p62 in the DNA damage response has not been well 
characterized (Yu et al., 2011).  Here, for the first time, we show a p62-dependent 
effect on DNA damage repair in cells with active autophagy. p62 has previously been 
shown to mediate increased tumorigenesis in response to loss of autophagy. In a 
study from the White group they describe that induction of metabolic stress in cells 
lacking autophagy leads to increased expression of endoplasmic reticulum (ER), 
accumulation of damaged mitochondria, p62, ROS and genomic instability. They 
attribute this effect of increased tumorigenesis in the absence of autophagy to 
increased levels of p62, as overexpression of p62 in the same cell model leads to 
increased tumor volume following mouse xenograft experiments. It is possible that in 
the absence of autophagy increased levels of ROS could, in turn, lead to the 
induction p62 expression. This p62 overexpression could then contribute to 
additional ROS generation, leading to genome instability (Mathew et al., 2009). It 
should be noted that the lack of p62 has also been associated with an increase in 
ROS, this time through inhibition of NF-B (Duran et al., 2008). This inhibition of NF-
κB is in contrast to that reported in (Sanz et al., 2000a), where small p62 puncta are 
proposed to serve as signalling hubs leading to NF-B activation. It is possible that 
large aggregates actually lead to the sequestration of key proteins involved in 
signalling, leading to an inhibition of the pathway. Taken together, these data 
suggest that intracellular levels of p62 play an important role in the modulation of 
ROS. However, the exact influence appears to be cell type and context specific.  
Nonetheless, variances in ROS could well be influencing the differences seen 
in DNA damage foci repair kinetics in fixed cells. DDF kinetics was followed in live 
cells. For this, cell lines were generated where p62-/- and p62+/+ MEFs stably express 
mCherry-53BP1. This has the added advantage of allowing the analysis of the 
lifespan of individual foci. It has previously been reported that DNA damage foci that 
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arise due to ROS are transient in nature (Passos et al., 2010). Here we were able to 
visualise secondary DNA damage foci that appear independently of those generated 
by the initial induction of DNA damage using 0.25Gy X-Ray irradiation. There was no 
difference between p62-/- and p62+/+ MEFs in the appearance of these secondary 
DNA damage foci, suggesting that ROS generated DNA damage foci were not the 
reason for the differences seen in DDF repair kinetics.  
Although it has been suggested that p62 may mediate autophagy-dependent 
differences in DNA damage repair (Bae and Guan, 2011), the effect of p62 on DNA 
damage has not previously been described independently of autophagy.  Results in 
this chapter indicate that autophagy inhibition is having no effect on DNA damage 
repair in the absence of p62. These data also indicate that increased levels of p62 
do not require active autophagy to affect DDF repair.  The lack of effect on DNA 
damage foci at 5h following 1Gy IR in p62-/- MEFs with Bafilomycin A1 treatment is in 
agreement with data from the previous chapter suggesting that other lysosomal 
degradation pathways are not influencing DNA damage repair kinetics following low 
dose IR. These data suggest that the CMA mediated degradation of Chk1 that was 
observed by the Cuervo lab (Park et al., 2015) may only influence the repair of DNA 
damage induced by higher doses of IR. 
Re-introduction of p62 in p62-/- MEFs and overexpression in p62+/+ MEFs lead 
to an increase in 53BP1 foci 300 minutes following 1Gy X-Ray IR. These data show 
that differences seen between p62+/+ and p62-/- MEFs were indeed dependent on 
p62 and not due to clonal differences in MEFs derived from different animals. 
Overexpression of p62 at super physiological levels leads to the formation of large 
cytoplasmic aggregates; these aggregates are able to sequester a number of 
proteins leading to a loss in their function (Donaldson et al., 2003). In an attempt to 
prevent the formation of these aggregates and try to achieve ubiquitous low level 
expression of GFP-p62 the construct was co-transfected with pcDNA (empty control 
plasmid) in order to dilute its expression. Cells were also chosen that did not have 
massive cytoplasmic aggregates when performing analysis of 53BP1 foci. It can be 
seen that despite efforts to reduce expression levels, as well as select low 
expressing cells p62 aggregates are still present as a result of overexpression. This 
is a major limitation when trying to study p62 using mammalian expression vectors. 
This problem could be avoided by generating cell lines that stably express p62 using 
Chapter 4. Phenotypic characterisation of the role of p62 in the DDR  
 
144 
 
lentiviral transduction. Using this approach, one is able to transduce cells using 
different virus titres, then select and expand clones with the desired expression level. 
Newly developed knock-in technology such as CRISPR/Cas now allows the addition 
of tagged and mutated proteins in place of the wt version, allowing a far more 
physiological control of transcription and expression. The most recent advances in 
this technology allow for the creation of cell lines without the need for the selection of 
successfully altered cells with antibiotics (Zhu et al., 2015). This need for selection 
and subsequent loss of a percentage of the cell population has been a major limiting 
factor when using GM modification in primary cells, especially when studying 
processes such as senescence where accurately tracking the number of population 
doublings is essential. In order to achieve more physiological levels of expression 
cell lines were produced using lentiviral transduction of FLAG-p62 and control 
plasmid in p62-/- MEFs. It should be noted that when compared to p62+/+ MEFs the 
level of p62 expression in p62-/-+FLAG-p62 was lower. The cell line would have to be 
generated again using a higher virus titer to have comparable levels of p62 to wt 
MEFs.   
Data presented so far have shown comparison of DDF repair kinetics 
following DNA damage induction using fixed and live-cell microscopy. The 
measurement of DNA damage foci has been shown to correlate well with the number 
of DNA lesions; however it is not a direct measure. This is of particular importance 
as both autophagy and p62 are heavily involved in protein turnover. p62 has also 
been shown to serve as a scaffold protein (Ciuffa et al., 2015, Johansen and Lamark, 
2011). Therefore, differences in DNA damage foci may arise due to differences in 
protein degradation and foci disassembly potentially uncoupling the link between 
numbers of DNA damage foci as an accurate measure of DNA lesions. It was 
therefore important to assess the effect of p62 of  DNA lesions directly. This was 
done using both alkaline and neutral Comet assay. Results show that p62 has no 
effect of DNA lesions when assessed by alkaline Comet assay. This is a method that 
is believed to assess both single and double stranded DNA lesions as the alkaline 
conditions not only unwind DNA but also separate DNA stands (Singh et al., 1988), 
allowing both DSBs and SSBs to migrate with electrophoresis. Interestingly, when 
using neutral Comet, cells lacking p62 had a faster resolution of damage as 
measured by % DNA in the tail. Neutral Comet has been suggested to measure 
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predominantly double strand breaks as in neutral conditions it is only DNA containing 
DSBs that are able to migrate with SSBs being held in the head on the Comet by 
intact complementary strands (Olive et al., 1991). The specificity of this technique for 
DSBs can be verified by treating cells with hydrogen peroxide which has been shown 
to create 1000-fold or more SSBs compared to DSBs (Olive and Johnston, 1997). 
However, the specificity of neutral Comet as a measure of just DSBs is lacking when 
assessing low levels of damage, as both SSBs and DSBs have been shown to relax 
the super coiled structure of DNA held within nucleoids, the protein and membrane-
depleted nuclear bodies that result following lysis (Ostling and Johanson, 1984). This 
relaxation has been proposed to mediate the migration of DNA into a Comet tail 
within the electric field applied even in neutral conditions. The contribution of 
supercoil relaxation is outweighed by DSB migration at higher levels of damage and 
this assay has been shown to measure DSBs over a range of 50-10000 breaks per 
cell (Olive and Banath, 2006). Therefore, in order to achieve higher sensitivity when 
assessing DSBs a higher concentration of Etoposide was used in these experiments, 
10µM instead of 1 µM.  Assuming that following 10µM Etoposide treatment neutral 
Comet is an accurate measure of DSBs, these results indicate that p62 is affecting 
DSB repair directly. These results reinforce the hypothesis that differences in DDF 
seen in previous experiments arise due to different levels of DSBs and not just as a 
result in aberrant or impaired foci turnover. The lack of difference seen in the alkaline 
Comet could result as the number of SSBs present is sufficient to mask any 
difference in the number of DSBs that can be visualized using this technique. This 
would be consistent with the finding that Etoposide treatment induces predominantly 
SSBs (Muslimovic et al., 2009).  
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5. Chapter 5. Mechanistic Analysis of the role of p62 in the DDR 
  
 In the previous chapter we established that cells lacking p62 have 
increased DNA repair capacity as measured by kinetics of 53BP1 foci and Comet 
assay following X-ray irradiation. It is not yet known how p62 is able to influence the 
DDR. p62 is primarily a cytoplasmic protein but, as discussed previously, it contains 
both NLS and NES domains which mediate its transport in and out of the nucleus 
(Pankiv et al., 2010). Moreover, it has been shown to interact with PML bodies which 
contain DDR proteins such as BLM/WRN DNA helicases, MRN and DNA 
topoisomerase II binding protein (TopBP1) (Lallemand-Breitenbach and de The, 
2010). On the other hand p62 may interact with proteins in the cytoplasm to elicit its 
effect on the DDR. It is possible that p62 may have an effect on DNA damage 
resolution via its role as a scaffold protein, signal transduction or protein degradation. 
In this following chapter we aim to establish how p62 is able to influence DNA 
damage repair mechanistically.  
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5.1 Both PB1 and UB1 Protein Domains are required for p62 to impact on DNA 
Damage Repair 
 
p62 has multiple functional domains that are responsible for its cellular 
functions. Having established a role for p62 in DNA damage repair I aimed to identify 
the functional domains involved in the process. Here, p62-/- MEFs were transfected 
with GFP empty vector (control), wt p62-GFP or p62 mutants lacking either the PB1 
domain responsible for protein oligomerisation (ΔPB1), the UBA domain involved in 
binding to ubiquitylated substrates (ΔUBA), or the nuclear export signal (ΔNES). The 
domain structure for these constructs is shown in Figure 5-1A. Cells were then 
exposed to 1Gy of X-Ray irradiation and then fixed at 300 min following IR as well as 
non-IR control. Cells were stained with an antibody against 53BP1 and DDF 
analysed by microscopy (Figure 5-1B-C). Representative images shown in Figure 
5-1B indicate the distinctive expression pattern for each of these constructs.  ΔNES 
p62 is expressed almost exclusively in the nucleus as it is no longer transported out 
of the nucleus via nuclear transporter exportin 1. ΔUBA p62 lacks the cytoplasmic 
puncta of the wt protein due to its inability to bind to ubiquitylated substrates. ΔPB1 
p62, similar to ΔUBA p62, has a diffuse cytoplasmic appearance, this time due to its 
inability to form oligomers.  Results shown in Figure 5-1B demonstrate that re-
introduction of wt p62 into p62-/- MEFs increases the number of 53BP1 foci similar to 
results shown in Figure 4-5. Data shown in Figure 5-1B indicate that both ΔUBA and 
ΔPB1 mutants fail to increase levels of 53BP1 foci to the same extent as wt p62, 
suggesting that both of these domains are important for the effect p62 has on DNA 
damage repair. Interestingly, p62-/- MEFs expressing ΔNES-p62 show similar levels 
of 53BP1 foci 300 minutes following IR as those expressing wt p62, meaning that the 
NES domain is dispensable. These results suggest that p62 does not need to be 
shuttled from the nucleus into the cytoplasm to have an effect on this process 
(Figure 5-1B). 
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Figure 5-1:PB1 and UBA domains of p62 are required for a p62 mediated effect 
on DDR (A) Schematic representation of the domain structure of p62 constructs. Key 
structural domains are marked:  UBA: ubiquitin-associated domain; PB1: Phox and 
Bem1p domain; ZnF: ZZ type zinc finger domain; NES: Nuclear export signal; 
NLS1/2: Nuclear localisation signal. Quantification (B) and representative images (C) 
of 53BP1 foci in p62-/- MEFs overexpressing the indicated GFP-tagged p62 mutants 
300 minutes after irradiation. Scale bar 10 µm. n=3; Error bars represent S.E.M; NS: 
not significant, * p<0.05, ** p<0.01, *** p<0.001. 
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5.2 p62 co-localises with DNA Damage foci in vitro  
  
Although p62 is known to shuttle in and out of the nucleus (Pankiv et al., 
2010), little is known about its nuclear role. It was reported in Pankiv et al that upon 
inhibition of nuclear export via either treatment with Leptomycin B or deletion of the 
NES sequence, p62 forms distinctive nuclear puncta (Pankiv et al., 2010). Previous 
results (Figure 5-1B-C) indicate that both the PB1 and UBA domains of p62 are 
important for its role in 53BP1 foci repair, both of which are involved in protein-
protein interactions. In order to further understand the role of p62 on 53BP1 foci 
dynamics we decided to investigate interaction between p62 and DNA damage foci. 
Here, MRC5 human fibroblasts exposed to 1Gy of X-Ray irradiation, as well 
as non-irradiated controls, were treated with and without Leptomycin B for 1h prior to 
fixation in order to block nuclear export of p62. Cells were then stained with 
antibodies against 53BP1 and p62, both DDF and p62 puncta were analysed by 
microscopy.  Representative images shown in Figure 5-2A indicate, consistent with 
previously published work (Pankiv et al., 2010), that block of nuclear export using 
Leptomycin B results in the formation of nuclear p62 puncta. Results shown in Figure 
5-2B show an elevated number of p62 puncta in cells without Leptomycin B, 300 
minutes following IR, indicating an induction of foci formation in response to DNA 
damage. Cells treated with Leptomycin B show now significant increase in the 
number of p62 foci following IR (Figure 5-2B). This is likely due to p62 being at a 
maximal level in the nucleus with Leptomycin B treatment alone. Results shown in 
Figure 5-2C demonstrate that there is an induction of 53BP1 foci in cells treated with 
and without Leptomycin B 300 minutes following IR, and there is a slight increase in 
those treated with Leptomycin B versus control. Interestingly, data shown in Figure 
5-2D demonstrate that p62 co-localises with 53BP1 foci. Unsurprisingly, treatment of 
Leptomycin B increases the number of p62 foci and therefore co-localisation is 
increased. Taken together these results suggest that induction of irradiation can 
induce the formation of p62 foci within the nucleus and these foci are able to interact 
with proteins within DDF.   
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Figure 5-2: p62 interacts with DNA damage foci. (A-D) The colocalisation of p62 
and 53BP1 was analysed in human fibroblasts (MRC5) exposed to irradiation (IR) for 
0 and 5 hours in the absence or presence of Leptomycin B (Lepto B) as indicated. 
Representative images are shown in (A) and the mean number of p62 (B), 53BP1 
(C) and p62-53BP1 co-localisation (D) foci were quantified. Scale bars 10 µm; Data 
are mean for ≥30 cells. 
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5.3 p62 Interacts with members of the DDR CHD4 and filamin A 
 
Having observed that p62 and DDF co-localise following induction of DNA 
damage by X-Ray irradiation, I then aimed to understand which proteins p62 was 
interacting with. Here, Hela cells were transfected with FLAG-p62, exposed to 1Gy 
X-ray irradiation and treated with Leptomycin B as indicated (Figure 5-3). Nuclear 
fractionation was carried out and the resulting nuclear fractions were subjected to 
immunoprecipitation using M2-FLAG beads. Samples were then separated by gel 
electrophoresis and stained using Coomassie blue (Figure 5-3). A band of 
approximately 250kDa, marked by a red box in Figure 5-3, was evident specifically in 
the nuclei from IR/Leptomycin B treated cells. This band was excised and sent for 
mass spectrometry analysis.  
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 Figure 5-3: Identification of nuclear p62 interactors.  HeLa cells were transfected 
with FLAG-p62 overnight and treated as indicated (either non-irradiated or irradiated, 
in the presence or absence of Leptomycin B). Cells were subjected to 
immunoprecipitation with anti-FLAG antibody. The band indicated by a red box was 
identified as being present in association with p62 following irradiation.  
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5.4 Interaction of p62 with CHD4 does not mediate its effect on DDR 
  
Results shown in Figure 5-3 indicate that p62 interacts with a number of 
proteins in response DNA damage. One of these proteins, CHD4, has been shown 
to be involved in the multiple stages of the DNA damage response. CHD4 is 
recruited to the site of damage and its depletion has been linked to reduced DNA 
damage-induced histone ubiquitylation, reduced recruitment of BRCA1 and RNF168 
(Larsen et al., 2010, Smeenk et al., 2010). CHD4 has also been shown to affect the 
repair of DSBs (Polo et al., 2010, Pan et al., 2012). Interestingly, CHD4 has been 
shown to be recruited to the site of damage by PARP (Chou et al., 2010). PARP is a 
known interactor of p62 (Korolchuk Laboratory, unpublished data) and it is also 
closely involved in the DNA damage response. CHD4 and PARP are therefore 
attractive candidates to study when trying to understand a p62- meditated effect on 
DNA repair.  In order to confirm the interaction between p62 and CHD4 
immunoprecipitation of p62 was performed in the nuclear fraction p62-/-+FLAG-p62 
MEFs that have been exposed to 1Gy of X-ray irradiation and treated with 
Leptomycin B as indicated (Figure 5-4A). Immunoblotting was performed for both 
CDH4 and PARP (Figure 5-4A). It can be seen that p62 interacts with the cleaved 
form of PARP independently of IR-induced DNA damage. Interestingly, upon 
inhibition of nuclear export with Leptomycin B, p62 is able to interact with the full-
length protein, and there appears to be a reduction in the binding of cleaved PARP 
to p62. Results in Figure 5-4A show that p62 also interacts with CHD4, confirming 
the results seen in the mass spectrometry analysis in Figure 5-3. Next, I wanted to 
investigate which functional domains were responsible for this interaction. Having 
already found that both the PB1 and UBA domain were needed for p62 to have an 
effect on DNA damage repair, I hypothesized that these domains could be 
responsible for the interaction of p62 with CHD4. To investigate this, p62-/- MEFs 
were transfected with HA-CDH4 and either GFP empty vector (control), wt p62-GFP 
or p62 mutants lacking either the PB1 domain (ΔPB1), the UBA domain (ΔUBA) or 
the nuclear export signal (ΔNES). The domain structure for these contracts is shown 
in Figure 5-4B. Immunoprecipitation against GFP was performed followed by 
immunoblot analysis for both HA tag and PARP. Results shown in (Figure 5-4C) 
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indicate that CHD4 is able to interact with all p62 constructs. When coupled with the 
data showing that both the PB1 domain and UBA domain are required for the effect 
of p62 on DNA damage (Figure 5-1B) these data suggest that the interaction 
between p62 and CHD4 is not what is mediating this effect of p62 on DNA damage 
repair. Interestingly, both wt p62 and ΔNES p62 interact with PARP while PB1 and 
UBA domain mutants do not. Similar to the results shown with Leptomycin B 
treatment in Figure 5-4A, when p62 expression is restricted to the nucleus by the 
deletion of the export signal, it binds preferentially to full-length PARP instead of the 
cleaved form of the protein.      
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Figure 5-4 : Interaction  of p62 with CHD4 (A) p62-/- MEFs stably expressing 
FLAG-p62 (p62-/-+FLAG-p62) were irradiated where indicated and 60 min later 
nuclear fractions were subjected to anti-FLAG IP. The interaction of FLAG-p62 with 
endogenous CDH4 and PARP was detected by immunoblotting. (B) Schematic 
representation of the domain structure of p62 constructs. Key structural domains are 
marked:  UBA: ubiquitin-associated domain; PB1: Phox and Bem1p domain; ZnF: ZZ 
type zinc finger domain; NES: Nuclear export signal; NLS1/2: Nuclear localisation 
signal. (C) p62-/- MEFs transfected with GFP-p62 constructs as indicated and HA-
CDH4 were irradiated where indicated and 60 min later nuclear fractions were 
subjected to GFP IP. The interaction of GFP-p62 with HA-CDH4 and endogenous 
PARP was detected by immunoblotting. GFP-p62 construct expression in the 
cytoplasmic fraction was detected by immunoblotting as indicated.  
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5.5 p62-dependent proteasomal degradation of Filamin A (FLNA) and RAD51 
regulates DNA repair 
  
Having ruled out the interaction of p62 with CHD4 as a requirement for the 
differences seen in DNA damage resolution in short time-course experiments 
following low doses of IR, I decided to investigate Filamin A (FLNA), the second hit 
from the mass spectrometry analysis. FLNA has previously been shown to be 
involved in DNA repair, specifically through interaction with BRCA1 and 2 and 
recruitment of RAD51 in the HR repair pathway (Velkova et al., 2010, Yue et al., 
2012, Yue et al., 2009). Firstly, I set out to confirm the interaction between FLNA and 
p62. Here, p62-/-+FLAG-p62 MEFs or p62-/- MEFs were irradiated as indicated 
(Figure 5-5). Nuclear fractions were then subjected to p62 immunoprecipitation and 
the resulting IP analysed by immunoblotting for FLNA, RAD51 and Lamin B1 
(loading control). Results shown in Figure 5-5 indicate that both FLNA and RAD51 
interact with p62 in response to X-Ray irradiation. 
  
Chapter 5. Mechanistic Analysis of the role of p62 in the DDR 
 
157 
 
 
  
 
 
 
 
 
 
 
Figure 5-5: Immunoprecipitation of nuclear p62 and FLNA. (A) p62-/- MEFs, 
stably expressing FLAG-p62 (p62-/-+FLAG-p62) were irradiated where indicated and 
60 min later nuclear fractions were subjected to anti-FLAG IP. The interaction of 
FLAG-p62 with endogenous FLNA and RAD51 was detected by immunoblotting. (B) 
Hela cells transfected with GFP-FLNA were irradiated, where indicated, and 60 min 
later nuclear fractions were subjected to anti-GFP IP. The interaction of GFP-FLNA 
with endogenous p62 and RAD51 was detected by immunoblotting.  
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Having established that p62 and FLNA do indeed interact in response to DNA 
damage, next I investigated any differences in the levels of FLNA and RAD51 in  
p62-/- and p62-/-+FLAG-p62 MEFs. Here, cells were exposed to 1Gy X-Ray irradiation 
and collected at time points 5-480 min following IR. Nuclear fractionation was 
performed and the resulting nuclear and cytoplasmic fractions were analyzed by 
immunoblotting for FLNA, RAD51 and either Lamin B1 or tubulin as a loading control 
(Figure 5-6A-B). Quantifications shown in Figure 5-6C-D show that cells lacking p62 
have higher levels of both FLNA and RAD51 in the nuclear fraction. Interestingly, no 
difference in the cytoplasmic levels of FLNA and RAD51 was found in p62-/- and p62-
/-+FLAG-p62 MEFs (Figure 5-6B).     
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Figure 5-6: Nuclear and cytoplasmic levels of FLNA and RAD51. p62-/- and p62-/-
+FLAG-p62 MEFs were irradiated with 1Gy and subjected to cellular fractionation at 
the time points indicated. Nuclear (A) and cytoplasmic (B) fractions were analysed 
for FLNA, RAD51 and Lamin B1 as a loading control. Quantification is shown in (C-
D). n=2; Error bars represent S.D. 
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Having extablished that p62 was causing a reduction in nuclear levels of both 
FLNA and RAD51, I next investigated the mechanisms involved.  As previously 
mentioned, p62 is involved in targeting proteins for degradation by both the 
proteasome and autophagy. Having established that the effect of p62 on DNA 
damage repair was independent of its role in autophagic degradation (Figure 4-4A-B), 
I investigated whether this p62-dependent difference in nuclear levels of FLNA and 
RAD51 was dependent on proteasomal degradation.  Although previous results 
shown in Figure 5-1 suggest that p62 is able to affect DNA damage repair 
independently of its role in the cytoplasm, it is still possible that p62 is responsible for 
transporting FLNA and RAD51 to the proteasome within the nucleus. To answer 
these questions, p62-/- and p62-/-+FLAG-p62 MEFs were pre-treated with MG132, a 
potent proteasomal inhibitor, or Leptomycin B to inhibit nuclear export, for 3h and 
were then exposed to 1Gy of X-Ray irradiation. Cells were treated for a further 1h 
with MG132 or Leptomycin B and collected. Following nuclear fractionation the 
nuclear fraction was analyzed by immunoblotting for FLNA, RAD51 and Lamin B1 as 
a loading control.  Results shown in (Figure 5-7A-C) indicate that treatment with 
MG132 ablates p62-dependent differences in both FLNA and RAD51 indicating that 
these differences are dependent on p62-mediated degradation via the proteasome. 
In keeping with previous results (Figure 5-1) treatment with Leptomycin B did not 
affect p62-dependent differences in FLNA and RAD51. Taken together, these data 
suggest that p62 is able to mediate the degradation of FLNA via the proteasome and 
this is occurring in the nucleus.   
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Figure 5-7: p62-mediated proteasomal degradation of FLNA and RAD51. p62-/- 
and p62-/-+FLAG-p62 MEFs were pre-incubated with MG132 or Leptomycin B where 
indicated for 3h. Cells were irradiated and incubated in the presence of MG132 or 
Leptomycin B for further 60 min. Nuclear fractions were analysed for FLNA and 
RAD51 levels (A) and quantified relative to Lamin B1 (B,C). n=3; Error bars 
represent S.E.M; NS: not significant, * p<0.05, ** p<0.01, *** p<0.001. 
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Next, having established that p62 was responsible for the nuclear degradation 
of FLNA, I aimed to investigate the role of FLNA in DNA damage repair. It has been 
previously reported that cells with reduced levels of FLNA show a reduced formation 
of RAD51 foci, which is responsible for the reduced ability of these cells to perform 
HR (Yue et al., 2009). In order to investigate if similar mechanisms were responsible 
for the differences in DNA damage repair seen between p62-/- and p62-/-+FLAG-p62 
MEFs, I knocked down FLNA using siRNA and exposed MEFs to 1Gy of X-Ray 
irradiation. Cells were then fixed at time points 60-480 min following IR and stained 
with an antibody against RAD51. The number of RAD51 foci per cell was then 
analysed by microscopy. Western blot analysis shown in Figure 5-8A indicate 
successful knockdown of FLNA in whole cells, cytoplasmic and nuclear fractions. 
Data shown in Figure 5-8B-C indicate that cells lacking p62 show a greater induction 
of RAD51 foci following X-Ray irradiation compared to wt cells and knockdown of 
FLNA reduces the number of RAD51 foci in both p62-/- and p62-/-+FLAG-p62 MEFs. 
These data are in agreement with those shown by others (Yue et al., 2009), where 
knockdown of FLNA has been shown to result in a reduction of RAD51 foci following 
DNA damage. The authors also relate this knockdown of FLNA to a reduced ability 
of cells to perform HR.  
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Figure 5-8: The effect of FLNA knockdown on RAD51 foci kinetics in p62-/- and 
p62-/-+FLAG-p62 MEFs.  p62-/- and p62-/-+FLAG-p62 MEFs treated with control or 
FLNA siRNA and subjected to 1Gy X-Ray irradiation and collected at time points 60-
480 min following IR as indicated (A-C) Blot showing scrambled control (Sc) and 
FLNA siRNA in p62-/- and p62-/-+FLAG-p62 MEFs in nuclear (Nuc), cytoplasmic 
(CYTO) and whole cell fractions (WC) (A). Representative images of RAD51 foci are 
shown in (B). Quantification of the mean number of RAD51 foci with statistical 
comparison is shown in (C). n=3; Error bars represent S.E.M; NS: not significant, * 
p<0.05, ** p<0.01, *** p<0.001. 
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Having established that levels of FLNA impacted on RAD51 foci induction 
following X-Ray irradiation, a process previously shown to be indicative of HR (Li and 
Heyer, 2008), I next aimed to assess the effect of FLNA knockdown on 53BP1 foci 
repair.  Here, p62-/- and p62-/-+FLAG-p62 MEFs cells were transfected with FLNA 
siRNA and exposed to 1Gy of X-Ray irradiation. Cells were then fixed 300 minutes 
following IR and stained with an antibody against 53BP1. The number of RAD51 foci 
per cell was then analysed by microscopy. Data shown in Figure 5-9A-B indicate that 
knockdown of FLNA results in a reduced ability of p62-/- MEFs to repair 53BP1 foci 
compared to Scrambled siRNA control similar to that seen in p62-/-+FLAG-p62 MEFs. 
These data support the idea that increased levels of FLNA in p62-/- MEFs result in an 
increase in HR which is able to repair DSBs more readily.  
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Figure 5-9: The effect of FLNA knockdown on 53BP1 foci kinetics in p62-/- and 
p62-/-+FLAG-p62 MEFs.  p62-/- and p62-/-+FLAG-p62 MEFs treated with control or 
FLNA siRNA and subjected to 1Gy X-Ray irradiation and collected at 300 min 
following IR as indicated (A-B). Representative images of 53BP1 foci are shown in 
(A). Quantification of the mean number of 53BP1 foci is shown in (B). n=3; Error bars 
represent S.E.M; NS: not significant, * p<0.05, ** p<0.01, *** p<0.001. 
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5.5 Discussion 
 
The previous chapter characterized the role of p62 in DNA damage repair; 
this is to our knowledge the first work reporting a role for p62 in DNA damage repair 
independent of its role in autophagy. p62 is a multifunctional protein comprised of 
many functional domains. Understanding which of these domains are required for 
p62 to illicit an effect on DNA damage repair can help shed light on how this is 
functionally occurring. Data presented above show cells expressing p62 with a 
deletion of the PB1 or UBA domain have a reduced number of 53BP1 foci 300 min 
following 1Gy X-ray IR, implying that both of these domains are required for p62 to 
influence DNA damage repair. 
 The PB1 domain is essential for interaction of p62 with other PB1 containing 
proteins as well as self-oligomerization (Lamark et al., 2003). This has been shown 
to be central to its role in mediating the selective degradation of proteins via 
autophagy (Itakura and Mizushima, 2011, Pankiv et al., 2007, Wurzer et al., 2015, 
Ciuffa et al., 2015). The PB1 domain has been shown to interact with Rpt1, a subunit 
of the 26S proteasome allowing p62 to serve as a shuttling factor, targeting 
polyubiquitylated proteins bound by the UBA domain for proteasome degradation 
(Seibenhener et al., 2004). Interaction of p62 via its PB1 domain has also been 
shown to mediate its involvement in many signalling cascades (Joung et al., 1996, 
Lamark et al., 2003). The involvement of the PB1 domain in this process suggests 
that p62 could be involved in DNA damage repair via scaffolding, signalling or 
degradation processes. The UBA domain is required for the interaction between p62 
and ubiquitylated targets, mediating degradation via both autophagy and the 
proteasome (Seibenhener et al., 2004, Vadlamudi et al., 1996, Geisler et al., 2010). 
Taken together the involvement of both of these domains suggests that p62 may be 
influencing DNA damage repair through its role in protein degradation, signalling or 
scaffold formation. Deletion of each of these domains only had a partial effect 
therefore it would be interesting to assess if deletion of both of these domains 
simultaneously was able to cancel the effect of p62 on DNA damage repair.   
Interestingly, p62 lacking the NES domain had the same effect on the number 
of 53BP1 foci as wild type p62. This additional piece to the puzzle suggests that the 
action of p62 in this process is occurring in the nucleus, indicating that the 
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cytoplasmic process of autophagy degradation is not involved, beyond modulating 
levels of p62 itself. Having eliminated the role of autophagy, the involvement of both 
the PB1 and UBA domains of p62 suggest that p62 may be eliciting an effect on 
DNA damage repair via scaffold function, signalling or proteasomal degradation in 
the nucleus.  
Previous work by Pankiv at al has described a role for p62 in coordinating the 
recruitment of proteasomes to nuclear aggregates. They also note that p62 mediates 
the accumulation of polyubiquitylated proteins at PML bodies when nuclear export is 
inhibited (Pankiv et al., 2010). PML bodies are known to co-localize with DDF as well 
as play a role in their processing (Xu et al., 2003, Varadaraj et al., 2007, Munch et al., 
2014, Boichuk et al., 2011). This p62-dependent recruitment of proteasomes to PML 
bodies or DDF may well mediate the differences in DDF repair kinetics seen in p62-/- 
and p62-/- MEFs. Interestingly, we found that p62 co-localizes with a fraction of DDF 
following 1Gy X-ray IR and the percentage of co-localization was increased following 
inhibition of nuclear export with Leptomycin B. Further investigation is required to 
understand if these p62 nuclear puncta are recruited to PML as well as subunits of 
the 20S proteasome, as was observed by the Johansen lab (Pankiv et al., 2010).  
Together, these data suggest that p62 is interacting with proteins within DDF. It 
would be interesting to analyse the importance of both the PB1 domain and UBA 
domain in mediating this localization of p62 to DDF.  It would help to elucidate if this 
localisation to DDF is indeed important for the function of p62 in DNA damage repair. 
Interestingly, the recruitment of different proteasomal subunits has been 
shown to play an important role in DNA damage foci kinetics (Tsolou et al., 2012), as 
well as the choice of DNA repair pathway (Gudmundsdottir et al., 2007). 
Proteasomal subunit Rpn7 has been shown to co-localize with long lived DNA 
damage foci and is suggested to stabilize DNA damage foci, preventing premature 
resolution. Knock down of Rpn7 was shown to increase the resolution of DDF 
(Tsolou et al., 2012).  Moreover, Rpn7 has been shown to interact with BRCA2, a 
key component of HR and inhibition of the proteasome has been shown to inhibit HR 
in favor of more error prone repair pathways (Gudmundsdottir et al., 2007, Krogan et 
al., 2004, Murakawa et al., 2007). p62 has been shown to interact with several 
proteasomal subunits such as Rpt1 (Babu et al., 2005) and S5a (Seibenhener et al., 
2004).  It is an interesting possibility that p62 may be influencing DNA damage repair 
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via recruitment or both 19S and 20S proteasomal subunits to DNA damage foci. p62 
mediated recruitment of the 20S proteasome could facilitate turnover of DNA 
damage proteins, while recruitment of 19S subunits could confer foci stability  such 
as was shown with Rpn7 (Tsolou et al., 2012).     
Following the observation of p62 localizing to DDF, mass spectrometry 
analysis identified CHD4 and FLNA as interacting partners of p62 within the nucleus 
in response to DNA damage. The chromodomain-helicase-DNA-binding 3/4 (CHD3/4) 
proteins were originally identified as autoantigens in the connective tissue disease 
dermatomyositis, which is associated with in increased risk of malignancy (Ge et al., 
1995, Seelig et al., 1995, Brehm et al., 2000). CHD proteins belong to the SNF2 
superfamily of ATPases, which, through ATP hydrolysis, remodel nucleosome 
structure (Eisen et al., 1995, Seelig et al., 1996). In particular, the ATPase/helicase 
domain of CHD4 has been shown to facilitate the mobility of nucleosomes along 
DNA (Wang and Zhang, 2001).  
CHD4 is a key component of the nucleosome re-modelling and deacetylation 
(NuRD) complex. The NuRD complex couples chromatin remodeling activity (CHD4) 
and deacetylation activity (histone deacetylase 1/2 (HDAC1/2) (Wade et al., 1998, 
Zhang et al., 1998, Tong et al., 1998). The primary function of NuRD is the 
remodeling of chromatin to inhibit transcription (Lai and Wade, 2011). It has been 
shown that NuRD plays an important role in DNA damage repair as well as cell cycle 
progression. It has also been shown that both CHD4 and HDC1 interact with ATR 
(Schmidt and Schreiber, 1999). More recently, it was demonstrated that CHD4 is in 
fact phosphorylated by ATR and ATM (Matsuoka et al., 2007, Mu et al., 2007) and its 
expression increases upon exposure to UV irradiation (Burd et al., 2008). These data 
are suggestive of a role for NuRD and CHD4 in the DDR. A number of studies have 
now identified that depletion of CDH4 in mammalian cells leads to an increase in 
markers of replication stress, spontaneous DNA damage as well as hypersensitivity 
to ionizing radiation (Luijsterburg et al., 2012, Larsen et al., 2010, Sims and Wade, 
2011).   
The mechanisms by which CHD4 is influencing DDR and DNA repair are 
beginning to be elucidated. Recently, it has been shown that CHD4 is recruited to 
sites of DNA damage by two distinct mechanisms (Luijsterburg et al., 2012, Polo et 
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al., 2010). First, it was suggested that CHD4 was recruited to DNA damage via 
interaction with poly(ADP-ribosyl)ated proteins, such as PARP1 (Polo et al., 2010). 
This interaction, in turn, leads to the recruitment of NuRD components HDAC1 and 
MTA2. Treatment with PARP inhibitors prevented the accumulation of CHD4/NuRD 
at sites of DNA damage. Interestingly, while this study showed that CHD4 is 
phosphorylated by ATM, as previously observed, it does not seem to influence its 
function in the DDR (Polo et al., 2010). The second proposed mechanism for 
recruitment of CHD4 to the site of DNA damage is via interaction with RNF8 
(Luijsterburg et al., 2012). RNF8 is recruited to DNA damage via interaction with 
MDC1, which itself is recruited to γH2A.X during the initial activation of a DDR. 
Following recruitment to RNF8, CDH4 is proposed to mediate chromatin relaxation, 
stimulating the ubiquitin ligase activity of RNF8 and RNF168 resulting in the 
formation of ubiquitin conjugates (Luijsterburg et al., 2012). The ubiquitylation activity 
of RNF8/RNF168 serves as an amplification step in the DDR promoting the 
recruitment of downstream DNA-damage repair proteins (Smeenk et al., 2010). 
Knockdown of CHD4 was shown to reduce ubiquitylation as well as RNF168 and 
BRCA1 accumulation at DSBs highlighting the importance of CHD4 in amplification 
of the DDR downstream of RNF8. Interestingly, the tethering of RNF8 to chromatin 
was shown to bypass CHD4 recruitment suggesting that CHD4-mediated chromatin 
remodelling facilitates access of RNF8 to DNA damage sites allowing the assembly 
of downstream checkpoint and repair proteins (Luijsterburg et al., 2012). Notably, 
expression of a CHD4 mutant lacking helicase activity was unable to rescue the 
effect of depletion on DDR, highlighting the importance of the chromatin remodelling 
activity of CHD4 in its role in the DDR (Smeenk et al., 2010).  Interestingly, reduced 
levels of some NuRD components were reported in Hutchinson–Gilford progeria 
syndrome, a disease associated with premature ageing. Similarly, NuRD expression 
was reduced as a consequence of normal ageing. Higher levels of DNA damage 
marker γH2A.X were observed in aged cells as well as following knockdown of 
NuRD components such as metastasis-associated protein 3 (MTA3), HDAC1 and 
CHD4 (Pegoraro et al., 2009).  
These data indicate a role of CHD4 and the NuRD complex in the DDR as 
well as organismal ageing. Therefore, the interaction between p62 and CHD4 could 
be a potential mechanism by which p62 is influencing DNA damage repair. As 
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PARP1 is a known interactor of p62 (Korolchuk Laboratory, unpublished data), 
playing a role in the recruitment of CHD4 to the sites of DNA damage (Polo et al., 
2010), we hypothesized that it could take part in the interaction between p62 and 
CHD4 in response to DNA damage induction. 
PARP1 is activated in response to DNA damage and catalyses poly(ADP-
ribosylation) of a number of proteins (Satoh and Lindahl, 1992). Activation of PARP 
has been shown to mediate the increased access of DNA repair enzymes and 
transcription factors to chromatin (Satoh and Lindahl, 1992). PARP1 has been 
shown to play a crucial role in DNA damage repair as well as cell death. It has been 
reasoned that in response to high levels of DNA damage, high levels of PARP 
activity lead to the depletion of cellular levels of NAD+ and ATP. This can lead to 
energy collapse and cell death. Recently it has been suggested that PARP1-
dependent energy collapse was not dependent on NAD+ depletion, instead it occurs 
due to inhibition of glycolysis through inhibition of hexokinase (Andrabi et al., 2014). 
It has been shown that in response to high levels of PARP activation it is cleaved by 
caspase 3 and 7 (Cohen, 1997) resulting in separation of the DNA binding domain, 
contained in a 24KDa fragment, from the catalytic domain within a 89KDa fragment 
(Cohen, 1997). The remaining 24KDa fragment is still able to bind damaged DNA, 
however lacks catalytic activity. Therefore, this inactive 24KDa fragment competes 
for binding with remaining full length PARP setting up a negative feedback reducing 
PARP activity and NAD+ and ATP consumption (Yung and Satoh, 2001). The 
cleavage of PARP has been suggested to facilitate cellular disassembly during 
apoptosis and its cleavage serves as a marker of active apoptosis (Oliver et al., 
1998). 
In this chapter we show that p62 and CHD4 interact, however their interaction 
is not increased upon induction of DNA damage. Moreover, CHD4 was shown to 
interact with PB1 and UBA p62 mutants. Both of these constructs were shown to 
be required for p62 to illicit an effect on DNA damage repair. Interestingly, PARP1 
also co-immunoprecipitated with p62 and, like CHD4, this interaction showed no 
dependence on the induction of DNA damage. These data suggest that the 
interaction between CHD4 and p62 is not responsible for the effect of p62 on DNA 
damage repair. Further work is required in order to understand the cellular processes 
in which this interaction is important.  Full-length p62 was shown to interact 
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predominantly with the cleaved form of PARP whilst, strikingly, NES p62 is shown 
to interact mainly with full length PARP. Similarly, blocking nuclear export on p62 
with Leptomycin B treatment resulted in an increased interaction with full length 
PARP. These data suggest that cytoplasmic p62 may play an active role in PARP 
cleavage.  Interestingly, it has been suggested that autophagy may be involved in 
PARP cleavage; specifically through an interaction with LC3 and p62 as inhibition of 
autophagy results in a reduction of PARP cleavage and double silencing of LC3 and 
p62 resulted in a complete suppression of PARP cleavage (Zhang et al., 2011). 
Notably, PARP1 has been shown to activate autophagy in response to DNA damage 
(Munoz-Gamez et al., 2009), as well as nutrient deprivation (Rodriguez-Vargas et al., 
2012), and oxidative stress (Huang et al., 2008). Interaction with p62 and 
subsequent degradation of PARP1 may serve as a negative feedback loop 
regulating PARP-dependent autophagy. 
 The cytoskeletal protein Filamin A (FLNA) was first suggested to be involved 
in DNA damage repair following identification of its interaction with BRCA2 (Yuan 
and Shen, 2001). Furthermore, it was noted that the melanoma cell line M2 was 
more sensitive to several genotoxic agents such as: gamma irradiation, bleomycin, 
and ultraviolet-C light due to the lack of FLNA (Yuan and Shen, 2001). Later, the 
same group found that FLNA deficiency leads to an 8h delay in recovery from G2 
arrest in response to ionizing radiation (Meng et al., 2004). Following these 
observations, Yue and colleagues reported that FLNA plays a role in HR through its 
interaction with BRCA2 and recruitment of RAD51 (Yue et al., 2009). FLNA has also 
been shown to interact with BRCA1, with cells lacking FLNA showing reduced 
formation of BRCA1 and RAD51 foci in response to IR. Interestingly, FLNA was also 
reported to interact with other components of the HR pathways DNA-PKcs and Ku86 
in a BRCA1-independent manner (Velkova et al., 2010). Recently FLNA was also 
found to interact with ssDNA-binding proteins RPA1-3 (Marechal et al., 2014). Taken 
together, these data suggest a role for FLNA in the early stages of HR. Interestingly, 
levels of FLNA have been shown to negatively correlate with drug sensitivity in 
melanoma cells in response to both Bleomycin and Cisplatin  (Yue et al., 2012). 
 Work presented in this chapter shows that both FLNA and RAD51 co-
immunoprecipitate with p62 in response to X-ray irradiation-induced DNA damage. 
Similarly, both p62 and RAD51 co-immunoprecipitate with FLNA in the reverse 
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experiment.  Next, data is presented showing a significant reduction of both FLNA 
and RAD51 in the nuclear fraction of p62-/-+FLAG-p62 compared to p62-/- MEFs. 
These data suggest that interaction with p62 is involved in modulating nuclear levels 
of FLNA and RAD51.  
As discussed previously, increased levels of both RAD51 and FLNA have 
been shown to enhance DNA repair through the HR pathway. It has, however, been 
shown that elevated levels of RAD51 in some circumstances can lead to hyper-
recombination and genome instability (Richardson et al., 2004). Importantly, these 
data indicate that expression levels of these proteins are equivalent, however p62-/- 
MEFs show an increased nuclear distribution. The nuclear redistribution of RAD51 is 
a key component of the cellular response to DNA damage. Interestingly, both 
BRCA2-dependent (Davies et al., 2001, Yuan et al., 1999a) and -independent (Yu et 
al., 2003, Tarsounas et al., 0000, Lee et al., 2009) mechanisms of RAD51 nuclear 
redistribution have been observed. Depletion of ATM, ATR and CHK1 has been 
shown to reduce the nuclear re-localization of RAD51 (Jeyasekharan et al., 2013). 
There are a number of possible mechanisms by which p62 could influence the 
nuclear levels of these proteins. p62 has been shown to promote the turnover of 
proteins through both the proteasomal and autophagy degradation pathways (Pankiv 
et al., 2010). Degradation, via either pathway, would result in a p62-dependent 
reduction in protein levels. p62 has also been shown to shuttle rapidly between the 
nucleus and cytoplasm (Pankiv et al., 2010). It is possible that through this process 
p62 could mediate the nuclear export of its binding partners. Additionally, p62 
expression is associated with the formation of cytoplasmic aggregates. 
Sequestration of proteins within these aggregates has been shown to influence a 
number of cellular processes (Donaldson et al., 2003, Korolchuk et al., 2009). 
Therefore, p62 could be reducing the nuclear levels of RAD51 and FLNA through 
their cytoplasmic sequestration.  
Since there is no marked increase in cytoplasmic levels of both FLNA and 
RAD51 in p62-/-+FLAG-p62 compared with p62-/- MEFs, it is unlikely that p62 is 
inhibiting the nuclear transport of these proteins through cytoplasmic sequestration. 
It should be noted, however, that the method of nuclear fractionation employed in 
this study results in around 5 times enrichment of the nuclear fraction compared to 
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cytoplasmic (Suzuki et al., 2010).  Therefore, comparison between these two cellular 
fractions should not be used to directly assess cellular distribution as a percentage of 
total protein.  The method does, however, allow the relative comparison of each 
fraction between different cell types. 
 Next, data is presented showing that inhibition of proteasomal degradation 
using MG132 cancelled differences in the nuclear levels of RAD51 and FLNA 
suggesting that p62 is involved in orchestrating the proteasomal degradation of 
these proteins. Interestingly, inhibition of nuclear export using Leptomycin B resulted 
in increased nuclear levels of RAD51 and FLNA in p62-/-+FLAG-p62 and p62-/- MEFs 
but did not cancel the differences between them. This suggests that the nuclear 
export of proteins via exportin 1 can alter nuclear levels of both RAD51 and FLNA, 
however, this is not required to mediate p62-dependent differences.  These data 
suggest that p62 is influencing levels of RAD51 and FLNA exclusively through 
nuclear degradation via the proteasome. These data are in agreement with the 
previous observation that neither nuclear export of p62 or autophagy are required for 
its influence on DDF repair kinetics. 
While increased nuclear levels of RAD51 in cells lacking p62 is suggestive of 
increased ability to perform HR, it is not clear if this excess of RAD51 was indeed 
functioning in HR. Immunofluorescence analysis confirmed that increased nuclear 
levels of RAD51 seen in p62-/- MEFs corresponded with an increased number of 
RAD51 foci following IR. These data suggest that the increased levels of RAD51 do 
indeed correlate with increased HR activity.  While RAD51 foci have been shown to 
correlate with HR activity (Raderschall et al., 1999), it is not a direct measure. 
Further analysis is needed to confirm that increased levels of nuclear RAD51 in p62-/- 
MEFs facilitate an increase in HR-mediated DNA repair. This could be done using 
GFP reporter plasmids like those described in (Mao et al., 2008). It would also be of 
interest to assess genomic stability in p62-/- MEFs as it is still not clear if increased 
HR in the context of p62 knock-out would be cytoprotective or if it would, in fact, lead 
to increased genome instability as has been observed with RAD51 overexpression 
(Richardson et al., 2004) . 
We have shown that p62 interacts with both FLNA and RAD51 which appears 
to influence the nuclear levels of both via proteasomal degradation.  It is not clear if 
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p62 is facilitating the degradation of one or both of these proteins. It has previously 
been shown that nuclear levels of FLNA are able to influence levels of RAD51 (Yue 
et al., 2009). Data presented in this chapter show that knockdown of FLNA using 
siRNA resulted in a reduction in RAD51 foci formation in response to X-Ray IR in 
p62-/-+FLAG-p62 and p62-/- MEFs, consistent with previous reports (Yue et al., 2009).  
It is therefore possible that nuclear levels of RAD51 are reduced in p62-/-+FLAG-p62 
MEFs as a result of reduced levels of FLNA. Interestingly, FLNA knockdown caused 
a reduction in RAD51 foci in p62-/- MEFs to those below observed in p62-/-+FLAG-
p62 cells. This reduction in RAD51 foci corresponded with an increase in 53BP1 foci 
to similar level seen in p62-/-+FLAG-p62. These data suggest that the effect of p62 
on DNA damage repair could well be mediated by the proteasomal degradation of 
FLNA within the nucleus. 
Further work is required to understand the role of autophagy on nuclear levels 
of RAD51 and FLNA. It is tempting to hypothesize that autophagy, and subsequent 
increase in p62 levels, would lead to an enhancement of the proteasomal 
degradation of RAD51 and FLNA within the nucleus. However, it is important to 
consider cross-talk between these two pathways as it has previously been shown 
that inhibition of autophagy can also inhibit proteasomal degradation in a p62-
dependent manner (Korolchuk et al., 2009). Nuclear levels of RAD51 and FLNA, as 
well as the contribution of proteasomal degradation, would need to be assessed in 
the context of autophagy inhibition in order to link the p62-dependent decrease in 
DDF repair kinetic observed in chapter 3 with the mechanism proposed here. 
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6. Chapter 6. Interaction between p62 and the DDR during 
Organismal Ageing  
 
In the previous chapters, we have identified that autophagy inhibition was able 
to reduce DNA repair capacity in a p62-dependent manner in vitro.  In this chapter, 
we hypothesise that the p62-dependent effect on DNA damage repair observed in 
vitro may also exist in vivo, specifically in the context of cellular ageing.  
6.1 Levels of p62 in the Nucleus Increase with Age and are reduced with DR. 
  
Dietary restriction is an intervention known to increase lifespan in an 
autophagy-dependent manner in a number of model organisms (Morselli et al., 2010, 
Rubinsztein et al., 2011, Jia and Levine, 2007). Dietary restriction has also been 
shown to reduce age-dependent increase in DNA damage (Wang et al., 2010). We 
hypothesise that increased level of autophagy in DR mice could be affecting DNA 
damage repair in a p62-dependent manner, similar to in vitro data shown in previous 
chapters. In order to investigate age-dependent changes in p62, liver tissues from 
C57BL/6 mice of 3, 15 and 24 months age, either fed ad libitum (AL) or dietary 
restricted (DR, 60% of AL), were stained with an antibody against p62.  The numbers 
of cells containing nuclear p62 puncta were quantified by microscopy. Cells that are 
positive for p62 puncta are marked in white in Figure 6-1, quantification is shown in 
(Figure 6-1B).  Results shown in Figure 6-1A-B demonstrate an age-dependent 
increase in nuclei positive for p62 puncta.  Interestingly, DR mice show no significant 
increase in p62-positive nuclei compared to AL mice (Figure 6-1B).    
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Figure 6-1: Nuclear foci of p62 increase with age in mouse hepatocytes and are 
decreased by DR.  Representative images of hepatocytes from 3, 15 and 24 month 
old male C57BL/6 wild type mice maintained on ad libitum (AL) or DR. Sections were 
immunostained with an antibody against p62. p62 positive nuclei are indicated in 
white (A) and quantified in (B). A higher magnification of a p62 positive nucleus is 
shown with arrowheads pointing to p62 foci. Scale bars represent 80µm; n=3; Error 
bars represent S.E.M* p<0.05, ** p<0.01, *** p<0.001. Done in collaboration with Dr 
Diana Jurk and Mikolaj Ogrodnik. 
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6.2 Co-Localisation of p62 with DDF increases with age and is reduced with 
DR. 
 
Having established there was an age-dependent increase in nuclear p62 we 
then set out to establish what role this may be having on the DDR. In previous 
chapters we have shown that p62 co-localizes with DDF in vitro. To test if that is 
true in vivo, liver tissues from 3, 15 and 24 months old C57BL/6 mice on AL or DR 
diets were stained with antibodies against p62 and DNA damage marker H2A.X. 
p62 and H2A.X foci were then analysed using microscopy. Results shown in Figure 
6-2A-B indicate an age-dependent increase in the number of nuclear p62 foci that 
was suppressed by DR, similar to results shown in Figure 6-1B. Further to an age-
associated increase in p62 foci, there was a similar increase in the number of 
H2A.X foci (Figure 6-1C). This age-dependent increase in DDF was also 
suppressed by DR, in agreement with data published earlier (Wang et al., 2010). 
Interestingly, there was also an age-dependent increase in the number of co-
localization events between p62 and H2A.X foci (Figure 6-2D). Next, I wanted to 
ascertain whether recruitment of p62 to DDF was common to different tissue types. 
Here, intestinal tissues from AhCre; APC f/wt mice were stained with antibodies 
against p62 and DNA damage marker H2A.X. p62 and H2A.X foci were then 
analysed using microscopy. Images shown in Figure 6-1D indicate that p62 is 
recruited to DDF in enterocytes in a fashion similar to that seen previously in 
hepatocytes in vivo (Figure 6-1C) and fibroblast in vitro (Figure 5-2D). These data 
indicate that p62 is dynamically recruited to DDF. Furthermore, clearance of nuclear 
p62 foci following DR correlates with the reduction of DDF suggesting a role of p62 
in mediating the effect of autophagy on DNA repair in vivo.  
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Figure 6-2: The interaction of p62 with DDF in mouse hepatocytes increases 
with age and is decreased by DR. (A) Representative images of hepatocytes from 
young (3 months old) and old (24 months old) male C57BL/6 wild-type mice 
maintained on ad libitum (AL) diet. Sections were immunostained with antibodies 
against p62 and H2A.X. The mean number of p62 (B), H2A.X (C) and p62-H2A.X 
colocalisation (D) foci were quantified in hepatocyte sections from mice maintained 
on AL or dietary-restricted (DR) diets. (E) Representative images of enterocytes from 
male C57BL/6 wild type mice. Sections were immunostained with antibodies against 
p62 and H2A.X. Arrowheads in the zoomed merged image  indicate points of co-
localisation. Scale bar 10 µm.  Scale bars 10 µm; n=3; Error bars represent S.E.M. 
Done in collaboration with Dr Diana Jurk and Mikloaj Ogrodnik. 
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6.3 Discussion 
Data presented in this chapter show an age-dependent increase in the 
formation of nuclear p62 puncta. The presence of p62 nuclear aggregates has 
previously been observed in several proteinopathies (Nagaoka et al., 2004, Kuusisto 
et al., 2003, Pikkarainen et al., 2008). Although these are age-related pathologies, 
nuclear p62 inclusions have not yet been studied in the context of ageing. This age 
dependent increase was reduced in mice undergoing dietary restriction. It is tempting 
to speculate that this age-dependent increase in p62 occurs due to an age-
dependent decrease in autophagy as previously observed (Terman, 1995, Vittorini et 
al., 1999). Dietary restriction is an intervention that is well known to activate 
autophagy. In fact is has been shown that autophagy activity is required for the 
ability of DR to extend life span (Jia and Levine, 2007, Rubinsztein et al., 2011). It 
could also be postulated that the reduction in nuclear p62 foci seen in DR mice is a 
result of activated autophagy. Similarly, dietary restriction has been shown to result 
in the upregulation of components of the 20S and 19S proteasome (Lee et al., 1999). 
As p62 has been shown to be a substrate for proteasomal degradation, an increase 
in this pathway could also result in reduced levels of p62 (Lee et al., 2012b, 
Seibenhener et al., 2004). These hypotheses would of course need to be tested 
experimentally. Alternatively, nuclear levels of p62 could be altered by changes in 
the rate of nuclear import and export. It was shown by Pankiv et al. that 
phosphorylation of p62 at serine-266, threonine-269 and serine-272 residues 
regulates the nuclear-cytoplasmic shuttling of p62 (Pankiv et al., 2010). It would be 
interesting to test the phosphorylation status of p62 in the context of ageing as well 
as with DR to assess whether this was responsible for the age-dependent changes 
in nuclear p62 observed here. Our previous data suggest an increase in the number 
of nuclear p62 foci in response to DNA damage. Data presented in this chapter and 
in previous studies have shown an age-dependent increase in DNA damage foci 
(Wang et al., 2010). It is therefore possible that p62 is shuttled to the nucleus in 
response to increased levels of DNA damage seen with age. Similarly, data shown 
here indicate that DR leads to a reduced level of DNA damage and so the reduction 
in p62 foci could be a result of decreased DNA damage (Wang et al., 2010). Further 
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work is needed to understand the mechanisms driving this age-dependent increase 
of nuclear p62.  
Interestingly, we show that p62 and DNA damage foci co-localise in 
hepatocytes from aged animals. This co-localisation is reduced in animals under DR. 
Moreover levels of nuclear p62 and p62-DDF co-localisation correlate with an 
increase in the number of DDF. These data suggest that p62 may be playing a role 
in DNA damage in vivo. As discussed previously, the co-localisation between DDF 
and p62 was observed in vitro. Further analysis identified an interaction between p62 
and RAD51 and FLNA. An attempt was made to assess the co-localisation of p62 
and RAD51 in vivo, however immunofluorescence staining for RAD51 was 
unsuccessful in tissue. Further work is required to understand the exact role of the 
interaction between p62 and DDF in the context of ageing. A tempting hypothesis is 
that increased levels of nuclear p62 occur with age as a result of declining protein 
homeostasis. Increased p62 then has an inhibitory effect in DNA damage repair via 
homologous recombination through its proteasomal depredation of RAD51 and 
FLNA. The resulting increase in DNA damage may then contribute to a progression 
of the ageing phenotype through activation of cellular senescence. This could be one 
mechanism by which interventions that activate autophagy such as rapamycin 
treatment and dietary restriction influence DNA damage accumulation and longevity. 
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7. Conclusions 
 
The accumulation of misfolded and damaged proteins is a hallmark of ageing and 
age-related diseases. This has been attributed to both an increase in the formation 
of damaged proteins due to ROS and errors in translation, as well as a gradual age-
related decline in cellular proteolytic pathways. Autophagy has long been in the 
spotlight as a modulator of longevity; however the exact mechanisms by which this is 
mediated are not yet fully understood. Similarly, the accumulation of DNA damage 
has been suggested as a causal factor in organismal ageing. Again, an increase in 
the rate of generation of DNA damage as well as a decline in the ability a cell to 
resolve this damage have been observed in ageing. Data in this thesis identify a 
novel link between autophagy and DNA repair via HR through its control of 
intracellular levels of p62. This observation provides a potential link between the 
gradual decline in autophagy and DNA repair capacity that occurs with age. This 
interaction could have far reaching influence on a number of age-associated 
phenotypes and pathologies.  
Interestingly, the Gorbunova lab has observed a decline in functional HR in 
human fibroblast with progressive population doublings and the initiation of cellular 
senescence. This was accompanied by a decline in proteins from the HR pathway 
such as RAD51, RAD51L and RAD52. This decline could be halted by the 
expression of SIRT6 (Mao et al., 2012b). Interestingly expression of SIRT6 has been 
shown to be a potent activator of autophagy. Moreover, it has been observed that 
autophagy is required for the anti-senescence effects of SIRT6 overexpression 
(Takasaka et al., 2014). It is therefore possible that this decline in HR occurs via p62 
mediated degradation of RAD51 as observed in this thesis. Thus, activation of 
autophagy would lead to reduced levels of p62 inhibiting the proteasome-mediated 
degradation of RAD51 and resulting in reinstated levels of RAD51 and HR activity. It 
would be interesting to assess the effect of both p62 knockdown and activation of 
autophagy, via a SIRT6 independent mechanism, on HR in this context to test the 
relevance of this newly discovered mechanism in this system. 
The accumulation of p62-positive nuclear inclusions is common in a number of 
proteinopathies (Nagaoka et al., 2004, Kuusisto et al., 2003, Pikkarainen et al., 
2008). This role for p62 as an inhibitor of HR could provide another mechanism by 
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which these pathologies lead to cell death and disease progression. Investigation of 
the relative efficacy of DNA damage repair pathways in the context of 
proteinopathies could provide further mechanistic insight into these pathologies.   
Interestingly, mutations in the UBA domain of p62 are a common feature of familial 
and sporadic ALS (Teyssou et al., 2013) as well as Paget’s disease (Laurin et al., 
2002, Hocking et al., 2002). Here we identify the UBA domain of p62 as a functional 
domain required for its effect on DNA damage. It would therefore be interesting to 
test the relevance of these observations in the context of these diseases.   
Lastly, although not the focus of this thesis, both DNA damage and autophagy 
have been shown to play central roles in cancer development. Indeed, the role of 
both of these processes in cancer is multifactorial and highly context-dependent. 
Autophagy has been suggested as a tumour survivor mechanism when tumour cells 
undergo metabolic and therapeutic stresses (Degenhardt et al., 2006)  However 
many studies have suggested a role for autophagy in tumour suppression (Mathew 
et al., 2007b, Mathew et al., 2009). Genomic instability is a hallmark of cancer and 
results from the combined effect of DNA damage, tumour specific DNA repair 
defects as well as impaired cell cycle checkpoints. Although a central part of cancer 
progression, genetic instability has also provided many therapeutic opportunities in 
cancer treatment. The identification of novel mechanisms of crosstalk between 
autophagy and DNA damage repair will aid our understanding of these complex 
processes and present further therapeutic opportunities. The ability of autophagy to 
influence HR-mediated repair, could offer some way to explain its apparent duel role 
in cancer progression. An increase in HR activity could mediate cell survival in 
tumour cells with increased autophagy in response to therapeutic stress. Conversely, 
an activation of this process prior to transformation could infer a reduced 
accumulation of DNA damage serving as a tumour suppressor mechanism.  It is 
important to note that genome instability has not been assessed in this context. It is 
possible that a reduction in p62-mediated RAD51 degradation could lead to hyper-
recombination and increased genome instability. Nonetheless, both of these 
possibilities would be relevant in the context of cancer progression.  
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Schematic representation of proposed mechanism: (A) In response to DNA 
damage p62 interacts with FLNA within the nucleus, targeting it for degradation via 
the proteasome. Reduced levels of FLNA lead to a reduced recruitment of RAD51 to 
the site of damage. We propose this results in a reduced activity of the HR repair 
pathway. (B) Cellular levels of p62 are modulated by autophagy; therefore inhibition 
of autophagy leads to increased levels of p62. We suggest that this mechanisms 
links autophagy status as a modulator of HR-mediated DNA repair. 
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